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Abstract 
Understanding the evolution of virulence appeals to both academics and clinicians alike. For the 
former, it is of interest to fathom the wide range of virulence phenotypes seen in natural populations, 
and for the latter, understanding the selective factors that maintain these different virulence schedules 
offers hope of manipulating them for the benefit of human health. This thesis focuses on the 
determinants of virulence in single and mixed-clone malaria infections, and the consequent impact of 
these infections for host- and parasite-fitness. Controlled experiments were conducted using a rodent 
model of malarial disease, Plasmodium chabaudi. Mice were infected with precise numbers of 
virulent and avirulent parasites. In the mixtures, known ratios of two clones that differed in virulence 
were used. Virulence was quantified in terms of host morbidity and mortality. 
Experiments investigating how virulence is determined in mixtures revealed that both the 
proportion of virulent clone in the inocula, and the genetic diversity of the infection determine 
virulence. Replacing virulent parasites with avirulent ones in a mixture was shown to confer 
protection for the host. These results challenge the various assumptions made in the models of the 
evolution of virulence about how virulence is determined in mixtures. They also suggest that selection 
against virulence can be reduced if virulent clones coinfect with avirulent ones, because host mortality 
is reduced in mixtures when the avirulent clone dominates. 
In single infections, the inoculating dose of virulent and avirulent parasites affected the 
virulence of the infection. Larger doses caused greater anaemia. They also caused additional weight 
loss, and death, but only for the virulent clone. Clone differences in virulence were maintained over 
the range of doses. Dose effects were manifested through the timing and/or magnitude of peak parasite 
densities, broadly supporting the idea that disease severity is due to the time the host has to control 
parasite densities and ameliorate the effects of parasites. To investigate the correlates of mortality, 
multivariate analyses were conducted. These generally showed that both the initial weight and red 
blood cell density of mice, and the rate at which they lost red blood cells and weight affected their 
probability of survival. The initial red blood cell density of mice, and the change in their weight over 
the first two days that parasites were detectable were good indicators of the outcome of infection. If 
robust, these measures could be valuable in defining the endpoint of infections. 
By definition, the virulence of the infection negatively affects host fitness, but what impact 
does it have on parasite fitness? The assumption that within-host reproduction is linked to between-
host transmission was partially supported: more gametocytes (the malaria parasite's only transmission 
stage) were produced from infections with higher asexual parasite densities, but only for the avirulent 
clone. Furthermore, gametocyte production was higher in mice that died, suggesting that death might 
not act to reduce selection against virulence in the ways previously thought. 
The results from this thesis suggest that the determinants of virulence are more complex than the 
evolution of virulence models assume, and also question how generalisable the patterns of virulence 
and transmission are between clones. 
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Chapter 1. 	Introduction 
1.1. 	Host-parasite interactions 
By definition, parasites reduce host fitness (Begon et al., 1996). The costs of 
parasitism may be direct, due to parasites extracting resources from their hosts to 
divert towards their own life history traits. In addition, there may be indirect costs 
associated with the physical presence of the parasite, the chemicals and by-products 
parasites excrete, or the immune system's response to the parasite. 
A variety of different costs of parasitism have been documented. There are 
many examples of parasites reducing either the survival or longevity of their hosts. 
For example, survival and longevity of the grasshopper, Melanoplus san guinipes, 
were reduced by a parasitoid (Danyk et al., 2000), the survival of the crustacean 
Daphnia magna was reduced by microparasites (Ebert et al., 2000a), trematode 
infections reduced the survival of common gobys (Pampoulie et al., 1999) and 
amphipods (Jensen et al., 1998), and the survival of nematode-infected sea urchins 
was reduced by up to 86% (Stien, 1999). Such reductions in longevity may be due to 
damage caused by parasites, but in other cases, they may represent the host changing 
its life history in an adaptive fashion to reduce the costs of parasitism (e.g. Agnew et 
al., 1999). 
Similarly, parasites have been shown to reduce host fecundity. For example, 
the grass, Danthonia spicata, is castrated by its fungal parasite (Kover, .2000), 
Daphnia by a bacteria parasite (Carius et al., 2001) and a variety of insects by their 
parasitoids (Godfray, 1994). Wolbachia reduces the fecundity of its parasitoid host 
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(Fleury et al., 2000), as well as the egg hatching rate of Tribolium beetles (Fialho & 
Stevens, 2000), nematodes reduced the fecundity of grouse (Hudson et al., 1998), 
and trematodes that of snails (Sorensen & Minchella, 1998). The implications of 
these survival and fecundity costs for host fitness are clear. 
However, parasites can also exact more subtle costs: protozoan parasites 
reduce the rate of cell regeneration in lizards, increasing the time it takes to regrow 
their tails (Oppliger & Clobert, 1997), and feather damage by lice increases thermal 
conductance causing metabolic rates to be upregulated (Booth etal., 1993). Finally, 
even when hosts successfully avoid parasitic attack, generating an immune response 
to achieve this can also be costly (Demas etal., 1997; Lochmiller & Deerenberg, 
2000; Moret & Schmid-Hempel, 2000). 
Thus, a host is critical for a parasite's fitness, and parasites can have 
important effects on host fitness. Over evolutionary time, this interaction will lead to 
what has been coined a coevolutionary arms race (Dawkins & Krebs, 1979): 
parasites are evolving to evade host immune responses, whilst hosts become better at 
preventing parasitic attack. Host-parasite coevolution has implications for several 
fields in biology, including medicine. One recent advance in this area has been the 
application of evolutionary theory, giving rise to what has been called "Darwinian 
medicine" (Williams & Nesse, 1991). This seeks to classify disease symptoms into 
adaptive and pathological brackets in order to direct treatments at what are parasitic 
side-effects, and steer intervention away from beneficial host responses. Thus, 
evolutionary thinking has the potential to provide insight in a disease context, and 
has advanced our understanding (or at least focussed attention on the relevant 
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questions to ask) of established areas of medical research such as senescence 
(Kirkwood et al., 1999), and vaccine design (McLean, 1999). 
1.2. 	The evolution of virulence 
One field that has received considerable attention from evolutionary biologists is the 
evolution of virulence (reviewed by Bull, 1994; Read, 1994; Frank, 1996; Ebert, 
1999). The term virulence has been used to mean different things in different 
disciplines (Read et al., 1999). However, in this thesis, I define it as "the harm 
suffered by hosts following parasitic infection", and quantify "harm" in terms of 
morbidity and mortality. 
The principle reason that the evolution of virulence is of interest is because of 
the extensive range of parasite life history strategies seen in natural populations, and 
the corresponding levels of virulence that these generate. Why is it that some 
parasites are benign, whilst others are rapacious? For example, most people maintain 
their daily routine in the face of the common cold, retreat to their beds if influenza 
parasites infect them, and require undertakers if they are unfortunate enough to 
contract Ebola disease. However, this diversity is not limited to parasites of different 
species, even within a species, parasites exhibit a wide range of virulence 
phenotypes. For example, the pathology that Plasmodiumfalciparum parasites cause 
can vary from symptoms similar to the common cold to death (Marsh, 1992). Why 
do parasites vary so greatly in their virulence schedules? 
A second motivation for understanding the evolution of virulence is because 
of the practical implications it may have for disease control (Ewald, 1983). For 
Chapter 1 Introduction 	 3 
example, the impact of intervention strategies designed to reduce virulence can only 
be ascertained once we have some idea about the selective pressures that have shaped 
current levels of virulence. 
13. 	Explanations for the evolution of virulence 
Evolutionary biologists have offered several different types of explanation for how 
virulence has evolved (Bull, 1994; Read, 1994; Frank, 1996; Ebert, 1999). Many (but 
not all) of the models are parasite-centred, ignoring the host. These fall broadly into 
the following framework: 
1.3.1. Virulence is coincidental 
The first class of explanation is that current levels of virulence are not adaptive, but 
rather, arise because of novel host-parasite interactions (Levin & Svanborg-Eden, 
1990). In this case, parasites have not been exposed to selection in their novel hosts, 
and can often be excessively virulent. For example, this has been proposed for Ebola 
virus and Toxocara canis, both of which have not evolved in association with 
humans, and can kill and blind humans respectively (Ebert, 1999). If it is true that 
virulence is coincidental, then the current diversity of virulence schedules is 
transitory, and given time, will be eroded by natural selection. Virulence in the novel 
host-parasite interaction will then reach an optimum (normally assumed to be low). 
Indeed, this is what was seen with the myxoma virus, introduced into Australia to 
control expanding European rabbit populations. Initially it was extremely virulent, 
but within a decade, mortality had dramatically decreased (Penner & Radcliffe, 
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1965). However, whilst it is true that some host-parasite combinations are relatively 
recent (for example, both BSE and HIV appear to be recent zoonotics), this seems 
unlikely to be a general explanation. 
1.3.2. Virulence is adaptive 
The second class of explanations invokes parasite adaptation. Virulence is either 
thought to be directly beneficial to the parasite, correlated with a fitness-enhancing 
trait, or a consequence of within-host evolution (so called short-sighted evolution). 
Virulence is directly beneficial 
In these models, virulence per se enhances parasite transmission. For example, it has 
been suggested that sneezing could be a viral parasite manipulation of their host's 
physiology in order to transmit themselves (Williams & Nesse, 1991). Similarly, 
malaria parasites that debilitate their hosts so that they are less likely to resist 
mosquito attack may increase the probability of reaching their vector (Ewald, 1983). 
Finally, parasite induced host castration could be explained as an adaptation because 
longevity of the host (and hence the infection duration) can increase at the expense of 
reproduction. 
Virulence is a correlated trait 
This popular group of models assume that virulence itself is an unavoidable 
consequence of within-host replication, which is favoured by natural selection 
(Bremermann, 1980; Levin & Pimentel, 1981; Anderson & May, 1982; Bremermann 
& Pickering, 1983; Antia et al., 1994). In this scenario, parasites are under selection 
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to produce as many transmission stages as possible, but to achieve this they may 
have to expand to large population sizes, or extract more resources from their hosts. 
The damage that the host suffers is a consequence of this. However, replication rate 
cannot increase indefinitely because, above a certain threshold, it will kill the host 
and so reduce the parasite's own transmission (Figure 1.1). This trade-off between 
prudent exploitation (longevity) and rapid reproduction (fecundity) (Frank, 1996) is 
what parasites have to resolve to maximise their own fitness. The key assumption 
that within-host replication is correlated with between-host transmission has been 
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The relationship between parasite virulence and fitness as assumed by the adaptive trade-off models of 
the evolution of virulence. 
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iii) Virulence is a consequence of short-sighted evolution 
In the previous models, selection is assumed to have generated virulence schedules 
that maximise the net output of parasites from a host. Such group selection 
arguments may apply in situations where infections are initiated by a single strain of 
parasite. However, natural parasite infections will often contain parasites from more 
than one lineage, and this can lead to competition between strains. This is the basis of 
a class of models that assume virulence evolves as a consequence of competition 
between strains within an individual (Levin & Bull, 1994). 
The single infection models described above can be extended to within-host 
competition. What happens to virulence when genetically distinct, conspecific 
parasites infect the same host? One general finding is that the optimal parasite 
virulence schedule differs for single-genotype and mixedgenotype infections. It is 
expected that "prudent" parasites which slowly exploit host resources will be 
outcompeted by "ruthless" ones, resulting in higher optimal levels of virulence in 
mixtures (e.g. Axelrod & Hamilton, 1981; Levin & Pimentel, 1981; Bremermann & 
Pickering, 1983; Knolle, 1989; Sasaki & Iwasa, 1991; Frank, 1992; Bonhoeffer & 
Nowak, 1994; Nowak & May, 1994; Sasaki, 1994; May & Nowak, 1995; van Baalen 
& Sabelis, 1995; Mosquera & Adler, 1998; but see Chao, 2000 for the opposite 
prediction). Indeed, mixed malaria infections are more virulent than their single 
counterparts (Taylor et al., 1998). This might lead to situations where parasite 
transmission is lower than it would have been in a single-genotype infection - so-
called short-sighted evolution (Levin & Bull, 1994). Given the importance of the 
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genetic diversity of the infection for virulence evolution, it is obviously of interest to 
know how diverse natural infections are. 
1.4. 	Genetic diversity of malaria infections 
Malaria parasites generally share their hosts with other malaria parasites. Ritchie 
(1988) reported that up to 50% of world-wide malaria infections are made up of 
more than one species of Plasmodium. Between 30 and 83% of P. falciparum 
infections from around the world were found to consist of more than one genotype 
(Day et al., 1992), and up to 52% of patients reporting for treatment in the Gambia 
had mixed-clone infections (Conway et al., 1991). Even within an infection, clonal 
diversity can be high: seven distinct parasite types were found in one patient 
(Thaithong et al., 1984). 
There is growing evidence that individual parasite strains differ in virulence. 
Chotivanich et al. (2000) found that the multiplication rates and invasiveness of P. 
falciparum taken from patients with severe malaria were higher than those taken 
from patients with uncomplicated malaria. Similarly, other parasite traits such as 
cytoadherence and rosetting are associated with host mortality (Carlson et al., 1990; 
Rowe et al., 1995). In the laboratory, virulence traits were assessed for a suite of 8 
strains of P. chabaudi and found to differ (Mackinnon & Read, 1999a). The impact 
of mixed-infections made up of clones with different virulence schedules on 
aggregate virulence is one of the areas of investigation in this thesis. 
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1.5. 	The Plasmodium chabaudi model of malarial disease 
Throughout this thesis, the experiments I describe were performed using a rodent 
model of malaria, Plasmodium chabaudi, which infects laboratory mice. As well as 
being a specific malaria model, it is also a generic host-microparasite model system 
that has been used to investigate a variety of questions associated with the evolution 
of virulence. However, the validity of extrapolating from a rodent malaria model to 
human malaria has been questioned (Cox, 1988), so are there superior alternatives? 
There is a wealth of published data making use of natural infections in 
humans (e.g. Babiker et al., 1994; Roper et al., 1996; Babiker & Walliker, 1997; 
Babiker et al., 1998; Cavanagh et al., 1998; Aidoo & Udhayakumar, 2000; Babiker 
et al., 2000). But these studies are unavoidably hampered by a multitude of 
confounding variables, and patients have to be treated as soon as they are parasite 
positive. Also, since humans cannot be deliberately infected with life-threatening 
disease, they are restricted to be of a correlational nature. For the conduction of 
controlled experiments, primate malarias probably provide the best model for human 
disease (Butcher, 1996). However, ethical considerations demand that experiments 
involving primates should be few, and only be carried out to address pivotal 
questions with direct benefits to humans when information from other model systems 
would be uninformative (for example, the later stages of vaccine trials). Experiments 
involving primates are also extremely expensive to conduct. Given the wealth of 
questions that remain unanswered, a more amenable system is required, and to fill 
this space we have rodent models. These are the best available option if we wish to 
study malaria in the context of a natural mammalian immune response and also 
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control for other confounding factors (Mons & Sinden, 1990). However, there are 
reasons to believe that rodent systems deserve a better reputation than simply being 
second best, and can make excellent models. 
P. chabaudi infections have several features in common with the most 
virulent human malaria parasite, P. falciparum. These include synchronous 
schizogony, capillary sequestration, a preference for mature red blood cells (RBCs), 
and the occurrence of peak gametocyte production late in the infection, (Walliker, 
1983; Carter & Graves, 1988; Mons & Sinden, 1990). Strain-specific immunity and 
antigenic variation, which are evident in P. falciparum infections, have also been 
demonstrated for P. chabaudi (Jarra & Brown, 1985; Jarra et al., 1986; Jarra & 
Brown, 1989; McLean et al., 1990). 
The parasites used were originally isolated from their natural host - the 
thicket rat, Thamnomys rutilans. Isolates were collected in the Central African 
Republic in 1969 and 1970 and then stored in liquid nitrogen until they were recently 
cloned out (Mackinnon & Read, 1999a). To obtain parasite lineages derived from a 
single asexual parasite (hereafter called a clone), each isolate was taken from a 
different host and injected into groups of mice (14-30 mice per group) with an 
inoculum expected to contain an average of one parasite (Beale et al., 1978). 
Assuming a Poisson distribution for the number of parasites infecting the mice, it 
was highly probable that infections were initiated with a single parasite. 
The four clones used in the experiments reported here differed in virulence, 
as measured by both weight- and RBC loss (Mackinnon & Read, 1999a). Using a 
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relative scale of virulence, AS and CW were equally avirulent, and AT and BC were 
equally virulent. 
It has been suggested that the patterns of natural infection in thicket rats are 
different from artificially-induced infections in the mouse (Landau & Chabaud, 
1994). Infections in thicket rats are generally chronic and produce low parasite 
densities, whereas in the mouse, infections tend to be short-lived, and produce high 
parasite densities which can result in host death in certain mouse genotypes 
(Stevenson et al., 1982). However, two lines of evidence suggest that these apparent 
discrepancies could well be the result of sampling bias. Firstly, following the primary 
asexual parasite peak, P. chabaudi infections generate additional smaller peaks 
(recrudescences) that have been detectable for as long as they have been looked for 
(up to 3 months: Read and Anwar unpublished data), suggesting that infections are 
not as short-lived as previously thought. Secondly, primary infections of P. chabaudi 
in laboratory bred colonies of thicket rats show similar dynamics to those in mice 
(Carter & Diggs, 1977), suggesting that the short-time window available to view 
these is responsible for the failure to observe this in the wild. 
1.6. 	Plasmodium chabaudi life-cycle 
A general Plasmodium life-cycle is shown in Figure 1.2. The life cycle of P. 
chabaudi is split between its rodent host and the mosquito. Sporozoites from the 
mosquito's salivary gland are injected into the mammalian host when they take a 
blood meal, and these migrate to the liver where they undergo a single round of 
























The life-cycle of Plasmodium parasites. In this schematic, the mammalian host is human, but in P. 
chanbaudi, the host is a rodent. 
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asexual reproduction within hepatocytes. On release, the haploid parasites return to 
the bloodstream and infect the host RBCs. Now begins a 24-hour cycle of 
reproduction. These asexual parasites are responsible for the pathology of the 
infection. 
A small proportion of these asexual parasites become committed to producing 
gametocytes (the only stage capable of transmission to the mosquito vector), thus 
forfeiting any further reproductive potential within the mammalian host. When 
gametocytes are taken up by a feeding female mosquito, the gametocytes rapidly 
mature into male and female gametes and fertilisation occurs within 20 minutes to 
form a motile diploid zygote (ookinete). This penetrates the midgut wall and 
develops into an oocyst, within which meiosis and recombination occurs (Walliker et 
al., 1987). After approximately 12 days, haploid sporozoites emerge and migrate to 
the mosquito's salivary glands where they mature in readiness to complete the life 
cycle when they are injected into another host. 
The whole life cycle of P. chabaudi can be reliably reproduced in the 
laboratory. Mice can be infected with an exact dose of parasites made up of either a 
single clone, or a mixture containing a specific ratio of clones. Laboratory-reared 
Anopheles stephensi mosquitos can be infected by allowing them to feed on 
gametocyte positive mice, and their consequent parasite burden quantified by 
counting the oocysts on their dissected midguts (Taylor et al., 1997b). Where they 
have fed on a mixed-clone infection, the relative transmission success of the 
individual clones can be assessed by PCR of individual oocysts (Taylor et al., 
Chapter 1 Introduction 	 13 
1997a). Finally, sporozoite-induced mouse infections can be generated when infected 
mosquitos feed on naïve mice. 
1.7. 	Experimental aims 
The aims of the work described in this thesis were to address the following three 
questions: 
How is virulence determined in mixtures composed of clones with different 
virulence schedules (Chapters 3 & 4)? 
How do parasites cause disease (Chapters 2 & 5)? 
How does the virulence of the infection impact on parasite fitness (Chapter 6)? 
These questions were tackled with a series of controlled mixed- and single-clone 
infections initiated with known densities of parasites. Virulence measures and 
parasite densities were monitored through time, allowing several theoretical 
assumptions to be tested. These experiments also generated results that might be 
relevant for falciparum malaria. The following §pecific questions were addressed 
within each chapter: 
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Chapter 2: Do infections initiated with greater parasite densities cause more severe 
disease? (Will intervention strategies that aim to reduce parasite burdens effectively 
reduce virulence?). Are clone differences in virulence robust to variation in dose? 
Chapter 3: How do coinfecting parasites with different virulence schedules determine 
aggregate (infection-wide) virulence? (Is the ubiquitous theoretical assumption that 
the most virulent clone determines virulence, for example, justified?) 
Chapter 4: Can the presence of an avirulent clone protect the host against damage 
from a coinfecting virulent clone? (Can avirulent clones reduce selection against 
virulence, and could a potential reduction in parasite genetic diversity in the field 
have detrimental effects on virulence?) 
Chapter 5: Can morbidity measures account for host death (is there a link between 
morbidity and mortality?), and can death be predicted from early measures of 
virulence (can animal welfare be improved?)? 
Chapter 6: How does the virulence of the infection impact on parasite fitness? (Do 
parasites transmit more from virulent infections?) 
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Chapter 2. 	The effect of parasite dose on disease 
severity in Plasmodium chabaudi infections 
Published as Timms, R., N. Colegrave, B. H. K. Chan, and A. F. Read. 2001. The effect of parasite 
dose on disease severity in the rodent malaria Plasmodium chabaudi. Parasitology. 123:1-11 
2.1. 	Introduction 
The clinical outcome of malaria infection in humans is highly variable. Some people 
harbour malaria parasites and show no symptoms, while others die rapidly. Many 
factors may influence this outcome, and one candidate is the inoculating dose of 
parasites (Greenwood etal., 1991; Marsh, 1992). Dose might affect disease severity 
by altering the time available for hosts to mount a defensive response before parasite 
loads cause clinical disease (Marsh, 1992). Alternatively lower doses could cause 
less severe disease by giving the host more time to ameliorate the effects of parasites, 
rather than just control their densities. For example, the host can, to some extent, 
offset RBC destruction by increasing erythropoiesis. 
The prevailing view that dose and severity are positively related has been 
largely encouraged by indirect evidence (Snow et al., 1988; Alonso et al., 1991; 
Bermejo & Veeken, 1992), which may have other interpretations (Glynn et al., 
1994). Direct data on the impact of infecting dose on severity of malarial disease in 
humans are ambiguous. Glynn (1994) has systematically reviewed the medical 
literature on artificially-induced malaria infections, including malaria therapy 
administered to neurosyphilis patients. No strong, consistent relationships were 
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found: a few studies suggested a positive relationship between dose and severity 
(variably measured as duration of illness, experience of chills, type and number of 
fevers, relapse rates, or whether the patient made a spontaneous recovery), but many 
found no effect (Glynn & Bradley, 1995a, b; Glynn et al., 1995). There are also 
problems with estimating dose in many of these studies which make it difficult to 
draw unequivocal conclusions (Glynn, 1994). For instance, in mosquito-induced 
infections, dose is often equated with bite rate, which is true only if all mosquitoes 
are infected and transmit the same dose of sporozoites. 
Experiments have also been performed in birds, monkeys and rodents (see 
references in Glynn, 1994), but most concentrate on how dose affects the time course 
of infection (of prepatent period or death usually). The only studies of which I am 
aware that report relevant data do not explicitly test for a dose-severity relationship, 
or involve confounding factors (Coggeshall, 1937; Hewitt, 1942; Hewitt et al., 1942; 
Ferraroni, 1983). 
Here, I report the results of a controlled experiment designed to look at the 
relationship between dose and disease severity using two clones of Plasmodium 
chabaudi chabaudi known to differ in virulence. I ask (i) whether there are dose-
severity relationships, (ii) whether clone differences in virulence are maintained over 
a range of doses, and (iii) whether the severity of disease can be accounted for in 
terms of the time hosts have to develop responses capable of controlling infection. 
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2.2. 	Materials and Methods 
2.2.1. Parasitology 
Two cloned lines of the rodent malaria parasite, P. c. chabau di, were used to infect 
7-week-old female C57 bl6J mice (Harlan, England and B&K Universal, England). 
The two clones, CW and BC, were obtained from different isolates collected in the 
Central African Republic in 1969 and 1970 from their natural hosts (Thamnomys 
rutilans) and were stored in liquid nitrogen until cloning (Mackinnon & Read, 
1999a). BC infections peak at higher parasite densities and induce greater weight loss 
and anaemia than CW infections (Mackinnon & Read, 1999a). 
Mice were fed on 41B maintenance diet (Harlan, England). Drinking water 
was supplemented with 0.05% para-amino benzoic acid to enhance parasite growth 
(Jacobs, 1964). Artificial light was provided from 0530 until 1730 hours. 
Parasite densities were estimated from the proportion of RBCs infected 
(calculated from a Giemsa' s-stained thin blood smear) and the number of RBCs per 
ml of blood (counted using flow cytometry: Coulter Electronics). Blood sampling 
and measurements of body weight (to the nearest 0.01g) were carried out daily 
between 1500 and 1900 hours. 
2.2.2. Experimental design 
Mice were weighed and allocated at random to treatment groups. Within each 
treatment group, groups of 5 mice were infected with 1x10 2, 1x103, 1x104, 1x106 , 
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lx io, or lx 108  parasitised RBCs of either clone CW or clone BC. The whole 
experiment was replicated in a second block that also contained an additional dose 
treatment of lx i05 parasitised RBCs for each clone. Thus, with one uninfected 
control group in each block, there were 13 groups in the first block (a total of 65 
animals) and 15 groups in the second block (a total of 75 animals). In the second 
block, one animal from the CW lx 106  treatment unexpectedly died on the day after 
infection, and two animals, one from each of the CW ix 102  and IX103  treatments, 
failed to develop patent parasitaemias. Data from these three mice were excluded 
from the analyses. 
To administer an exact dose of parasites in a fixed volume of liquid, the 
appropriate volume of infected blood from the donor mice was diluted in a solution 
of calf serum-Ringers (50% heat-inactivated calf serum; 45% Ringers solution 
[27mM KCL, 27mM CaCl2, and 0.15M NaC1]; 5% heparin [20units/ml Ringers]). 
Each infection was initiated with an intra-peritoneal injection of 0. imI of this 
solution. Control mice received the same volume of uninfected calf serum-Ringers. 
Disease severity was measured in terms of mortality and morbidity. From 
surviving mice, acute and chronic morbidity measures were estimated: minimum 
weight and RBC density, and average weight and RBC density (from day -4 to 35 
p.i. for average weight and RBC in block 1 and, in block 2, from day —1 to 35 for 
average weight, and day 0 to 40 for average RBC). 
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2.2.3. Statistical analyses 
Mortality data were analysed using binary logistic regression. Only the data from 
surviving mice were included in the morbidity analyses, and these were analysed 
using general linear models (Crawley, 1993). Maximal models were fitted first and, 
beginning with higher order interactions, non-significant terms were sequentially 
removed in a process of backward elimination to generate minimal models. 
Fitted terms in the maximal models included dose (specified as a covariate), 
block and clone (factors), and all linear interactions between factors and covariates. 
In addition, pre-infection RBC density or body weight was fitted as a covariate to 
control for initial differences between mice. 
Minimal models frequently had weakly significant, biologically uninteresting 
higher-order interactions, usually involving block and/or clone. These interactions 
involved quantitative but not qualitative differences between blocks. To simplify the 
analysis, I report the results of separate models for each clone. All p-values reported 
for significant terms are from the appropriate minimal models and p-values for non-
significant terms are from the step at which they were removed. My comparison of 
clone differences in dose-severity relationships is based on the approximate 95% 
confidence intervals of the slopes (taken as twice their standard errors). 
In most cases there were significant differences between the two 
experimental blocks because both parasite clones were more virulent in the second 
block (possibly because they had been through two additional mice passages). In the 
current context, block main effects are of little interest in their own right, and so only 
significant interactions between block and other model terms are reported. 
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Infective dose was logarithmically transformed to reduce the levering effects 
of the highest dose treatment, and because this transformation linearised any 
relationships with virulence. In no cases did log io dose fitted as a quadratic or cubic 
term significantly improve model fit. Two of the three RBC densities (minimum 
RBC density and day-1 p.i. RBC density, but not average RBC density) were also log 
transformed to satisfy the assumptions of the statistical models. 
For each infection, the growth rate of the parasite population on day t was 
calculated by subtracting the log parasite density on day t from the log parasite 
density on day t+i (McCallum, 1999). Thus, the daily growth rate is the number of 
new infected RBC produced by a single parasite after 24 hours. The maximum 
parasite growth rate for all mice (including those that died) was used in the analyses 
and usually occurred on the first or second day that parasites were detected (parasite 
growth rates were not different in mice that died or survived). Similarly, data from 
all mice were used for analyses of maximum parasite density. Mice that died had 
higher maximum parasite densities (mean parasite density x10 9 ml-1 ± s.e: survivors 
= 1.5 ± 0.06, dead = 2.4 ± 0.09; F1 121 = 79, p<0.001), but excluding them from the 
relevant analyses would only serve to strengthen my conclusions. The total number 
of parasites produced in infections, obtained by summing the daily parasite densities 
from days 1 to 23 p.i. in the first block and 1 to 16 p.i. in the second, was calculated 
for surviving mice only. 
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2.3. 	Results 
2.3. 1. Mortality 
About half of the mice infected with parasites of clone BC subsequently died 
(37/70), whereas just one CW-infected mouse died. Among BC-infected mice, death 
occurred about a day earlier for every 10-fold increase in inoculating dose (Figure 
2.1a). Mortality rates also increased with inoculating dose (Figure 2.1b, X2=455, 
d.f.=1, p<0.05). However, dose only explains a small amount of the variation in the 
probability of death (around 7%), and this result is highly sensitive to the two 
extreme dose treatments (10 and 100 million parasites). When either of these were 
removed, dose no longer explained a significant amount of variation in death rates. 
2.3.2. Morbidity 
The infection kinetics, RBC dynamics and patterns of weight change in one 
experimental block are illustrated in Figure 2.2; the dynamics were qualitatively 
similar in the other block. BC infections grew faster (mean number of new infected 
RBCs produced by a single parasite ± s.e: BC=7.36 ± 1.05; CW=5.07 ± 1.06, F 1 , 
121=24.2, p<0.001), reached higher parasite densities (F 1 , 81=90.8, p<O.00l), and 
generated more parasites over the whole infection (F 1 , 81=26.4, p<0.001) than did 
infections with clone CW. BC also induced greater maximum weight loss and more 
anaemia (Figure 2.2). The same patterns were also found for average weights and 
RBC densities p.i. (data not shown). 
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Figure 2.1 
The effects of dose on (a) the timing of mortality and, (b) the mortality rate for BC-infected mice. In 
(a), points shown are the mean per treatment (± s.e.) and the line is the least-squares regression from 
the minimal model which contains log dose only. Slope ± s.e. = -1.14 ± 0.13, n=37 mice. In (b), points 
are the proportion of mice from the two blocks that died in each dose treatment (± s.e. calculated 
using the formula 	- p)) / n , where p = proportion that died), and the line is from logistic 
regression (see text for further details). 
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Figure 2.2 
Mean daily RBC densities (a & b), changes in weight (c & d) and parasite densities (e & 0 for mice 
infected with parasite clone CW (a, c, & e) or BC (b, d, & t) for each dose treatment in the second 
experimental block. Each line represents the mean of the mice in the dose treatment. Initially there 
were 5 mice per group, but subsequently numbers were reduced where mice died. For example, in (d) 
the 108 treatment contains only 1 mouse from day 7 onwards. Continues on next page. 
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Dose had a substantial impact on the time course of infections (Figures 2.2-
2.3). For both clones, maximum parasite densities, anaemias and weight losses 
occurred later in infections initiated with fewer parasites. Overall this delay was 
around one day for every ten-fold decrease in dose (Figure 2.3). 
Dose also had an effect on morbidity (Figure 2.4). For both clones, mice 
inoculated with more parasites were more anaemic (Figures 2.2a-b, 2.4a, Table 2.1). 
Once initial weight was controlled for, dose affected minimum weight, but only for 
the more virulent clone (BC). Here, mice lost about a third of a gram more for every 
10-fold increase in inoculum size (Figures 2.2d, 2.4b, Table 2.1). Within a dose 
treatment, mice lost a fixed amount of weight, irrespective of their initial weight (F 1 , 
83= 106, p<0.001, slope ± s.e. = 0.96 ± 0.09). The administered dose of CW had no 
effect on either the minimum weight or the average weight of mice, even allowing 
for initial mouse weight (Figures 2.2c, 2.4b, Table 2.1). 
Dose had an effect on parasite dynamics. The total number of parasites 
produced in infections was greater in high dose treatments for clone CW (Table 2. 1), 
and bigger inoculating doses led to greater peak parasite densities for both clones 
(Figures 2.2e, f, 2.4c, Table 2.1). Nevertheless, it is striking that variation in dose 
across six orders of magnitude generates peak densities that differed by substantially 
less than one order of magnitude. Parasite population growth rates early in the 
infections were unrelated to inoculating dose (Table 2.1). 
In summary, inoculating dose affected morbidity as measured by maximum 
anaemia and weight loss. But bigger doses also led to earlier and higher peak parasite 
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densities. In order to investigate whether dose affected morbidity independently of its 
effects on parasite dynamics, I incorporated peak parasite density and the timing of 
peak parasite density into models relating dose with anaemia or weight loss. 
Once peak parasite density, and the timing of it, had been controlled for, there 
was no independent effect of dose on morbidity. Similarly, there were no 
independent effects of parasite dynamics on morbidity when dose was controlled for, 
with one exception: peak parasite density independently affected minimum RBC 
density of CW-infected mice (F 1 55=29.6, p<0.001). However, peak parasite density 
and the timing of it are highly correlated, making it hard to disentangle their effects. 
Thus, dose affects morbidity only through its effects on the timing and/or magnitude 
of peak parasite density (or variables highly correlated to these). 
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Figure 2.3 
The effect of dose on the timing of (a) minimum RBC density, (b) minimum weight, and (c) 
maximum parasite density, for BC- (circle and solid line) and CW-infected (square and dashed line) 
mice. Lines are the least squares regressions from separate minimal models for each clone. Only data 
from surviving mice are included. In (a) the numbers in brackets represent the number of mice the 
means represent, and are the same for Figures. 3b, c and 4a, b. The least squares slopes (j s.e.) and p 
values for log dose from models controlling for block are: (a) BC: -0.99 ± 0.16, p<O.00l ; CW: —1.48 
± 0.083, p<0.001. (b) BC: -0.76 ± 0.17, p<O.00l; CW: —1.32 ± 0.16, p<O.00l. (c) BC: -0.99 ± 0.17, 
p<O.00l ; CW: —1.51 ± 0.074, p<0.001. 
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Figure 2.4 
The effect of dose on (a) minimum RBC density, (b) minimum weight, and (c) maximum parasite 
density, for BC- (circle and solid line) and CW-infected (square and dashed line) mice. Lines are the 
least squares regressions from separate minimal models for each clone, except for (b). Here, to 
produce the figure, maximum weight and block were included in the first model for BC and CW 
simultaneously (to correct for initial body size and block), and the residuals from this model were then 
run against log dose and clone. Thus, the fitted values come from the same model. Only data from 
surviving mice were included in the analyses for (a) and (b), and each point represents the mean (± 
s.e.) with sample sizes as shown in Figure 3(a). For (c), data from all mice (including those that died) 
were used - see methods for sample sizes. 
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Table 2.1 
The effects of inoculating dose on morbidity and parasite densities. Tabulated values are least squares 
slopes ( s.e.) from models controlling for block, and incorporating the relevant covariate (initial 
weight or RBC density) if present in the minimal model (shown as ,). 
I. 
	 cw 
Minimum RBC density 	 -0.039 ± 0.01 **, 	 -0.023 ± 0.006w 
[log (RBC x 109/ml)] 
Average RBC density 	 -0.13 ± 0.04** 	 -0.090± 0.02*** 
(RBC x 1091m1) 
Minimum weight (g) 	 -0.38 ± 0.09***, 	 -0.084 ± 0.07 ns+t 
Average weight (g) 	 -0.11 ± 0.06 ns, 
	
0.032± 0.05 ns,t 
Maximum parasite density 	 0.076 ± 0.02** 	 0.14 ± 0.03***t 
(parasites x 10 9/ml) 
Total number of parasites 	 0.18 ± 0.1 ns 	 0.70 ± 0.09***t 
(parasites x 10 9/ml) 
Initial parasite population growth 	-0.026 ± 0.03 nst 	 0.0026 ± 0.02 ns 
rates 
t = significant block x dose interaction, but the relationship between dose and the relevant variable is 
in the same direction in each block. * p<0.05, ** p<O.Ol, ***p<0.001,  ns = not significant. 
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2.4. 	Discussion 
Fatal infections were common for only one of the two clones used in these 
experiments (BC), but there, inoculating dose affected the probability of death 
(Figure 2.1b). Dose also had an impact on morbidity. Anaemia was greater among 
mice given larger infective doses of either clone (Figure 2.4a). Larger doses also led 
to greater weight loss, but only for infections with the more virulent clone (Figure 
2.4b). Dose also affected the timing of morbidity, with maximum anaemia and 
weight loss occurring earlier in infections initiated with larger doses (Figures 2.3a, 
b). Death, where it occurred, was also earlier in the higher dose treatments (Figure 
2.1a). Finally, inoculating dose affected parasite dynamics, with earlier and higher 
peak parasite densities in larger dose infections (Figures 2.3c, 2.4c). In so far as 
death, anaemia and weight loss are measures of disease severity, I have thus 
demonstrated positive dose-severity relationships. As far as I am aware, these are the 
first controlled experimental demonstrations of these relationships in mammalian 
Plasmodium. 
The two clones used in this study, CW and BC, were chosen because they 
were known to differ in virulence (Mackinnon & Read, 1999a). This difference was 
also evident in my experiments: BC was more often lethal (Figure 2. lb), and induced 
greater anaemia (Figure 2.4a) and weight loss (Figure 2.4b). The clone difference is, 
at least in part, because BC populations grow more rapidly (see results), and achieve 
higher parasite densities than do CW (Mackinnon & Read, 1999a). That earlier work 
(Mackinnon & Read, 1999a) involved infections initiated with iø, 10 5, and 106 
parasites in different experiments, with the onset of symptoms being earlier in the 
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experiments involving larger doses. The experiments I report here confirm that the 
dose effects on the timing of symptoms reported there were not due to uncontrolled 
confounding variables across experiments. They are also consistent with the 
widespread finding from several other studies that larger doses lead to earlier 
symptoms (for example, Hewitt et al., 1942; Cox, 1966; Glynn, 1994). 
For most of my measures of morbidity, timing of morbidity and parasite 
dynamics, the form of any relationship with dose is quantitatively similar for the two 
clones (comparing the slopes of relationships given in Figure 2.4 and Table 2.1 for 
the two clones). The relative virulence of the two clones is unaltered by dose and the 
more virulent clone is always more virulent. Thus, an avirulent clone cannot be 
transformed into a virulent clone by simply giving it a numerical boost early in the 
infection. Models of the evolution of virulence (for reviews see Ewald, 1983; Bull, 
1994; Levin & Bull, 1994; Read, 1994; Frank, 1996) assume that virulence 
phenotypes are at least partly determined by heritable genetic parasite variation on 
which selection can act. Substantially more complex models would be required if the 
relative virulence of strains is qualitatively altered at different doses, and/or if the 
severity of disease rose with dose and hence the force of infection. The broad picture 
which emerges from my experiments is that, at least to a first approximation, the 
implicit assumption that infective dose is irrelevant to evolutionary models of 
virulence is probably justified. The effects of dose on transmissibility are described 
in Chapter 5. 
It has been postulated that dose may affect the severity of disease by altering 
the time the host has to control parasite density before it reaches a clinical disease 
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threshold (Marsh, 1992). In the particular scenario sketched out by Marsh (his Figure 
5), he envisages a set time interval before an immune response can be activated, and 
implicitly assumes this response will control parasite growth after a further fixed 
delay. This hypothesis generates two testable predictions. First, that peak parasite 
density will increase with increasing dose, and second that across dose treatments, all 
parasite peaks will occur on the same day. 
My results support the first of these (Figure 2.4c), but there is no support for 
the second: the timing of peak parasite density was not constant, and instead 
occurred later with decreasing dose. Nevertheless, my data do bolster the idea that 
dose effects are dependent on parasite dynamics if the assumption of a fixed time 
interval from immune activation to parasite control is relaxed. 
The timing of peak parasite density across treatments is consistent with the 
suggestion made by Cox and Millott (1984) that, for P. vinckei, parasite-controlling 
mechanisms are triggered at a fixed threshold level. However, if the speed of this 
response, once activated, was similar across dose treatments, then one would expect 
peak parasite densities to be of similar magnitudes. My data suggest that this is not 
the case, and something more complex must be involved. I am currently exploring 
theoretical models that can account for the dual effects of dose on the timing and 
magnitude of peak parasite density (see Appendix). 
The effect of dose appears to be manifested through the timing and 
magnitude of peak parasite density: higher dose treatments have earlier and higher 
parasite densities, which cause greater morbidity. This implies that there is a per 
parasite effect of virulence, because more parasites cause greater morbidity. It also 
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suggests that the number of parasites mice are initially exposed to are secondary to 
how much time they have to mount a defensive immune response which can temper 
parasite growth. This might be because having more time to mount an immune 
response allows the host to reallocate resources that aid this response, and help to 
minimise the damage that parasites can potentially cause. For example, experiencing 
RBC destruction induces erythropoiesis. If this is stimulated before too many RBCs 
are destroyed (i.e. when there are few parasites causing it), then the host might be 
better able to withstand the parasitic assault on RBCs. However, if hosts experience 
high parasite densities before they can mobilise these processes, then the damage 
they endure could be more devastating. 
The different dose treatments in this experiment cover 6 orders of magnitude. 
However, the effects of dose on mortality (Figure 2.1b) were highly sensitive to the 
two extreme dose treatments (100 and 100 million parasites), and overall, dose 
accounted for just 7% of the probability of death. And while the effects of dose on 
morbidity are statistically highly significant, dose explains only 20% of the between-
mouse variation in anaemia for both clones, and just 10% of weight loss for the most 
virulent clone. These effects are small in comparison to those caused by clone 
differences (Figures 2.2a-d, 2.4a, b). 
In the field, it is extremely unlikely that naturally infected hosts experience 
this range of inoculating doses. The average number of P. falciparum sporozoites 
transmitted is typically less than 25 (Rosenberg et al., 1990; Beier, 1993), and more 
than 1000 has never been observed (Beier etal., 1991; Lines & Armstrong, 1992). 
Liver schizonts produce up to 30,000 merozoites (Garnham, 1966). Thus, a 
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biologically realistic dose of merozoites released into the blood from a single 
infective bite is in the region of between IX105  and lx 106,  and exceptionally lx 10. 
If only these treatments are considered, then dose has no effect on the severity of 
disease (p>0.5 in all cases). 
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Chapter 3. 	The impact of coinfection on virulence 
using two clones with different virulence schedules 
3.1. 	Introduction 
Why do some parasites harm their hosts a great deal, whilst others are relatively 
benign? The evolution of virulence (the reduction in host fitness caused by parasite 
infection) has received considerable attention from theoretical evolutionary 
biologists (reviewed by Bull, 1994; Read, 1994; Ewald, 1995; Ebert & Herre, 1996; 
Frank, 1996; Ebert, 1999). A popular group of models assumes that risk of host (and 
hence parasite) death provides the source of selection against ever more virulent 
pathogens. 
Pathogen virulence phenotypes are usually determined in single-clone 
infections. Yet many infections consist of genetically distinct clonal lineages (Read 
& Taylor, 2001). In these cases, selection on individual clones due to host death will 
depend on the virulence phenotype of the aggregate. For instance, selection against 
virulent clones could be weakened if the probability they will kill the host is reduced 
by the presence of coinfecting avirulent parasites. And otherwise benign pathogens 
may be selected against if, for instance, mixed infections are harder or more costly 
for the host to control (Taylor et al., 1998). There is currently little understanding of 
how the virulence phenotypes of constituent clones interact to determine virulence. 
The question is not simply of interest to evolutionary biologists: many medical and 
intervention strategies may alter the number of clones per host. We have little idea of 
the impact of this on community health burdens. 
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Mixed infections are the norm in human Plasmodiumfalciparum malaria 
infections (Day et al., 1992; Walliker et al., 1998; Arnot, 1999; Smith et al., 1999). 
Virulence is multi-factorial (Marsh, 1992), but there is evidence that Plasmodium 
clones can differ in virulence (Carlson etal., 1990; Gravenor et al., 1995; Mackinnon 
& Read, 1999a, b; Chotivanich et al., 2000). Field evidence points to relationships 
between genetic diversity and disease severity, but in contradictory directions (Al-
Yaman et al., 1997; Roper et al., 1998; Zwetyenga et al., 1998; Smith etal., 1999). 
In laboratory mice, infections consisting of two similarly virulent clones of P. 
chabaudi were more virulent than the two single infections with the constituent 
clones (Taylor et al., 1998). 
Here I investigate the effects of inoculating mice with a fixed number of 
parasites consisting of various ratios of two clones with markedly different virulence 
schedules in single clone infections. This experimental situation is based on the 
following understanding of malaria in the field. Infectious mosquitoes appear to 
inoculate hosts with a small number of parasites (c. 10-15), independent of sporozoite 
densities in their mouth parts (Rosenberg et al., 1990; Beier, 1993). Multi-clone 
infections in mosquitoes are very common, largely arising from earlier blood meals 
on humans with multiple infections. These circumstances make it likely that the 
relative frequency of inoculated genotypes will vary. I ask how this relative 
frequency will act to determine virulence when constituent clones differ in virulence. 
I am therefore investigating the effect on virulence of substituting virulent for 
avirulent parasites in the inoculum. Multi-clone infections can also arise when hosts 
are infected by the bites of different mosquitoes over a short space of time. This is in 
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effect an additive process, with the number of inoculating parasites rising linearly 
with the number of bites. Although these experiments are substitutive, and hence not 
directly analogous to this case, variation in doses over the ranges used in this 
experiment generate differences in the time course of infection, but not virulence 
(Chapter 2, Timms et al., 2001). These experiments may thus be relevant to both 
cases. 
So, how might the co-infecting clones contribute to the total virulence of the 
infection? Envisage the case where two clones, one virulent and the other relatively 
avirulent, infect a single host at the same time. There are various possible scenarios 
(Figure 3.1). 
The most virulent clone alone determines the aggregate virulence of the 
infection. This could arse if, for example, the most virulent clone rapidly 
displaces coinfecting clones. This assumption, contradicted by a substantial body 
of data on the competitive advantages of avirulence (Read & Taylor, 2001), is the 
basis of most models of virulence evolution, largely because of its mathematical 
tractability (Levin & Pimentel, 1981; Bremermann & Pickering, 1983; Knolle, 
1989; Sasaki & Iwasa, 1991; Frank, 1992; Bonhoeffer & Nowak, 1994; May & 
Nowak, 1994; Nowak & May, 1994; Sasaki, 1994; May & Nowak, 1995; 
Mosquera & Adler, 1998). 
The clone that is numerically dominant in the inocula determines aggregate 
virulence. 
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Figure 3.1 
How virulence might be determined in mixtures when two clones with different virulence schedules 
co-infect. Possible scenarios include virulence being determined by the: 1. Virulent clone, 2. Majority 
clone, 3. Unweighted sum of clonal virulences, 4. Weighted average virulence, with initial frequencies 
as weights, 5. Genetic diversity, incorporating the initial frequency of the virulent clone. See text for 
details. 
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Aggregate virulence is a function of the unweighted sum of the clonal virulences. 
Aggregate virulence is the weighted average of the virulence of the two 
constituent clones. This is the assumption of a minority of virulence evolution 
models (Leung & Forbes, 1998; Chao et al., 2000; Gandon & Michalakis, 2000). 
The weights could be determined by frequency in the inoculum (the model I test 
here), or by the frequencies at some point during the infection (a possibility to 
which I return in the discussion). 
Aggregate virulence is affected by a combination of the genetic diversity of the 
infection, and the proportion of virulent clone in the mixture. This is based on the 
assumption that additional virulent parasites cause more damage, plus the idea 
(Taylor et al., 1998) that mixed infections could be harder or more costly to 
control. Hence, one would expect total virulence to peak somewhere between 
where the clones have equal representation and when the virulent clone is alone. 
Other scenarios are also possible. For instance, van Baalen and Sabelis, (1995) 
assume that virulence in a mixture is a fixed level above that in single clone 
infections. Others allow a certain probability of clonal takeover, which may be 
unrelated to clonal virulence (e.g. Gandon et al., 2001), so that the dominating clone 
determines aggregate virulence. Finally, some theoreticians have suggested that 
virulence schedules may be facultative, with pathogen clones adjusting their host 
exploitation schedules in mixed infections (e.g. Sasaki & Iwasa, 1991; Frank, 1992; 
van Baalen & Sabelis, 1995; Frank, 1996). Although not definitive, all available 
evidence points to genetically fixed virulence schedules in malaria parasites 
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(reviewed by Read etal., 2001). I assume this to be so, but return to the issue in the 
discussion. 
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3.2. 	Materials and Methods 
3.2.1. Experimental system 
Two clones, CW and BC, of P. c. chabaudi were used to infect 6-week-old male 
C57BL/6J mice (B&K Universal Ltd). The two clones were obtained from different 
isolates collected in the Central African Republic in 1969 and 1970 from their natural 
hosts (Thamnomys rutilans) and have been stored in liquid nitrogen until cloning. 
Each clone was obtained by asexual proliferation from a single infected RBC 
(Mackinnon & Read, 1999a). On the basis of anaemia, weight loss and mortality, 
CW is relatively avirulent, and BC is virulent (Mackinnon & Read, 1999a; Timms et 
al., 2001). 
Mice were fed on 41B maintenance diet (Harlan, UK). Drinking water was 
supplemented with 0.05% para-amino benzoic acid to enhance parasite growth 
(Jacobs, 1964). Artificial light was provided from 0530 until 1730 hours. 
Parasite densities were estimated from the proportion of RBCs infected 
(calculated from a Giemsa-stained thin blood smear taken daily between day 6-16 
p.i. and on 19, 21, 32 p.i.) and the number of RBCs per ml of blood (counted using 
flow cytometry: Coulter Electronics). Blood sampling and measurements of body 
weight (to the nearest 0.01g) were carried out daily between 1500 and 1900 hours. 
3.2.2. Treatments and inoculations 
Mice were weighed and allocated at random to experimental treatment groups. 
Within each treatment, groups of 5 mice were infected with either a single clone 
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(CW or BC), or a mixture of them both, successive mixtures containing an increasing 
proportion of the virulent clone (Figure 3.2). All mice received the same total 
number of parasites. The virulent clone made up 0.01, 0.1, 0.233, 0.366, 0.5, 0.633, 
0.767, and 0.9 parts of the mixtures respectively. There were 11 treatments (10 
infected groups and one uninfected control group) containing a total of 55 mice. 
Mice were injected intra-peritoneally with 1x10 5 infected RBCs, diluted in a 
0. imi solution of calf serum-Ringers (50% heat-inactivated calf serum; 45% Ringers 
solution [27mM KCL, 27mM CaC1 2, and 0.15M NaC1]; 5% heparin [20units/ml 
Ringers]). Control mice received the same volume of uninfected calf serum-Ringers. 
3.2.3. Measuring virulence 
Disease severity was measured in terms of mortality and morbidity. Two biologically 
sensible parameters that capture morbidity are weight and RBC loss. However, 
morbidity can be further broken down into acute and chronic components. Thus, 
minimum weights and minimum RBC densities (acute measures), and average 
weights and RBC densities throughout infection (from days 0 to 31 p.i. - chronic 
measures) were calculated. 
RBC densities were collected on days -1, 0, 4, 6, 8, daily from 9-12, and 14, 
16, 19, 21, and 31 post-infection (p.i.), giving parasite densities on days 6, 8-12, 14, 
16, and 19 p.i. For each measurement 2.tl of blood was taken from the end of the tail, 
diluted in a balanced electrolyte fluid (Isoton), and analysed using flow cytometry 
(Coulter Electronics). Weights were also measured, to an accuracy of 0.01g, on 
days -1, 0, daily from day 3 - 21, and 31 p.i. Each day the order of data collection 
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Figure 3.2 
Experimental design. 10 groups of 5 mice were infected with either the avirulent or virulent clone on 
its own or a mixture of the two, each mixture containing an increasing proportion of the virulent 
clone. See text for details. 
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was randomised among treatments. 
3.2.4. Statistical analyses 
Mortality rate data were analysed using binary logistic regression. To discriminate 
between the five possibilities shown in Figure 3. 1, General Linear Models were fitted 
to the morbidity data (Crawley, 1993), including all mice in the analyses unless 
stated otherwise. Maximal models were fitted first and, beginning with higher order 
interactions, non-significant terms were sequentially removed in a process of 
backward elimination to generate minimal models. All p-values reported for 
significant terms are from the appropriate minimal models, and p-values for non-
significant terms are from the step at which they were removed. 
Maximal models included the terms PROPORTION OF VIRULENT 
CLONE, the GENETIC DIVERSITY of the inoculum (covariates), the MAJORITY 
CLONE (factor), and all linear interactions between factors and covariates. GENETIC 
DIVERSITY was calculated as the proportion of virulent clone in the mixture 
multiplied by the proportion of the avirulent clone. Hence, diversity peaks when 
there is an equal proportion of both clones (0.5 of each clone, giving maximal 
diversity of 0.25), and decreases to zero in the two single infections. MAJORITY 
CLONE was fitted as a three-level factor for the morbidity analyses: the 0.5 virulent 
clone treatment was specified as a third group since there is no majority clone here. 
However, in the mortality data, all mice in the 0.5 virulent clone group behaved in 
exactly the same way as those in all the avirulent majority groups (all the mice 
survived). Hence, a third level could not account for any extra variation, so this 
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group was excluded from the analyses. In addition, DAY —1 (p. i.) RBC 
DENSITY or DAY -1 (p. i.) WEIGHT was fitted as a covariate to control for 
initial differences between mice. Minimum RBC density and DAY -1 (p. i.) RBC 
DENSITY were logarithmically transformed (10gb) to satisfy the assumptions of the 
statistical models. 
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3.3. 	Results 
The dynamics of control (single-clone) infections are shown in Figure 3.3. Minimum 
weights and RBC densities typically occurred 3 days after peak parasite density. 
Following this, surviving mice made a gradual recovery, reaching the weight and 
RBC density of control mice by around day 20 p.i.. As found previously (Mackinnon 
& Read, 1999a; Timms et al., 2001), the two clones differed in virulence. Mice 
infected with BC had lower minimum weights (F1,7=1 1.5, p<0.05), lower average 
weights (F 1 , 7=9.7, p<0.05), lower minimum RBC densities (F 1 ,7=17.9, p<O.Ol), and 
also higher maximum parasite densities (F 1 ,8= 36. 1, p<0.00 1). Three of the five mice 
infected with BC died, whereas none of those infected with CW did. There was no 
difference in the average RBC density of mice infected with BC and CW (F 1 , 8= 0.3, 
p>O.O5). 
3.3.1. Virulence and coin fection 
In the mixed infections, all mice died wherever the virulent clone was numerically 
dominant in the inoculum, whereas no mice died when the virulent clone was in the 
minority. I am therefore formally able to reject Models 1 and 3: both predict that 
there is no relationship between PROPORTION OF VIRULENT CLONE and 
mortality in the mixed infections, yet there is (Figure 3.4, X2=37•5,  d.f.=1, p<0.001). 
I note that the pattern of death observed in the mixed infections is precisely that 
predicted by the majority clone hypothesis (Model 2, Figure 3.1). Indeed, the 













j210 000S* 7 
19 , 







0 1 2 3 4 5 6 7 9 9 10 11 12 13 14 15 16 17 18 19 20 
Figure 3.3 
The mean daily (a) red blood cell density, (b) weight, and (c) parasite density of groups of mice 
infected with either BC or CW alone, along with the uninfected (control) group. Points represent the 
mean of the mice in the treatment. Initially there were 5 mice per group, but in the BC treatment one 
mouse died on day 8 P1, and a second on day 10 P1. 
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Figure 3.4 
The effect of an increasing proportion of virulent clone on mortality. The points shown, along with the 
numbers next to each point, are the mice in each treatment that survived and died. 
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MAJORITY CLONE explains more variation than PROPORTION OF VIRULENT 
CLONE when each is fitted alone (79% of the variation vs 60%), and also explains a 
significant amount of the variation left over in a model containing PROPORTION 
OF VIRULENT CLONE (x2=17.5,  d.f.=1, pcz0.001). Thus, for the mortality data, the 
majority clone determines virulence. 
For the morbidity measures, four of the five models outlined in Figure 3.1 are 
contradicted by the data (Table 3.1). Models 1 and 3 can be rejected for both 
measures of acute virulence, and for one measure of chronic virulence. Among the 
infections containing both clones, PROPORTION OF VIRULENT CLONE is 
related to minimum RBC density (Figure 3.5a), minimum weight (Figure 3.5b), and 
average weight, (Table 3.1). Models 2 and 4 can also be rejected: GENETIC 
DIVERSITY is related to all four morbidity measures even after fitting 
PROPORTION OF VIRULENT CLONE and MAJORITY CLONE. This is not 
because mouse death removed extreme levels of morbidity. When dead animals are 
excluded from the morbidity analyses, GENETIC DIVERSITY still explains 
additional variation in models incorporating PROPORTION OF VIRULENT 
CLONE (minimum RBC: F1,29= 22.0, pczO.00l; minimum weight: F 1 ,28= 12.9, p=O.Oi; 
average RBC: F1,29= 7.45, p<O.OS). Thus, I am unable to reject Model 5: in mixtures 
made up of two clones with different virulence schedules, a combination of genetic 
diversity and the individual virulence of the two clones determine virulence. 
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Table 3.1 
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Figure 3.5 
The effect of an increasing proportion of virulent clone on a) maximum anaemia, and b) maximum 
weight loss. The points shown are the maximum RBC losses, or weight losses, for all mice in each 
treatment (including those that died), and the line is that predicted from the minimal model 
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3.3.2. Parasite densities and virulence 
PROPORTION OF VIRULENT CLONE affected maximum parasite density 
(F1 ,48=80.8, p<0.001). Increasing the proportion of virulent clone from 0 up to 1 
approximately doubled the maximum parasite density (Figure 3.6). In turn, 
maximum parasite density affected virulence for both acute measures (minimum 
weight: F 1 , 48=9.3, p<O.Ol; minimum RBC density: F 1 , 48=4.7, p<0.05), and one of the 
chronic measures (average weight: F 1 , 48=6.8, p<0.05). However, the effect of 
PROPORTION OF VIRULENT CLONE on virulence was independent of its effect 
on parasite density for two of the morbidity measures (average weight: F1,46=14.2, 
p<0.001 ; minimum RBC density: F1 , 47=8.4, p<O.Ol) and the same trend was apparent 
in the third (minimum weight: F 1 ,=3.5, p=0.069). These patterns are unaltered if 
only survivors are included in the analyses. Thus, the proportion of virulent clone in 
the inocula affects both virulence and parasite density, and the effect on virulence is 
independent of parasite number. 
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Figure 3.6 
The effect of an increasing proportion of virulent clone on peak parasite density. The points shown are 
the mean of 5 mice per treatment (± s.e.) and the line is the least-squares regression from the minimal 
model which contains the proportion of virulent clone only. Slope ± s.e. = -1.37 ± 0.15, n = 50 mice. 
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3.4. 	Discussion 
The data I report here with clones that differ in virulence point to a role for the 
individual virulence of the constituent clones, and their relative frequency in the 
initial inocula, as determinants of virulence. Mortality and morbidity increased with 
the frequency of the virulent clone in the inoculum, ruling out two models which 
assume clone frequency to be an irrelevant determinant of virulence (Figure 3.1). 
Mortality accorded most closely with a step-function model (Model 2) - virulence of 
an infection is determined by the majority clone. No such step function was detected 
with morbidity, which increased with the proportion of the virulent clone. Moreover, 
it increased more steeply than expected from a simple weighted average of the 
virulences of the constituent clones, even among surviving mice, suggesting that 
genetic diversity per se can be a determinant of virulence (Model 5). 
In experiments free of mortality, Taylor et al. (1998) also showed an effect of 
genetic diversity on morbidity using P. chabaudi infections consisting of two equally 
virulent clones. They suggested this diversity effect could arise if mixed infections 
are harder or more costly to control. They favoured the latter idea, because they too 
found an effect of diversity independent of any effect of parasite density. They 
suggested that mixed infections might initiate the proliferation of more B- and T-cell 
lineages. On its own, such a process would be insufficient to explain data from the 
current experiment, because here, both clones are present in all the mixed infections. 
However, if processes such as antibody interference or antigenic competition are 
occurring, it may be that increased costs of fighting infection may account for the 
morbidity patterns I report. 
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The analyses have concentrated on initial frequencies as explanatory factors. 
However, more virulent clones grow more rapidly (Mackinnon & Read, 1999a), and 
certainly BC grows faster than CW (Timms et al., 2001) in single clone infections. 
Thus, it may be that when weight loss and anaemia are occurring, the virulent clone 
(BC) will have increased in frequency from that in the initial inoculum. If so, this 
could account for the more than linear increase in morbidity among the survivors that 
I am attributing to genetic diversity. However, maximum parasite densities were a 
linear function of the frequency of the virulent clone in the inoculum (Figure 3.6). If 
the virulent clone was beginning to outgrow the avirulent clone, one might have 
expected a curvilinear relationship, similar to that seen for morbidity. I note that the 
linear relationship is itself unexpected. It implies some sort of infection-wide parasite 
regulation at a level that is the average for the single clone controls weighted by their 
initial frequencies. Yet on their own, these clones are capable of achieving similar 
parasite densities from a range of starting densities (Timms et al., 2001). 
The existence of a linear relationship also argues that these Plasmodium 
clones are not facultatively adjusting their growth rates in mixed infections. Several 
theoreticians have argued that such adjustment might be advantageous because it 
would allow strains to achieve an optimal growth rate under a variety of competitive 
scenarios (Sasaki & Iwasa, 1991; Frank, 1992; van Baalen & Sabelis, 1995; Frank, 
1996). The linear relationship (Figure 3.6) is consistent with each clone having a 
fixed growth rate, and the clone with the higher growth rate increasing its 
representation, causing the differences in peak parasite density. This lack of evidence 
for a facultative change in growth rate agrees with the findings of Taylor et al. 
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(1998) where the growth rate of individual clones was measured in mixtures, and no 
change compared to single infections was detected. Thus, all evidence points to the 
fact that the virulence of these clones is genetically determined, and not subject to 
modification in the presence of multiple infections. If there is facultative adjustment 
of virulence schedules, it is not detectable in terms of peak parasite densities. 
This result that aggregate virulence is determined by either the majority clone 
(for mortality), or by the proportion of virulent clone together with genetic diversity 
(for morbidity), is discordant with all of the models addressing the evolution of 
virulence in mixtures (Levin & Pimentel, 1981; Bremermann & Pickering, 1983; 
Knolle, 1989; Sasaki & Iwasa, 1991; Frank, 1992; Bonhoeffer & Nowak, 1994; May 
& Nowak, 1994; Nowak & May, 1994; Sasaki, 1994; May & Nowak, 1995; Leung & 
Forbes, 1998; Mosquera & Adler, 1998; Chao, 2000; Gandon & Michalakis, 2000). 
So far as I am aware, no models have considered the possibility that initial infection 
conditions could themselves play a role, even though these are likely to be affected 
by epidemiological conditions, which will in turn be affected by virulence evolution. 
Many theoreticians have assumed a link between virulence and competitive ability, 
in which case the majority clone may frequently be the virulent clone. I am unaware 
of any evidence relating competitive ability to virulence in malaria parasites, but in a 
range of other microparasitic systems, there is no direct support for a positive link 
between virulence and competitive ability, and some evidence to the contrary (Read 
& Taylor, 2001). 
It may be that the conclusions of virulence models are rather robust to 
violations of assumptions about the determinants of aggregate virulence in mixtures. 
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However, intuition is unlikely to be a useful aid in working out these implications for 
the evolution of virulence: the most complex outcomes can fall out from the simplest 
of models, and the models rapidly become complex when evolutionary and 
epidemiological processes are coupled, as they are in nature. However, at the very 
least, I suspect the dynamics of evolution and the quantitative position of optima will 
be affected. If the risk of host death is moderated by the presence of other clones, 
then the strength of selection acting to remove the more virulent clones from the 
population will be reduced. It will be interesting to see how the complexities 
revealed by this experiment play out in theoretical models. 
Even leaving aside the evolutionary consequences, these results have 
implications for public health. The genetic diversity component of virulence suggests 
that reductions in diversity, either through vaccines targeted at specific strains, or 
through non-specific measures such as bednets, could have beneficial or detrimental 
consequences for public health. The direction of the impact will depend on the 
relative frequencies of virulence phenotypes in a population and on the conditions 
initiating infections. 
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Chapter 4. 	Can a co-infecting avirulent clone 
protect the host from damage caused by a virulent 
clone? 
4.1. 	Introduction 
Each year, over 300 million people become clinically ill with malaria, 90% of whom 
live in sub-Saharan Africa (WHO website). The outcome of these infections is highly 
variable (Marsh, 1992), and depends on various socio-economic factors as well as 
host genetics and previous exposure record. However, there is growing evidence that 
an additional factor influencing how sick hosts become, and even whether they live 
or die, is parasite genetics. Evidence of this from the field is hard won for two 
reasons. Firstly, humans cannot be deliberately infected with a potentially fatal 
disease, so controlled trials to isolate the effect of parasite genetics are beyond the 
remit of ethical science. Secondly, natural infections from patients attending clinics 
for treatment are confounded by all the other risk factors. However, circumventing 
these problems has proved possible by isolating parasites from patients and looking 
for differences in a uniform environment: the petri dish. 
Malaria infections causing clinical disease fall into one of two types: mild 
and severe. Patients differ in the symptoms they express - severe malaria cases being 
typified by either severe anaemia, or cerebral malaria. Hence, mild and severe cases 
serve as a starting place to look for parasite differences. The first parasite trait that 
has been shown to express variation is rosetting, where infected RBCs become 
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surrounded by uninfected RBCs. Carlson et al. (1990) looked at isolates taken from 
children with cerebral malaria and compared their ability to form rosettes with those 
taken from mild infections. Rosetting was more frequent in the samples from the 
cerebral malaria group and appeared to contribute to the pathogenesis of cerebral 
malaria. The second trait that varies is parasite growth rate. Growth rates are higher 
in isolates taken from patients with cerebral malaria, than those from asymptomatic 
individuals (Chotivanich et al., 2000). Faster growing parasites cause more damage. 
So there appears to be variation between parasites in naturally occurring infections, 
and these traits are linked to virulence. 
Additional evidence of parasite variation comes from controlled infections in 
the laboratory. Clones of P. chabaudi consistently differ in the amount of weight 
loss, anaemia, and death that they cause (Mackinnon & Read, 1999a; Timms et al., 
2001), and more virulent strains have higher growth rates (Timms et al., 2001). 
The majority of human Plasmodium infections in the field are made up of 
more than one parasite lineage (Conway et al., 1991; Day et al., 1992; Walliker et 
al., 1998; Arnot, 1999; Smith et al., 1999). Given the parasite variation in disease 
linked traits observed in the field, it is likely that the composite clones differ in 
virulence. To understand the implications this might have for the harm suffered by 
hosts, and also for virulence evolution, we first need to understand how aggregate 
virulence is determined in mixtures made up of clones that differ in virulence. 
Chapter 3 examined how virulence is determined in a mixture made up of two 
clones that cause different amounts of damage to their hosts when in single 
infections. The results indicate that the proportion of virulent clone in the inocula, 
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and also the genetic diversity of the infection, both interact to determine morbidity. 
The fact that there was a relationship between the proportion of virulent clone and 
virulence suggests that replacing virulent parasites with avirulent ones can reduce the 
overall virulence of the infection. From the host's point of view, this means that in a 
mixed infection made up of two clones with different virulence schedules, 
numerically dominant avirulent parasites can protect them against damage from more 
virulent parasites. 
The most parsimonious explanation for how this could arise is as follows. 
Imagine a host has a fixed number of parasites it can support (carrying capacity). 
When a parasite infects a host, it will grow until it has filled this space ("bucket"). 
Now if parasite X infects the host at the same time as parasite Y (coinfection), then 
this reduces the amount of the bucket available for X to fill. Hence, when the bucket 
is full, there are fewer X parasites in it than compared to a single infection of parasite 
X. If X is more virulent than Y, and each additional parasite causes a unit increase in 
virulence, then the host will suffer less damage. 
Is there any evidence that adding a second clone to an infection protects the 
host from damage that would otherwise have occurred? Several studies have 
demonstrated that the population growth rates or densities of a clone are suppressed 
by the presence of another, both in vivo and in vitro (in vivo: Hargreaves et al., 1975; 
Miller & Turner, 1981; Onderdonk et al., 1981; Morrison et al., 1982; Duvaliflah et 
al., 1983; Seed et al., 1984; Dwinger et al., 1986; Allaker etal., 1988; Sundin & 
Beaty, 1988; Snounou etal., 1989; Sones et al., 1989; Berchieri & Barrow, 1990; 
Taylor et al., 1997a; Lenhoff etal., 1998; Heithoff etal., 1999; in vitro: Sugita, 
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1981; Dittmar et al., 1982; Hart & Cloyd, 1990; Riley & Gordon, 1996). However, 
most of these do not measure the impact of this on the host: is the host better off 
when one of the parasite densities is reduced, or is the level of virulence experienced 
unaltered? If one assumes that parasite density will be positively related to virulence, 
then evidence of competitive suppression in a mixture could well be interpreted as 
protection for the host. However, this is by no means clear. 
The only study of which I am aware that directly addresses the impact of 
within-host competition for the host is by Hargreaves et al. (1975). They inoculated a 
million parasites of a virulent strain of what was then known as Plasmodium berghei 
yoelii into either naïve mice, or mice infected three days earlier with a million 
avirulent parasites, and looked at the effect on mouse survival. In the single virulent 
infection, parasitemias reached high levels (>60%) and all the mice died. However, 
when the virulent strain was added to the avirulent infection, the magnitude of peak 
parasitemia was reduced (<30%), and all the mice survived. 
Whilst this study shows that adding a virulent clone to an avirulent infection 
increases the probability of host survival, it does not address the impact of this on 
morbidity. Can differences be detected on a finer scale than alive/dead? Also, the 
experiment was designed to look at sequential inoculations: the second clone was 
injected three days after the first by which time the latter would have increased by 
three orders of magnitude. It is of interest to know if the result will hold if they 
coinfect and the avirulent clone does not have such a head start? Finally, the 
generality of this result across clone pair combinations cannot be tested since only 
one clone pair was used. 
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To assess whether substituting virulent parasites for avirulent ones in a 
mixture conferred any protective effects on the host, two extreme ratios of avirulent 
and virulent malaria parasites were allowed to coinfect. Virulence was measured by 
weight- and RBC loss. In addition, to look at the generality of any protective result, 
this was replicated with a second pair of clones, made up of a similarly virulent, and 
similarly avirulent clone to the first pair. 
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4.2. 	Materials and methods 
4.2.1. Parasitology 
Four cloned lines of the rodent malaria parasite, P. c. chabaudi, were used to infect 
6-week-old male C57 bl6J mice (Harlan, England). The clones, CW, BC, AS and 
AT, were obtained from different isolates collected in the Central African Republic 
in 1969 and 1970 from their natural hosts (Thamnomys rutilans) and were stored in 
liquid nitrogen until cloning (Mackinnon & Read, 1999a). The four clones were 
specifically chosen to be similarly virulent, or avirulent. Within each pair, BC/CW 
and AT/AS, the clones differed in virulence: BC and AT infections peak at higher 
parasite densities and induce greater weight loss and anaemia than CW and AS 
infections (Mackinnon & Read, 1999a). 
Mice were fed on 41B maintenance diet (Harlan, England). Drinking water 
was supplemented with 0.05% para-amino benzoic acid to enhance parasite growth 
(Jacobs, 1964). Artificial light was provided from 0530 until 1730 hours. 
Parasite densities were estimated from the proportion of RBCs infected 
(calculated from a Giemsa' s-stained thin blood smear) and the number of RBCs per 
ml of blood (counted using flow cytometry: Coulter Electronics). Blood sampling 
and measurements of body weight (to the nearest 0.01g) were carried out between 
1500 and 1700 hours. 
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4.2.2. Experimental design 
Mice were weighed and allocated at random to treatment groups. Within each group, 
4 mice were infected with either a single clone (CW, BC, AT or AS alone), or with a 
mixture of one of the clone pairs, in one of two ratios (1CW:9BC, 9CW: 1BC, 
1AS:9AT or 9AS:1AT) (Figure 4.1). The whole experiment was replicated in a 
second block, with 5 mice per treatment group. A substitutive design was used which 
keeps the total inocula size constant across treatments (1x10 5). However, this meant 
that, in the mixed infections, the amount of virulent clone in the inocula was smaller 
than in the single virulent infections (for example, in the 1 virulent: 9 avirulent case 
there were 90% fewer virulent parasites). To investigate whether any differences 
between the single virulent infections, and the 1 virulent: 9 avirulent mixtures were 
due to a reduced dose of virulent parasites in the mixtures, two additional single 
treatments were added in block 2. These were initiated with the same number of 
virulent parasites (CW or BC) as in the 1 virulent: 9 avirulent mixtures (and so one 
tenth of the parasites in the original single virulent treatments = lx 10). Thus, with 
one uninfected control group in each block, there were 9 groups in the first block (a 
total of 36 animals) and 11 groups in the second block (a total of 55 animals). 
In the first block, one animal from the single AT treatment, and one from the 
9AS:1AT treatment, died unexpectedly before losing any weight or RBCs. Data from 
these two mice were excluded from the analyses. 
To administer an exact dose of parasites in a fixed volume of liquid, the 
appropriate volume of infected blood from the donor mice was diluted in a solution 
of calf serum-Ringers (50% heat-inactivated calf serum; 45% Ringers solution 
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Figure 4.1 
Treatment groups in the second block of the experiment. The first block was identical except that 
there were only 4 mice per group, and the 10% single virulent treatment was not included. The 
virulent clones were AT and BC. 
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[27mM KCL, 27mM CaC1 2, and 0.15M NaC1]; 5% heparin [20unitslml Ringers]). 
Each infection was initiated with an intra-peritoneal injection of 0. imI of this 
solution. Control mice received the same volume of uninfected calf serum-Ringers. 
Disease severity was measured in terms of morbidity: minimum weight and 
minimum RBC density were calculated during infection. The weight of every mouse 
was taken on days —1, 2, daily between days 4-22, and on day 28 p.i. RBC density 
was measured every second day from day 2-22 p.i. and on day 28 p.i., and the 
proportion of RBCs infected was measured daily from day 6-10, every second day 
between days 12-22 and on days 13 and 28 p.i. This gave parasite densities every 
second day from days 6-18 p.i. and on day 28 p.i. In each case, the order of 
collection was randomised at the treatment level. 
4.2.3. Statistical analyses 
Data were analysed using General Linear Models (Crawley, 1993). Maximal models 
were fitted first and, beginning with higher order interactions, non-significant terms 
were sequentially removed in a process of backward elimination to generate minimal 
models. 
Fitted terms in the maximal models were clone pair (specified as one of two: 
AS/AT or CW/BC), treatment (single avirulent, single virulent, majority avirulent, or 
majority virulent), and block. All were fitted as factors. In addition, a measure of 
each individual's normal weight or RBC density was fitted as a covariate to control 
for differences between mice. All linear interactions between factors and covariates 
Chapter 4 Protection in mixtures 	 67 
were also fitted. Post-hoc analyses were carried out using t-tests (using the pooled 
variance from the full model) to ascertain which treatment pairs were significantly 
different among the many pairwise comparisons. In cases where differences between 
two treatment groups were investigated, each of which contained two clone groups, a 
sequential procedure was employed to reduce the number of necessary comparisons 
(Underwood, 1997). The two means within each treatment were arranged in size 
order, and the two nearest between group values were compared first. All p-values 
reported for significant terms are from the appropriate minimal models, and p-values 
for non-significant terms are from the step at which they were removed. 
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4.3. 	Results 
In the single infections, the two virulent clones (AT and BC) did not differ in the 
amount of damage they caused their hosts (RBC density: t=0.06, d.f.=15, p>0.05; 
minimum weight: t=-0.3, d.f .= 15, p>0.05). Similarly, for the two avirulent clones 
(CW and AS), minimum RBC densities (t=1.6, d.f.=16, p>O.OS) and minimum 
weights (t=0.3, d.f.=16, p>0.05) did not differ. However, as expected, the virulent 
clones were indeed more virulent than the avirulent clones. AT and BC infections 
had lower minimum RBC densities (t=-4.7, d.f.=16, p'<O.00l); and lower minimum 
weights (t=-2.7, d.f.=16, p<0.05) than those containing AS or CW. 
Whilst the behaviour of two clone pairs was similar across the single 
treatments, it was dramatically different in the mixtures (Figure 4.1. clone 
pair*treatment interaction, minimum RBC density: F3,61=3.2, p<0.05; minimum 
weight: F3,62=3.8, p<0.05). Infections made up of the AS/AT clone pair were always 
more virulent than the CW/BC infections. In the majority virulent clone treatment, 
the AS/AT clone pair caused lower minimum RBC densities (t=4.2, d.f.=16, 
p<z0.001) and lower minimum weights (t=3.5, d.f.=16, p<O.Ol). Similarly, in the 
mixture where the avirulent clone was numerically dominant, infections with AS/AT 
had lower RBC densities (t=3.2, d.f.=15, p<0.01) and lower minimum weights 
(t=3.0, d.f.=15, p<O.Ol) than the CWIBC treatment. Thus, AS/AT mixtures are 
always more virulent than CWIBC mixtures, despite there being no difference in the 
virulence of the two virulent and two avirulent clones respectively. Interestingly, the 
ratio of the difference between the AS/AT and CWIBC infections appeared to stay 
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Figure 4.1 
The impact on a) minimum red blood cell densities, and b) minimum weights, for mice singly infected 
with either a virulent clone, or an avirulent clone, or coinfected with a 1:9 or 9:1 mixture of 
virulent:avirulent clones. Bars shown are the least square means from the minimal models (+ s.e.) 
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constant across the two mixed infections (Figure 4.1). There were no differences in 
the two blocks 
The clones also differ in the maximum number of parasites they generate in 
the mixtures: AS/AT infections produce 27% more parasites at peak density (mean ± 
s.e: AS/AT = 1.48 ± 0.09; CWIBC = 1.17 ± 0.08; F 1 , 33=6.5, p<0.05). However, this 
is not enough to account for the increased virulence of the AS/AT mixtures. Even 
when the peak density of parasites have been controlled for, AS/AT mixtures still 
cause lower minimum RBC density (F 1 , 31=36.5, p<0.001), and lower weights (F 1 , 
3118.4, p<O.00l). 
To investigate whether substituting virulent parasites for avirulent ones 
conferred any protective effects on the host, the majority avirulent mixtures 
(9AS: 1AT or 9CW: IBC) were compared to their respective single virulent infections 
(AT or BC alone). There was no significant difference in the virulence of the two 
treatments for the AS/AT pair (minimum RBC density: t=1.2, d.f.=14, p>0.05; 
minimum weight: t=-1.2, d.f.=14, p>O.OS). However, for the CW/BC clone pair, the 
majority avirulent mixture caused less anaemia (t=4.7, d.f.=16, pczO.00l) than BC did 
alone. Minimum weight did not differ (t=2.2, d.f.=16, p>O.OS). Replacing 90% of the 
virulent parasites in the inocula with an equal number of avirulent parasites reduces 
the number of RBCs lost relative to mice in the virulent single treatment. 
The protective effect in the majority avirulent mixture for the CWJBC clone 
pair could be due to there being fewer virulent parasites in the mixed clone inocula 
than in the single virulent one. To test this, the 9CW: IBC treatment from each block 
was combined and compared to the 10% BC group in block 2, which contained the 
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same initial density of virulent parasites. The 10% BC group was more virulent than 
the avirulent majority mixture, experiencing lower minimum RBC densities 
(F1,12=15.4, p<O.Ol). 
Consistent with this, the 10% and 100% virulent single groups did not differ 
in minimum RBC density across both clones (F1,25=1.7, p>0.05). And whilst 
minimum weight differed (F 1 ,26=8.5, p<O.Ol), it was in the opposite direction to what 
one might expect: the 10% treatment was more virulent than the 100% treatment. 
There were no clone differences between the 10% and 100% virulent single 
infections for either virulence measure (minimum RBC density: F 1 , 25=0.9, p>0.05; 
minimum weight: F 1 ,=0.2, p>0.05). Thus, reducing the number of virulent parasites 
present in the inocula did not reduce the virulence of the infection, and adding 
additional avirulent parasites to a 10% inocula of virulent parasites still reduced the 
trough of RBCs reached during infection. 
A second explanation for the protection result is that there was a differential 
response between clones to an increase in the genetic diversity of the infection. If this 
were true, we would expect to see protection (higher minimum RBC densities) in the 
mixture where the virulent clone formed the majority, and we do not (t=2.4, d.f.=16, 
p>O.O5). 
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4.4. 	Discussion 
The two virulent clones did not differ in virulence, and neither did the two avirulent 
clones. However, across the clones, the virulent single infections were indeed more 
virulent. Substituting 90% of the virulent parasites in the inocula with an equal 
number of avirulent ones conferred a protective effect on the host, but only for one of 
the clone pairs (CWIBC), and even then, only for one of the two measures of 
virulence (minimum RBC density). The protection was not due to reducing the 
number of virulent parasites in the majority avirulent inocula: comparison with a 
single group initiated with an equal number of virulent parasites as in the mixture, 
showed that the mixture was still less virulent. Neither was it due to an increase in 
the diversity of the inocula, because no protection was seen in the majority virulent 
mixture. Finally, the AS/AT mixed infections were always more virulent than 
CW/BC mixtures. Whilst there were more parasites at the peak of infection in the 
AS/AT mixtures, these did not account for the difference between the clone pairs. 
The two clone pairs behaved in qualitatively similar ways in the two 
mixtures: infections consisting of the virulent clone in the majority were always 
more virulent than the mixture where the avirulent clone dominated, and by broadly 
the same degree. However, the virulence of AS/AT mixtures was shifted up so that it 
was higher in both mixtures relative to the CW/BC ones. Having 90% of the virulent 
parasites replaced with avirulent parasites was better for the host than only 
substituting 10% of them for both clone pairs, but this was only an improvement on a 
single virulent infection for the CWIBC combination. Why should the clone pairs 
behave differently when their virulence schedules in single infections are the same? 
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The additional virulence caused by AS/AT mixtures could be due to parasite 
mediated damage. However, the additional parasites present in the AS/AT mixtures 
did not account for the additional virulence of these infections, so each individual AS 
or AT parasite would have to cause more damage than a CW or BC. This could be 
conceivable if the ratio of virulent: avirulent parasites had increased in the AS/AT 
mixtures, although it is difficult to see why this would have happened when the 
virulence of the single virulent infections was the same. 
From chapter 3 it was seen that both the proportion of virulent clone present, 
and also the genetic diversity of the infection, determined aggregate virulence in 
mixtures. For a given mixture in this experiment, the proportion of virulent clone 
stayed the same for both clone pairs, so this is unlikely to account for the difference 
between clone pairs. However, even though the virulent clones have very similar 
virulence schedules, as do the avirulent clones, it could be that the AS and AT clones 
are more genetically different than CW and BC are from each other. Hence, while 
genetic diversity is constant across AS/AT and CWIBC mixtures, the host might see 
AS/AT as more genetically distinct. This could translate into additional virulence if 
hosts are facing increased costs of mounting an immune response against a more 
genetically diverse infection. This was proposed by Taylor et al. (1998) to account 
for an increase in virulence in mixtures as compared to single infections. The 
scenario is slightly different here because all the treatments contain two clones rather 
than one or two, but the same reasoning could apply. 
I have shown that in a given mixed infection treatment, the two clone pairs 
behaved differently. This difference was despite there being no difference in the 
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virulence of the respective virulent and avirulent clones in the single infections. 
Therefore, it is difficult to predict the virulence of mixtures made up of known 
quantities of clones, even when the virulence of the clones in single infections is well 
quantified. Such a genotype*genotype  interaction makes it difficult to draw 
unequivocal conclusions about the generality of any results tested with only one 
clone pair. 
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Chapter 5. 	An investigation into the factors 
predicting and contributing to host death in 
Plasmodium chabaudi 
5.1. 	Introduction 
When malaria parasites infect laboratory mice they initially replicate exponentially. 
However, the outcome and timing of what happens next is highly variable. More 
often than not, parasite densities peak and then rapidly decline, becoming hard to 
detect within a few weeks. In this scenario mice become sick almost as soon as 
parasites are detectable on thin blood smears, and reach their minimum weights and 
RBC densities around two days after peak parasite density (Figure 5.1) and rapidly 
recover. However, in other infections, they die shortly after parasites reach their peak 
density. Several factors are known to affect whether mice live or die including mouse 
genotype (Stevenson et al., 1982), parasite genotype (Timms et al., 2001), and also 
the inoculating dose of parasites (Chapter 2, Timms et al., 2001). In mixed infections 
(when two malaria parasite clones coinfect) both parasite genetic diversity, and also 
the relative frequencies of the composite clones play an important role in 
determining the outcome of infection (Chapters 2 and 3). 
To understand why mice die, one might look for an evolutionary, or causal, 
explanation. It is hard to envisage death being adaptive for the host, and whilst 
virulent parasites produce more transmission stages from mice that die, it is still less 
than avirulent parasites that do not kill their hosts (Chapter 6). Instead, several 
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models assume that virulence is an unavoidable consequence of within host parasite 
growth, which is positively related to transmission (fitness) (Levin & Pimentel, 1981; 
Anderson & May, 1982; Bremermann & Pickering, 1983; Ewald, 1983; May & 
Anderson, 1983). This assumption also has empirical support (Mackinnon & Read, 
1999a). However, an evolutionary understanding does not fill in the whole picture. It 
is also of interest to understand the proximate causes of host death. In this case, we 
seek to understand what factors and mechanisms underlie host mortality. 
The first reason for investigating this is to form a fuller understanding of what 
virulence is. Throughout this thesis, the term virulence is used to describe host 
morbidity and mortality. However, we currently have little understanding of how 
morbidity and mortality are related - if at all. It could be that mortality lies at the 
extreme end of a continuum of increasing morbidity. For example, mice might die 
because of the amount of body weight that they lose, if they lost less, they might 
survive the infection? Alternatively, mortality might be something that is 
unconnected to morbidity, and brought about by different pathways. In this case, one 
would not expect the morbidity measures taken to account for significant amounts of 
variation in death. 
A second motivation for understanding the factors leading to host death is to 
improve the welfare of experimental animals. The three tenets of animal welfare are 
the Three Rs: replacement, reduction and refinement. These were defined first by 
Russell and Burch (1959), and have been adopted since by the Home Office who 
regulate all animal work in the UK. They were developed as an ethical framework to 
diminish or remove animal suffering whilst still enabling the scientific objective to 
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be attained. If alternatives exist, animals should not be used in research. If they do 
not, then the numbers of animals used should be reduced to the minimum capable of 
detecting the desired effect (based on power calculations), procedures should be 
refined, and humane endpoints should be sought. However, in many fields of 
research, it is far from obvious what these endpoints should be (e.g. Hendriksen & 
Morton, 1999 and references therein). 
If we can successfully understand why an animal dies, it might be possible to 
predict from early measures in an infection if an animal will die, and thus define an 
objective endpoint. In this case animals can be euthanised so to avoid unnecessary 
suffering. 
In this chapter I have two specific aims: 
To investigate why mice die 
What factors contribute to host death, and are these factors common across 
experiments? For example, is death correlated with RBC destruction, the 
speed at which mice lose RBCs, the rate of weight loss etc.? Whilst these 
factors may not be the cause of death, they may be useful predictors of death. 
To define an endpoint for infections 
Can early measures from before mice become very sick be used to reliably 
predict which mice will go on to die? 
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To investigate these questions, data were selected from the experiments investigating 
the effects of dose on virulence (Chapter 2), and how virulence is determined in a 
mixture of two clones with different virulence schedules (Chapter 3). Within each 
experiment the age, sex, and genotype of hosts, as well as the parasite clones, were 
all held constant. In the dose experiment, 135 animals were infected with malaria, 
and virulence measures were assayed daily across the whole infection. This is an 
ideal data set to investigate both why mice die, and which mice will go on to die, 
because of the intensive sampling regime, and the uncommonly high death rates (not 
previously seen in any experiments in the research group): across the two blocks, 
57% of mice infected with the virulent clone died. In the ratio experiment 36% of 
animals died. Sampling concentrated on the time around peak parasite density and 
maximum morbidity, so data from early in the infection are not available to address 
the second aim of this chapter. 
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5.2. 	Methods 
Briefly, in the dose experiment, groups of five mice were infected with a range of 
doses over 6 orders of magnitude, and the experiment was repeated in a second 
block. Weights and RBC densities were measured daily. See Chapter 2 for details. 
Since death only occurred in treatments with the virulent clone (BC), only these 
treatments are included. In the ratio experiment, mice were infected with a fixed 
volume of parasites made up of a single clone (virulent/avirulent) or a mixture of the 
two (virulent + avirulent). The virulent clone made up an increasing proportion of the 
inocula in successive treatments. See Chapter 3 for details. 
One potential problem with using the dose data to look at factors contributing 
to death comes from the fact that the probability of death increases as dose increases, 
and dose also affects the timing of morbidity and death. Increasing the dose of 
parasites decreases the time p.i. for mice to reach their minimum weights and RBC 
densities, and mice in higher dose treatments are more likely to die (Chapter 2). 
Hence, one would expect the day of minimum weight or RBC density to account for 
significant amounts of variation in death, if only because it is confounded with dose. 
Thus, it would be difficult to know if timing plays a role in the outcome of the 
infection in its own right, independently of dose. To avoid this problem, all daily 
measures were aligned to coincide with the day that parasites first became detectable 
on thin blood smears. For example, if parasites were first seen on day 6 p.i., then the 
day 6 p.i. weight or RBC density was taken as day 1 post-parasite detection (PPD), 
day 7 p.i. as day 2 ppd, and day 8 p.i. as day 3 ppd etc. This minimised the 
confounding effect of dose on timing, and allowed mice to be fairly compared across 
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different dose treatments from the same starting parasite densities. This approach has 
also been used as a post-hoc control for the starting density of parasites in 
experiments where dose was not experimentally controlled (Paul et al., 2000). This 
was not necessary for the ratio data because the timings of peak parasite density and 
morbidity were broadly similar across treatments. 
All the data were analysed using logistic regressions (SPSS). Maximal 
models were fitted first and non-significant terms were removed in a stepwise order. 
From the minimal model it is possible to assign a probability of death for individuals 
and from this allocate them to a predicted group (alive if the probability of death is 
less than 0.5 otherwise dead). The percentages reported for the analyses are the 
percentage of individuals that are correctly assigned to their true groups, and give an 
indication of the predictive power of the model. 
5.2.1. Why do mice die? 
Various weight and RBC parameters could be important for determining whether a 
mouse lives or dies following malaria infection. The most obvious ones concern the 
amount of weight or RBCs that mice lose. It could be as simple as the grams of 
weight, or numbers of RBCs, that mice lose during an infection (MAXIMUM 
WEIGHT or MAXIMUM RBC LOSS). Or else it might be the minima they reach 
(MINIMUM WEIGHT or MINIMUM RBC DENSITY). Alternatively, it could be 
their maxima (MAXIMUM WEIGHT or MAXIMUM RBC DENSITY). Finally, both 
the speed and the magnitude at which they lose resources could be important (RATE 
OF WEIGHT LOSS or RATE OF RBC LOSS). All the above measures were 
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included in the maximal models for the dose and ratio data to ascertain which were 
important for separating groups of mice that lived and died. See Table 5.1 for how 
these measures were calculated. 
5.2.2. Can death be predicted from early morbidity measurements? 
The above measures may explain variation between mice that live and die, but since 
many of them are based on maxima and minima that occur just before death (if it 
occurs), they are not useful in predicting which mice will die in time to take 
preventative action. Earlier indicators need to be sought if mice are going to be 
euthanased. To investigate whether early measures can successfully predict the 
outcome of infection, the first four daily RBC densities and weights of mice from the 
day that parasites became detectable, and the pre-infection RBC densities and 
weights were analysed for the dose data set. 
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Table 5.1 
Description of variables and their derivation included in the analyses investigating correlates of death. 
For the dose data set, the timing of measurements (such as minimum weight etc.) were aligned from 
the first day that parasites became detectable (post-parasite detection = PPD) on thin blood films to 
minimise the confounding effect of dose on morbidity and timing of disease symptoms. See methods 
for details. 
Predictor variables 	 How they were calculated 
MAXIMUM WEIGHT 	 The maximum weight PPD prior to MINIMUM 
WEIGHT 
MINIMUM WEIGHT 	 The lowest daily weight PPD 
MAXIMUM WEIGHT LOSS 	MAXIMUM WEIGHT - MINIMUM WEIGHT 
RATE OF WEIGHT LOSS 	MAXIMUM WEIGHT LOSS / (day PPDof 
maximum weight - day PPD of minimum 
weight) 
MAXIMUM RBC DENSITY 
MINIMUM REC DENSITY 
MAXIMUM REC LOSS 
RATE OF RBC LOSS 
The maximum RBC density PPD prior to 
MINIMUM RBC DENSITY 
The lowest daily RBC density PPD 
MAXIMUM RBC DENSITY - MINIMUM 
RBC DENSITY 
MAXIMUM RBC LOSS / (day PPD of 
maximum RBC density - day PPD of 
minimum RBC density) 
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5.3. 	Results 
5.3. 1. Why do mice die? 
Dose data 
As a preliminary data exploration exercise, all the measures in Table 5.1 were run in 
8 separate univariate analyses. Of these, maximum RBC density, the rate of weight 
loss, and the rate of RBC loss explained significant amounts of variation in death. 
Minimum weight and maximum weight loss were almost significant (Table 5.2). 
Whilst these terms are important correlates of mouse death on their own, 
these basic analyses do not allow us to investigate the dependency of any variables 
on others. For example, although maximum RBC density was significantly higher in 
mice that survived, this might be relatively less important once maximum RBC loss 
is included in the model because it is already incorporated in this term etc. Thus, 
including all the weight or RBC loss measures simultaneously allows us to tease 
apart the important variables predicting the probability of death. Weight and RBC 
measures were included in separate models to simplify interpreting the results, so 
that each maximal model contained the 4 terms shown in the first half or second half 
of Table 5.1. 
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Figure 5.1 
The relationship between the timing of peak parasite density and minimum red blood cell density. The 
data shown are for the avirulent clone (CW) and the lx 102  dose treatment in the second block of the 
dose experiment. These data are representative of the general pattern seen across other dose treatments 
with both clones. The lines represent the mean of 5 mice' 
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Multiple measures of virulence made up the minimal models (Table 5.3). 
Firstly, in the RBC model, maximum RBC density (%2=7.46,  d.f.=1, p<O.Ol), and the 
rate of RBC loss (x2=13.12,  d.f.=1, p<0.001) were both correlated with the outcome 
of infection. A high maximum RBC density and a slow rate of RBC loss increased 
the probability that a mouse would survive. 
The minimal model for the weight measures was similar. Maximum- and rate 
variables were again good predictors of the outcome of the infection. A high 
maximum weight (x21  1.2, d.f.=1, p<0.001), a slow rate of weight loss (x2=9.0, 
d.f.=1, p<O.Ol; ) and counter-intuitively, a low minimum weight (x2=12.2,  d.f.=1, 
p<0.001) increased the probability of survival. Overall, based on these measures the 
two minimal models correctly allocated 74% and 72% of mice to their true groups 
for the RBC and weight models respectively. 
Thus, a mouse that is most likely to survive malaria infection has a high 
maximum weight and RBC density, a slow rate of weight and RBC loss, and a low 
minimum weight. 
To investigate whether maximum weight and minimum weight were in the 
minimal model because they were important in their own right, or because together 
they described weight loss, the minimal model was fitted with one or other of the 
terms removed to see if the other remained significant. When either maximum 
weight or minimum weight was removed from the model, the remaining maxima or 
minima no longer explained significant amounts of variation in death, leaving rate of 
weight loss the only term in the minimal model. 
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Ratio data 
None of the RBC measures significantly accounted for variation in death in the ratio 
experiment. However, two of the three weight variables that predicted the probability 
of death in the dose experiment also explained significant amounts of variation in the 
ratio data set (Table 5.3). Maximum weight ( 2=8.8, d.f.=1, p<0.05), and the rate of 
weight loss (x2=15.O,  d.f.=1, p<O.Ol) were both important predictors of death. A high 
maximum weight, and a slow rate of weight loss were good indicators that a mouse 
would survive. The model correctly assigned 76% of mice to their true groups. 
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Table 5.2 
Urn variate logistic regression analyses of the dose data. The following were the predictor variables, 
and alive/dead was the response variable. Means with standard errors are also presented for illustrative 
purposes. 
Mean (± s.e.) 
Predictor variables 	Statistic 	alive 	dead 
MAXIMUM WEIGHT 	 x2=Ø•Ø4, d.f.=1 19.54 (±0.265) 19.46  (±0.235) 
p=O.84 
MINIMUM WEIGHT 	 x2=3.2, d.f.=1 15.64 (±0.321) 16.39 (±0.273) 
p=O.07 
MAXIMUM WEIGHT LOSS 	X2=3.6, d.f.=1 2.78 (±0.199) 2.16 (±0.232) 
p=O.O56 
RATE OF WEIGHT LOSS 	%2506 d.f.=1 0.80 (±0.053) 1.0 (±0.065) 
p<0.05 
MAXIMUM RBC DENSITY 	x2=1O.5, d.f.=1 9.26 (±0.010) 8.79 (±0.102) 
P<0.001 
MINIMUM RBC DENSITY 	x2=0.07, d.f.=1 1.73 (±0.075) 1.68 (±0.163) 
p=O.78 
MAXIMUM RBC LOSS 	X2 1.4, d.f.=1 6.94 (±0.147) 6.59 (±0.236) 
p=0.23 
RATE OF REC LOSS 	%20.48, d.f.=1 1.53 (±0.068)  1.75  (±0.068) 
p<0.05 
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Table 53 
The independent variables used in the maximal logistic regression models to predict the probability 
that a mouse will live (column 1). Weight and RBC terms were analysed separately. Ticks indicate 
terms that explained significant amounts of variation and constituted the minimal model. The numbers 
in brackets are the coefficients for each predictor variable: a positive coefficient means that as that 
term increases, so does the probability of survival (vice versa for negative coefficients). 
Predictor variables 	Dose experiment 	Ratio Experiment 
MAXIMUM WEIGHT V (1.2) 	 V(0.8) 
MINIMUM WEIGHT V (-1.0) 
MAXIMUM WEIGHT LOSS 
RATE OF WEIGHT LOSS 	 V (-3.2) 	 V (73.7) 
MAXIMUM RBC DENSITY 	 V (1.9) 
MINIMUM REC DENSITY 
MAXIMUM RBC LOSS 
RATE OF REC LOSS 	 V 
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5.3.2. Can death be predicted from early morbidity measurements? 
The pre-infection weights and RBC densities of all mice were analysed along with 
the first four days after parasites became detectable, a total of 10 measures. Only 5 
remained in the minimal model, which correctly allocated 81% of mice to their true 
groups. The first measure was RBC density prior to infection (X2=13.8,  d.f.=1, 
p<O.Ol). This was higher in mice more likely to survive (coefficient = 2.4). For the 
first two days after parasites became detectable, neither RBC density explained a 
significant amount of variation in death, but both weight measures were important 
(day 1 PPD: X2=9 7,  d.f.=1, p<O.Ol; day 2 PPD: X 2=4 .6 d.f.=1, p<O.OS). A high 
weight on the first day PPD (coefficient = 3.6) and a low weight on the second 
(coefficient = -2.2) increased the chance of survival. Finally on day 4 PPD, both 
weight (2=4.4,  d.f.=1,  p<0.05).  and RBC density 	d.f.=1, p<0.05) predicted 
the outcome of infection. Mice with high RBC densities (coefficient = 0.6) and low 
weights (coefficient = -1.4) were most likely to survive. 
Although death never occurred on the first four days PPD, the first two mice 
died on day 5 PPD. To be conservative, the same analyses were performed on just 
the first two days PPD along with pre-infection measures. The weight on the first two 
days that parasites become detectable (day 1 PPD: X2=5•9,  d.f.=1, p<O.OS; day 2 
PPD: X2=6.3, d.f.=1, p<O.OS) and pre-infection RBC density ( 2=12.5, d.f.=1, 
p<O.Ol) successfully predicted whether or not a mouse would survive. Mice with a 
high day 1 PPD weight (coefficient = 2.4), low day 2 PPD weight (coefficient = -2.4) 
and high pre-infection RBC density (coefficient = 1.9) were the most likely to 
survive. The model correctly allocated 77% of mice to their true groups, a reduction 
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of only 4% on a model including an extra two days measurements to account for 
variation. 
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5.4. 	Discussion 
There was strong overlap in the models investigating the predictors of mouse death: 
maximas and rates of loss were common predictors of death in both weight and RBC 
models for the dose experiment, and for the weight model in the ratio experiment. 
Mice that were initially heavy and who lost their weight more slowly were more 
likely to survive in both experiments. A third factor was also important in the dose 
experiment: mice more likely to survive had relatively lower minimum weights. 
RBC measures were only predictive in the dose experiment, where mice were more 
likely to survive if they had high maximum RBC densities and slow rates of RBC 
loss. These minimal models successfully allocated in excess of 70% of mice to their 
true groups. 
The coefficients for a given variable (see Table 5.3) are analogous to the 
coefficients in a standard regression analysis, and give an indication of the biological 
significance of the variable. However, interpretation of these coefficients is more 
complicated because, unlike a standard regression, the relationships between the 
measured response variable (probability of survival) and the predictor variables are 
not linear. Rather, the coefficients show the relationship between the log of the odds 
of surviving (log [probability of survival/probability of death], also known as the 
logit link function) and the various predictors (Crawley, 1993). This transformed 
variable does vary linearly with the predictors. Thus, the coefficients give the 
expected unit increase (positive coefficients) or decrease (negative ones) in the log 
odds of staying alive for the variable measured. For example, for maximum weight in 
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the dose experiment, the coefficient is 1.2, which means that for a 1 g increase in 
maximum weight, the log odds of a mouse surviving the infection increase by 1.2. 
However, because the coefficients in Table 5.3 give the expected change in 
one unit of the predictor variable, and the number of units that different predictors 
vary over is different, they are not directly comparable with one another. The 
biologically realistic range over which mice can vary will differ for different traits: 
the minimum weight of mice ranged from 12.6 to 19g, whereas the rate of weight 
loss varied from 0.4 to 2.4g d'. So, to compare the relative importance of the terms 
in the minimal model, the biological range over which mice vary (the difference 
between the lowest and highest values) needs to be multiplied by the coefficient for 
that term (Table 5.4). 
From Table 5.4 we can see that the 5 different variables seem to have broadly 
equal biological effects. So what can we conclude about the link between morbidity 
and mortality? Are any of these factors related to death, or could their effect be a 
consequence of it? 
Mice with higher maximum weights are more likely to survive. However, 
when minimum weight is excluded from the minimal model, maximum weight 
ceases to explain significant amounts of variation in death. Thus, it appears to only 
be important in the context of minimum weight, and is therefore likely to be adding 
information about maximum weight loss rather than maximum weight per Se. In any 
case, since maximum weight occurs so long before death, it could probably only be a 
useful correlate (rather than a cause) of death. 
Chapter 5 Predictors of mortality 	 93 
Table 5.4 
Table of biologically relevant effects for the terms in the dose minimal model 
Predictor 	Minimum Maximum Difference Coefficient 	Biologically 
value 	value 	 from minimal relevant effect 
model 
Maximum 	16.81 	23.01 	6.2 	1.21 	 7.50 
weight 
Minimum 12.63 19.05 6.42 -1.01 -6.48 
weight 
Rate of 0.39 2.38 1.99 -3.17 -6.31 
weight loss 
Maximum 7.08 10.16 3.08 1.93 5.94 
RBC density 
Rate of 0.96 2.70 1.74 -1.99 -3.46 
RBC loss 
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Another factor is minimum weight, but the direction of its influence seems 
puzzling. Why should mice with a low minimum weight stand a better chance of 
surviving malaria infection? One might expect a low minimum weight to be 
associated with mice that were going to die. One possibility is that it is an artefact 
brought about by mice dying before they have had chance to lose additional weight. 
Weight loss is not instant, unlike RBC depletion which parasites cause both directly 
(through destruction of infected RBCs during schizogony) and indirectly (through 
immune mediated destruction of uninfected RBCs: Jakeman et al., 1999). Rather, 
weight loss is likely to be due to the energetic costs of fighting infection, and 
cessation of feeding during infection, both of which take time to toll their effects. 
Indeed, minimum weight occurs after minimum RBC density in mice that survive 
(t=3.7, d.f.=64, p<0.001). This, coupled with the fact that no mice died when their 
RBC density was in recovery, suggests that mice that died would have gone on to 
lose more weight had they survived. Therefore, the patterns in minimum weight are 
probably more a consequence than a cause of host death. 
Why might a slow rate of RBC loss decrease the probability of death? It 
could be directly related to death because a slow rate of RBC loss allows hosts time 
to ameliorate the effects (for example by increasing erythropoesis). Alternatively, the 
rate of loss could be related to death because it may indicate that the host is suffering 
from a more virulent infection. The rate of RBC loss is related to parasite growth 
because the host cell is destroyed at the end of each parasite cycle. In mice that 
survive, rate of loss is also related to how anaemic mice become: mice that 
experience higher rates of RBC loss also reach lower minimum RBC densities (F 1 , 
58=  8.9, p<O.Ol). Thus, one possible scenario is that the high rate of RBC loss 
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indicates an infection that is rapidly increasing and will ultimately push a mouse 
below a critical level of anaemia that it cannot recover from. Such a scenario might 
also lead to the prediction that mice with higher RBC densities at the beginning 
would have more chance of surviving as they can afford to lose more RBCs before 
they hit the threshold. This is exactly what was found with maximum RBC density. It 
is difficult to know if relationship between death and the rate of weight loss occurs 
because weight loss increases the probability of death, or is a consequence of the 
effects of anaemia. 
The second aim of this chapter was to investigate whether death could be 
predicted from early weights and RBC densities from the day that parasites become 
detectable on thin blood films. Three measures were found to be important: pre-
infection RBC density, and the weights on the first and second days PPD. Mice more 
likely to survive had high initial RBC densities and their weights on day 1 PPD were 
reduced on day 2 PPD. This model could potentially be useful in deciding whether or 
not an animal will die so that a decision can be made to euthanase it before severe 
symptoms manifest themselves. Using the coefficient for each term, an equation can 
be built that gives each individual a probability of survival, as follows: 
Logit probability of survival = -17.08 + (1.9 x maximum RBC density) + 
(2.4 x day 1 weight PPD) + (-2.4 x day 2 weight PPD) 
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This can in turn be solved to give a probability of survival for each animal. Any 
mouse with lower than a certain pre-defined probability of survival could then be 
killed. Deciding on the appropriate probability to use depends on balancing two 
opposing factors: the first is the risk of killing a mouse that would have survived 
infection, and the second is the risk that mice are not killed, but would go on to die. 
To see how these two criteria trade-off against one another, I determined which mice 
would be killed using three different threshold levels of survival probability. I then 
calculated the percentage of mice that died that would have been killed by a 
researcher using each threshold, and also the percentage that mice that survived that 
would not have been killed. If we use the rule that mice with a probability of 
surviving of less than 50% are killed, then applying this to the dose data set would 
mean that we would have killed 83% of mice that did indeed die, but would also 
have caused us to kill 33% of mice that actually survived (Figure 5.1). Decreasing 
the threshold to 25% would mean that only 36% of mice were correctly killed, but 
the percentage of mice that were incorrectly killed (they actually survived) is reduced 
to 26%. Finally, if we wanted to be even more confident that we only killed mice that 
were going to die, we could stipulate a probability of survival of 5% or less. In this 
extreme case, we would only kill 6% of mice that died, but no mice that survived the 
infection. 
Where the appropriate level should be is open to debate, but the following 
needs to be considered. When the event probability threshold of survival is relatively 
high (e.g. 50%), lots of animals will be killed when they would have survived the 
experiment, which in turn means that additional animals have to be used to achieve 
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Figure 5.2 
A bivariate plot of the difference in the weight of mice in the first two days that parasites became 
detectable on thin blood smears versus their maximum RBC density. Data shown are for dead (open 
circle) and alive (closed square) mice in the dose experiment. The line represents mice that have a 
50% chance of survival calculated from the regression equation (see text). Mice below this line have a 
predicted survival of more than 50% and so would not have been killed based on a 50% cutoff criteria. 
Therefore, mice that survived (closed square) that are above this line, would have been killed 
unnecessarily and vice versa for dead mice. 
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the experimental aims. However, very few of the animals that were not killed needed 
to be, so most of the animals do not suffer severe disease symptoms. Hence, to avoid 
many animals dying from experimental infection, we need to boost sample sizes and 
so use more animals. At the other extreme, if we used stricter criteria for killing 
animals (e.g. 5% survival probability), then many mice would die from infection, but 
sample sizes could be smaller because we would not be killing animals 
unnecessarily. Thus, one needs to balance animal numbers against the severity of 
their suffering. The results of the model provide a preliminary framework that can be 
used to determine endpoints in rodent malarial disease. 
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Chapter 6. 	Transmission stage production from 
infections differing in inoculating dose and the 
proportion of virulent clone 
6.1. 	Introduction 
The evolution of virulence presents an interesting problem that several theoretical 
evolutionary biologists have attempted to solve (for reviews see Bull, 1994; Levin & 
Bull, 1994; Read, 1994; Ebert & Herre, 1996; Frank, 1996). Among the many 
models published, a significant group have one particular assumption in common. 
They assume that virulence is an unavoidable side effect of within-host replication, 
which is favoured by natural selection (Levin & Pimentel, 1981; Anderson & May, 
1982; Ewald, 1983). However, parasites face a trade-off: as replication rate increases, 
so does the probability of killing the host, so parasites are under selection to balance 
these opposing forces (Frank, 1996). 
The previous chapters have focussed on the impact on virulence of both the 
inoculating dose of parasites (Chapter 2), and the ratio of different clones in mixtures 
(Chapters 3 and 4). However, the emphasis has so far been exclusively on host 
fitness, and if we wish to understand these results in the context of virulence 
evolution, we also need to look at the implications these different treatments have for 
parasite fitness. 
Both the inoculating dose of parasites and the proportion of virulent clone in 
a mixed infection affect asexual parasite dynamics. In Chapter 2 it was seen that the 
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elevation in virulence observed as dose increased was coupled with an increase in 
both the total and maximum number of asexual parasites produced in an infection. 
Similarly, in Chapter 3, virulence increased as the proportion of virulent clone 
increased, and patterns of virulence were again correlated with peak asexual density. 
This provides support for the idea that virulence is associated with within-host 
replication, and is thus consistent with the assumption that virulence is an 
unavoidable side effect of this. But ultimately, parasite fitness is determined by the 
number of new infections initiated, not by the density of asexual parasites, so we 
must turn to the only stage in the parasite's life cycle capable of transmission: the 
gametocyte. 
Each gametocyte is derived from a single asexual parasite, which thereafter 
forgoes its own replication. Therefore, there is a trade-off between the production of 
replicating parasites, and non-replicating transmission stages. Gametocyte densities 
are typically low in infections, usually making up an order of magnitude less than 
their asexual counterparts (Buckling et al., 1997; this chapter Figure 6. 1), which has 
prompted the obvious question of why they are so rare given their intimate link to 
fitness (Taylor & Read, 1997)? The cues to stimulate gametocytogenesis are not well 
understood (Sinden, 1983; Carter & Graves, 1988; Alano & Carter, 1990; Pearson, 
1998). However, both the presence of anti-malarial drugs (e.g. Buckling et al., 1997), 
high densities of infected RBCs (e.g. Bruce et al., 1990) and conditioned culture 
medium (Williams, 1999) can increase the rate of gametocyte production, suggesting 
that parasites can facultatively respond to conditions unfavourable for asexual 
reproduction. 
Chapter 6 Virulence and transmission 	 101 
How do gametocyte densities relate to transmission? Most evidence points to 
a positive relationship between gametocyte density and infectiousness to mosquitoes. 
In studies where mosquitoes were fed on gametocyte positive human blood (either 
directly or through artificial feeders), the proportion of mosquitoes that became 
infected, and/or the mean oocyst burden they carried, increased with gametocyte 
density (Carter & Graves, 1988; Graves etal., 1988; Gamage Mendis et al., 1991; 
Sattabongkot et al., 1991; Boudin et al., 1993; Gamage Mendis etal., 1993; 
Tchuinkam et al., 1993; Mulder et al., 1994; Robert et al., 1996). One similar study 
failed to detect a correlation (Burgess, 1960), but this could have been due to a 
number of confounding factors: in field trials, infected human blood is taken from 
people of different ages, with different malaria exposure records, and at different 
stages of infection. However, exposure record was controlled for in neurosyphilitic 
patients treated with malaria (this was their first infection) and there was a positive 
relationship between gametocyte density and the proportion of mosquitoes infected 
(Jeffery & Eyles, 1955). Similarly, work carried out on P. chabaudi in the controlled 
conditions of the laboratory, support the relationship between gametocyte density 
and infectiousness (Mackinnon & Read, 1999a). 
In this chapter I test the implicit assumption that within-host replication is 
linked to between-host transmission, by examining how the patterns of asexual 
parasite densities observed in the previous experiments translate into gametocytes. 
Specifically, I will investigate the effect of the different treatments (which are known 
to increase virulence) on gametocyte production, and also examine whether the 
patterns observed in asexual parasite numbers are realised by gametocytes. 
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6.2. 	Methods 
6.2. 1. Parasitology 
Two clones, CW and BC, of P. c. chabaudi were used to infect 6-week-old male 
(ratio experiment) or 7-week-old female (dose experiment) C57BU6J mice (Harlan, 
UK and B&K Universal Ltd). For clone histories, and general parasitology see 
Chapter 2. 
Gametocytes were identified using polarised light: digested haem pigments 
deflect the plain of polarised light causing them to shine. Only mature gametocytes 
were counted, which are identifiable by the fact that they totally fill the infected RBC 
membrane. On each smear, 25 000 RBCs were examined for gametocytes. Smears 
were counted from two days prior to peak asexual density until no more gametocytes 
could be found (usually 6 days after peak asexual density). Thus, with an average of 
8 smears per mouse, 130 animals in the dose experiment and 50 in the ratio 
experiment, in excess of 35 million RBCs were examined in total. 
Blood sampling was carried out daily between 1500 and 1900 hours. For the 
dose data, parasite densities were estimated from the proportion of RBCs infected 
and the number of RBCs per ml of blood (counted using flow cytometry: Coulter 
Electronics). Daily RBC densities were not taken in the ratio experiment so 
parasite densities are not available for analysis. 
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6.2.2. Treatments and inoculations 
Mice were weighed and allocated at random to experimental treatment groups as 
follows: 
Dose Experiment 
Briefly, within each treatment, groups of 5 mice were infected with a range of doses 
over 6 orders of magnitude of either clone CW (avirulent) or clone BC (virulent). 
The whole experiment was replicated in a second block. Inexplicably, six infections 
failed to develop detectable gametocytes, either because no, or very few, asexual 
parasites developed (block 1: BC 1x10 2 #4, CW 1x104 #1; block 2: BC 1x105 #5, 
CW lx 102  #3, lx 10 #5, lx 10 #3) and one mouse died on the day of infection 
(block 2: CW 1x10 6 #4). Data from these seven mice were excluded from the 
analyses. Full methods are given in Chapter 2. 
Ratio Experiment 
Again, briefly, within each treatment, mice were infected with either a single clone 
(CW or BC), or a mixture of them both, successive mixtures containing an increasing 
proportion of the virulent clone. All mice received the same total number of parasites 
(1x105). The virulent clone made up 0.01, 0.1, 0.233, 0.366, 0.5, 0.633, 0.767, and 
0.9 parts of the mixtures respectively. No gametocytes were detected in the infection 
of a mouse in the 0.767 treatment (#5) so this mouse was excluded from the analysis. 
Full methods are given in Chapter 3. 
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6.2.3. Statistical analyses 
Data were analysed using general linear models (Crawley, 1993). Maximal models 
were fitted first and, beginning with higher order interactions, non-significant terms 
were sequentially removed in a process of backward elimination to generate minimal 
models. All p-values reported for significant terms are from the appropriate minimal 
models, and p-values for non-significant terms are from the step at which they were 
removed. 
Total transmission potential was assessed by two measures: the total density 
of gametocytes produced during the infection, and the total gametocytaemia (number 
of gametocytes in 25000 RBCs). Infective dose, total density of gametocytes, and the 
total gametocytaemia were logarithmically transformed (log 10)  to reduce the 
levering effect of the highest dose treatment, and to normalise the residuals to satisfy 
the assumptions of the statistical models. Fitted terms in the dose maximal models 
included log dose (specified as a covariate), block and clone (factors), and all linear 
interactions between factors and covariates. Proportion of virulent clone was fitted 
on its own in the ratio model (as a covariate). 
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6.3. 	Results 
a) Dose Experiment 
The dynamics of asexual and sexual parasites in each dose treatment for one of the 
blocks are shown in Figure 6. la. See also Chapter 2. The relationship between 
infective dose and the log total density of gametocytes differed for the two clones 
(Figure 6.2, clone*log  dose: F 1 , 117 = 12.5, p<O.00l). For the virulent clone (BC) there 
was a weak negative relationship between dose and density of gametocytes (least 
squares slope ± s.e.= -0.014 ± 0.016), whereas for the avirulent clone (CW), there 
was a positive relationship (least squares slope ± s.e.= 0.096 ± 0.016). There was 
also an interaction between block and clone (block*clone:  F1 , 117 = 4.8, p<O.OS) 
brought about because, whilst more gametocytes were produced for both clones in 
block 1, the discrepancy between blocks was greater for CW infections (Figure 6.2). 
On average across the two blocks, the highest dose CW treatment produced 280% 
more gametocytes than the lowest dose one. These patterns were unaltered if log 
total gametocytaemia was used rather than log total density of gametocytes. 
The magnitude of the increase in gametocytes across CW dose treatments is 
larger than that observed for peak asexual density and the total asexual density in 
CW infections. The relationship between dose and both peak parasite density and 
total asexual density was steeper in block 1 than in block 2 (block*log dose. peak: F 1 , 
56 =  4.35, p<0.05; total: F 1 , 56 = 11.36, p<0.0 1). 
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The dynamics of asexual parasites (left hand column) and gametocytes (right hand column) 
throughout infections initiated with different doses of parasites, and one of two clones. Lines shown 
represent the mean of 5 mice initially, but subsequently numbers were reduced in the BC treatments 
where mice died (shown as t on the right-hand graphs only). Data shown are from the second 
experimental block. These average lines are a reasonable representation of the dynamics of individual 
-mice. Continued on next page. 
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Figure 6.1b - overleaf 
The dynamics of asexual parasites (left hand column) and gametocytes (right hand column) 
throughout infections initiated with a mixture of 2 clones made up of an increasing proportion of a 
virulent clone. Lines represent individual mice in a selection of different infections covering the range 
of treatments. 
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The relationship between infective dose and the total density of gametocytes. 
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However, on average, the highest dose treatment produced 105% more parasites at 
the peak of infection (Figure 2.4c in Chapter 2: least squares slope ± s.e.= 0.14 ± 
0.03), and an additional 150% more parasites over the whole infection, than did 
infections initiated with the lowest dose (least squares slope ± s.e.= 0.7 ± 0.09). 
To investigate whether the effect of dose on gametocyte production in CW 
infections was over and above the reported dose effects on total asexual density and 
peak asexual density (see Chapter 2), log io total asexual density or log 10 peak asexual 
density were fitted as covariates in the appropriate model. Only data for the CW 
clone were analysed because this was the only clone for which there was a 
significant relationship between gametocytes and dose. 
There was a positive relationship between gametocyte density and the total 
density of asexuals (F 55 = 129.4, p<0.001; least squares slope ± s.e.= 1.08 ± 0.09). 
Once this relationship had been controlled for, there was no consistent relationship 
between dose and total gametocyte density across blocks (block*log  dose: F 1 ,55 = 
15.0, p<0.001). Examination of the regression coefficients suggests that this is 
because the relationship between the residual density of gametocytes (once asexual 
parasite density had been controlled for) is relatively flat in block 1, and increases 
with dose in block 2 (least squares slope ± s.e. block 1 = -0.023 ± 0.01; block 2= 
0.059 ± 0.01). 
A similar pattern emerged for the relationship between gametocyte density 
and the peak density of asexual parasites: the more asexuals there were at the peak of 
infection, the more gametocytes were produced (F 55 = 116.6, p<O.00l; least squares 
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slope ± s.e.= 0.97 ± 0.09). Again, once this relationship was controlled for, the 
relationship between dose and total gametocyte density differed between blocks 
(block*log dose: F 1 ,55 = 10.4, p<O.Ol; least squares slope ± s.e. block 1 = -0.0026 ± 
0.01; block 2 = 0.068 ± 0.01). Thus, the overall effect of dose on total gametocyte 
density appears to be through the effect of dose on the density of asexuals. However, 
there is a suggestion that dose has additional effects on the total density of 
gametocytes in at least one of the blocks. 
The clone difference in the relationship between dose and the total density of 
gametocytes (Figure 6. la) could be due to differential mortality in high dose 
treatments: only 1 CW infected mouse died compared with 37 infected with BC, and 
both mortality and the timing of it were positively related to dose (see Figure 2.1 in 
Chapter 2). Therefore, higher dose BC infections could have had less time to produce 
gametocytes than CW infections. If this were the case, then one might not see the 
same positive relationship between dose and gametocyte density as in CW infections. 
To test this, the same analysis between log dose and log total density of gametocytes 
was conducted on the surviving mice only. 
The results were very similar to the previous analysis: the relationship 
between infective dose and the total density of gametocytes differed for the two 
clones (clone*log  dose: F 1 , 81 = 12.7, p<0.001). Again, more gametocytes were 
produced in block 1 (block: F 1 , 81 = 26.2, p<0.001), but this time the differences 
between the blocks did not differ between clones (block*clone:  F1 ,80 = 0. 8, p>0.05). 
Thus, the difference in the relationship between dose and total gametocyte density 
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for the two clones does not appear to be due to censoring of data brought about 
because of host death in high dose BC treatments. 
A second potential explanation for the lack of a relationship between dose 
and gametocyte density for BC was that I did not have enough power to detect one. 
A more explicit analysis tests for a difference between alive and dead mice (fitting 
log dose, block and alive/dead with interactions and using just the data for BC). Once 
survival status was controlled for, there was still no relationship between dose and 
total density of gametocytes (F 60 = 1. 8, p>0.05). However, there was a difference in 
the total density of gametocytes between alive and dead mice (F 1  60 = 7.4, p<0.0 1): 
mice that died produced more gametocytes than those that survived the infection, 
which is the opposite result one might expect if dead mice were biasing the result 
(Figure 6.3). 
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Figure 6.3 
Total gametocyte production for mice in the BC dose treatments that died or 
survived. Error bars represent 1 standard error. 
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b) Ratio Experiment 
As the proportion of virulent clone in the inocula increased, the total density of 
gametocytes produced in the infection decreased (Figure 6.4, F 1 , 47 = 79.2, p<0.001). 
This is despite a positive relationship between asexual parasite densities and the 
proportion of virulent clone (Chapter 3). 
Nonetheless, to check whether the patterns of gametocyte production 
followed those of asexual parasite production, total asexual density, peak asexual 
density, or peak proportion of RBCs infected were included in separate models along 
with the proportion of virulent clone. In no case was there a significant relationship 
between any asexual parasite measure and the log total gametocyte number (p>0.05). 
The proportion of virulent clone remained significant in all three models (p<z0.001). 
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Figure 6.4 
The relationship between the proportion of virulent clone at the start of the infection 
and total gametocyte production. The line is the least square slope from the minimal 
model. 
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6.4. 	Discussion 
If the assumption made in many models of the evolution of virulence is to be 
supported, then there needs to be a positive relationship between virulence and 
within-host reproduction, and also between within-host reproduction and between-
host transmission. 
Chapters 2 and 3 found evidence of the former: there were more parasites in 
more virulent infections. And the results from this chapter go part way to satisfying 
the second condition. In the dose experiment, more asexual parasites were associated 
with more transmission stages. However, this was only for one of the two clones 
used. No relationship was found between infective dose and the number of 
gametocytes for the virulent clone, despite higher dose treatments being more 
virulent and having greater peak parasite densities. 
Furthermore, in the ratio experiment, whilst there was a relationship between 
the proportion of virulent clone in the inocula and gametocyte production, it was 
negative. In infections where the proportion of BC was greater, virulence was higher 
and the numbers of asexual parasites greater. Nonetheless, there were fewer 
gametocytes. There was no relationship between any of the several measures of the 
number of asexual parasites produced, and the number of gametocytes. So where 
does this leave the implicit assumption that within-host and between-host 
reproduction are correlated? 
First of all, although the relationships between peak parasite density and 
gametocyte production seem to be in conflict for the two experimental data sets, 
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there could be grounds for resolution. In the dose experiment, there was a positive 
relationship for CW between parasite dose and gametocyte density, and the actual 
density of gametocytes produced was proportional to the density of asexual parasites, 
which in turn accounted for the virulence of the treatments. Yet, inexplicably, there 
was no correlation between gametocyte density and dose for BC. The treatments in 
the ratio experiment were made up of an increasing proportion of BC, and virulence 
increased in line .with an increasing density of parasites across treatments. Whilst one 
might have expected a positive relationship between the peak density of asexual 
parasites and the number of gametocytes formed in the ratio experiment (based on 
the results seen for CW in the dose experiment), this might be premature. Assuming 
that the majority of parasites at peak in the more virulent ratio treatments were BC, 
and given that there is no detectable relationship between asexuals and sexuals for 
BC, perhaps detecting a negative correlation between the proportion of virulent clone 
and production of gametocytes is consistent with the gametocytes being produced 
belonging to a declining ratio of CW clone? 
The fact that there is a relationship between dose and gametocyte production 
in CW infections challenges the assumption implicit in the operational definition of 
microparasites that the number of secondary infections arising from a microparasite 
infection is independent of dose (Anderson & May, 1991). However, there is still the 
anomalous (lack of a) relationship for BC between dose and gametocyte production, 
which suggests that the validity of the assumption is clone specific. 
CW and BC appear to pursue different strategies: both CW and BC parasites 
produce gametocytes around the time that asexual parasites reach their peak, but CW 
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parasites also produce a second (often larger) batch after this, whereas BC parasites 
rarely produce gametocytes at this time (Figure 6.1a). The dynamics of gametocyte 
production in CW infections are typical of those reported by several other authors 
(Sinden, 1983; Carter & Graves, 1988; Alano & Carter, 1990; Sinden et al., 1996; 
Buckling et al., 1997). Working with eight P. chabaudi clones, Mackinnon and Read 
(1999a, Figure 1) found that the day of peak gametocytaemia was always after peak 
asexual density had occurred. Thus, it seems that in the experiments I report here, BC 
is behaving in a way never seen before: almost without exception, the majority of its 
gametocyte production (and hence transmission potential) occurs before, or at the 
same time, as peak asexual parasite density, rather than after it. Why might this be, 
how can this be resolved with existing data, and what are the implications of it for 
the evolution of virulence? 
This early investment in gametocytes could be in response to a decline in 
future transmission potential. This has been seen in snails and coined the fecundity 
compensation hypothesis (Minchella & LoVerde, 1981): when snails became 
infected with castrating trematode parasites, they increased their egg production. It 
has been suggested that malaria parasites should increase gametocytogenesis in 
response to cues associated with a decline in future transmission potential such as 
parasite clearance or transmission blocking immunity (Koella & Antia, 1995; Taylor 
& Read, 1997). However, given BC has killed over 50% of the mice infected with it 
(Chapter 2), the cue could just as easily be factors indicating that the host is likely to 
die. Indeed, given the high probability of host death in BC infection, early production 
of gametocytes could well increase parasite fitness. 
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Why might the BC gametocyte dynamics reported here be different to those 
published by Mackinnon and Read (1999a)? One explanation could be that BC was 
more virulent in my experiments. In their study, 10 deaths occurred, but only under 
anesthetic during the mosquito feeds late in the infection, whereas over 50% of mice 
died around the time of peak asexual density in my single BC treatments. If the 
hypothesis suggested above is true and parasites are shifting gametocyte production 
forward in response to cues signalling the host is likely to die, one might expect to 
see a large early peak in more virulent infections when it is absent in less virulent 
ones. It is also possible that an early gametocyte peak happened in their experiments, 
but their sampling regime failed to detect it (see their Table 2). 
Finally, what are the implications of these findings for the evolution of 
virulence? A common assumption in the evolution of virulence literature is that death 
acts as a brake on how far virulence can evolve because death reduces parasite 
transmission (Bremermann, 1980; Levin & Pimentel, 1981; Anderson & May, 1982; 
Bremermann & Pickering, 1983; Ewald, 1983; May & Anderson, 1983). This has 
been supported by the results from a dose experiment using a microparasite infecting 
Daphnia (Ebert et al., 2000b). However, the results from the experiments reported 
here suggest that this is not the case, because for one of the clones at least, the peak 
of gametocytes was before any death occurred, and mice that died produced more 
gametocytes than those that survived. This implies that we may have to look 
elsewhere for constraints on virulence evolution. Rather than death per se reducing 
parasite transmission, it could be that imminent death is forcing parasites to produce 
their transmission stages earlier, and thereby limiting the number they can produce 
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because of the trade-off between asexual and sexual parasite production. Such a 
possibility would be an interesting avenue to pursue in further research. 
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Chapter 7. 	General discussion 
A specific discussion is presented at the end of each results chapter. Here, my 
intention is to briefly summarise the main results, draw together some common 
themes, and highlight directions in which the work presented here can be extended. 
7.1. 	Principle findings 
The aim of the work already described was to address three main questions, which 
are presented again along with the main findings: 
7.1.1. How is virulence determined in mixtures composed of clones with 
different virulence schedules? 
In a series of mixed clone infections initiated with an increasing proportion of a 
virulent clone, it was shown that aggregate virulence is not constant (Chapter 3). 
Rather, both the proportion of virulent clone in the inocula, and the genetic diversity 
of the infection interact to determine virulence. This result rebukes the almost 
ubiquitous assumption that the virulence of a mixture is determined by the most 
virulent clone present alone, and is inconsistent with other assumptions about 
virulence determinants in mathematical models. Additional experiments that 
concentrated on two extreme ratios of clones showed that replacing virulent parasites 
with avirulent ones in a mixture could protect the host (Chapter 4). Together, these 
results suggest that selection against virulence can be reduced if virulent clones 
coinfect with less virulent clones, because host mortality in mixtures where the 
avirulent clone dominates is decreased. 
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7.1.2. How do parasites cause disease? 
This question was tackled with an experiment investigating the effects of dose on 
morbidity and mortality (Chapter 2), and also by using the data generated from this 
(along with a second data set from Chapter 3) to investigate the predictors of 
mortality (Chapter 5). The dose experiment revealed that virulence phenotypes are 
robust to variation in dose: a virulent clone is always more virulent than an avirulent 
clone. Higher dose infections were more virulent than the lower dose infections, 
causing greater RBC loss. They also killed more mice and generated greater weight 
loss, but this was only evident for the virulent clone. Larger doses also induced 
earlier mortality and morbidity than did lower dose treatments. All these effects were 
manifested through the timing and/or magnitude of peak parasite densities. 
The predictors of mortality analysis generally showed that both the initial 
weight and RBC density of a mouse, and the rate at which mice lost RBCs and 
weight, affected their probability of survival. This is consistent with mice dying 
because of the speed at which they lose their weight and RB Cs, but these factors 
could also simply be correlates of death, and not the cause of death. Relatively 
simple measures from early in the infection were quite successful at predicting which 
mice would go on to die. Their initial RBC density and their change in weight over 
the first two days that parasites became detectable were good indicators of the 
outcome of the infection. These can be used to define endpoints of infections, leaving 
the researcher to decide on an appropriate level of probability of death to choose. 
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71.3. How does the virulence of the infection impact on parasite fitness? 
Parasite transmission stage production was assessed from the experiments 
investigating the impact of dose on virulence (Chapter 2) and determinants of 
virulence in mixtures (Chapter 3). More gametocytes were produced in higher dose 
treatments for the avirulent clone. As well as being more virulent, these treatments 
also produced greater numbers of asexual parasites, supporting the assumption that 
within-host reproduction is linked to between-host transmission made in the adaptive 
trade-off models of the evolution of virulence. However, there was no relationship 
between dose and gametocyte density for the virulent clone. Furthermore, death did 
not reduce the total density of gametocytes generated in the infection, suggesting that 
death might not act to reduce selection against virulence in the ways previously 
thought, although it still might by forcing parasites to produce gametocytes earlier. 
7.2. 	General themes 
Of the results that are discussed in detail in the individual chapters, two general 
themes have emerged that are developed here. 
72.1. Why do BC parasites produce higher peak asexual parasite densities 
than CW parasites? 
Phrased another way, what enables BC parasites to produce more asexuals? CW 
produces fewer parasites than BC and the total maximum parasite density increases 
additively as the proportion of BC increases. This is a curious finding: both are 
microparasites capable of expanding their within-host population sizes, yet BC 
parasites appear to be able to "take up more space" in their hosts, before their 
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numbers are reduced. This question is closely related to a second: what limits 
population size in these malaria parasites? This second question has been addressed 
in collaboration with others in the theoretical manuscript in the appendix; Various 
scenarios can be envisaged to account for the differences in CW and BC peak 
parasite densities. 
I. 	There is a fixed period between invasion and immune activation. 
This could account for the differences since CW grows more slowly than BC, so in 
the same time period BC parasites could achieve higher parasite densities. This is 
unlikely to. be true since the peak asexual parasite density is later for CW than BC, 
lower dose infections of both clones peak later, and there is no evidence of time 
dependent immunity in the model in the appendix. 
H. 	CW clone is more immunogenic, causing a larger per parasite upregulation of 
the immune system 
In this case, for a similar density of parasites, CW would generate a disproportionate 
immune response, which could then prevent it from reaching the same peak parasite 
density as BC. This also seems unlikely to be true since it assumes that in the 
absence of an immune response, CW and BC parasites are equally matched in terms 
of growth potential. In fact, evidence from the dose experiments shows that the 
growth rate of CW is less than that of BC in the earlier stages of infection when an 
immune response is negligible. 
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ifi. 	CW grows more slowly so the immune system has more chance to get it 
under control 
This could be the most likely explanation. The fact that CW parasites are growing 
more slowly than BC parasites also raises its own question: why should this be? 
Potentially it could be because CW parasites produce fewer merozoites per schizont, 
because their merozoites are more susceptible to destruction by immunity (because 
they are more immunogenic, or have slower invasion rates?), or because they 
produce more gametocytes and gametocytes trade-off against asexual parasites. The 
answers to the first two suggestions are unknown, but the latter is known to be true. 
Since peak parasite densities are correlated with the virulence of the infection, the 
answer to the question of why CW grows more slowly than BC could potentially 
shed light on the mechanisms of virulence. These are of interest to evolutionary 
biologists and clinicians alike, since these pathways offer the potential to target the 
causes of virulence with the aim of reducing disease severity in human populations. 
7.2.2. Generalising among clone pairs is dangerous 
The virulence of AS/AT clone pairs in a mixture was different to that of CWIBC 
parasites. Whatever the reason, this suggests that generalising from my results to 
other clone combinations is unwise. So why might AS/AT mixtures have generated 
different virulence profiles, even though the virulence of the component clones is 
similar? 
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I. 	AS and AT are more genetically distinct than CW and BC. 
It has been proposed that the part of the increase in virulence in mixtures could be 
host associated and attributable to the additional costs of mounting an immune 
response to a genetically diverse infection (Taylor et al., 1998). If this is the case, 
and AS/AT are more immunologically distinct than CWIBC, then this could account 
for the increase in virulence of the AS/AT mixtures. 
II. 	AS and/or AT facultatively increase their growth rate in mixtures whereas 
CW and/or BC do not. 
If AS and/or AT increase their growth rate when in the presence of another clone, 
and CW and /or BC do not, then the increase in virulence in AS/AT mixtures could 
be due to the additional parasites present? Indeed, there were more parasites at the 
peak of infection in the AS/AT mixtures. However, when these were controlled for in 
the analyses, these mixtures were still more virulent, over and above the number of 
parasites present, so this cannot be the whole story. 
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7.3. 	Future directions 
. How do clones interact in mixtures? Is the bucket model correct? 
This could be partially tested by looking at the individual growth rates of clones 
in mixtures using monoclonal antibodies or a quantitative PCR-based approach. 
. Are AS/AT infections more virulent because they are more antigenically distinct? 
This could be investigated by screening a suite of monoclonal antibodies against 
the two clones, and comparing their cross-reactivity to CW/BC. 
• To assess the generality of the results from both the ratio, and the protection 
experiment, further clone pairs could be screened. A useful starting point might 
be to assess the virulence and parasite densities of AS/BC and CW/AT mixtures. 
• How robust are the endpoints from the predictors of mortality analysis? To see 
how useful the initial RBC density and the change in weight over the first two 
days are for predicting death in other experiments, data could be collected using 
other clones that cause death. 
• Is the new pattern of BC gametocyte production seen in my experiments 
associated with its increase in virulence? Since there are freezer stocks of the BC 
clone taken at different numbers of passages these could be checked for the stage 
at which the pattern of gametocyte production changed, and correlated with its 
virulence. 
• Why does CW grow more slowly? The number of merozoites per schizont can be 
counted if sampled at the appropriate time of day (around midnight), and the 
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strength of the immune response against CW and BC tested to try and elucidate 
why CW grows more slowly. 
In conclusion, the results reported in this thesis show that determinants of virulence 
in mixtures are more complex (perhaps inevitably?) than the evolution of virulence 
models assume, and also question how generalisable the various patterns of virulence 
and transmission are between clones. 
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Appendices 
These appendices include other work that Ihave completed during my PhD. 
1. News stories that were written for the general public and published on the BBC 
Wildlife web site: 
Timms, R. (2000) Fire Alarm. www.bbc.co.uk/nature/animals/news/146news3.shtml  
Timms, R. (2000) Chopping down deforestation rates. 
www.bbc.co.uk/nature/animals/news/148news2.shtml  
Timms, R. (2000) UK says no to illegal logging. 
www.bbc.co.uk/nature/animals/news/148news3.shtml  
Timms, R. (2000) African rhinos march back from brink of extinction. 
www.bbc.co.uk/nature/animals/news/148news.shtm1  
Timms, R. (2000) Lope Reserve saved from threat of logging. 
www.bbc.co.uk/nature/animals/news/146news2.shtml  
2. An article that won a runners-up position in the Wellcome Trust-New Scientist 
Millennium Science Essay Competition 2000 (When parasites become unlikely 
allies). 
3. A news and views manuscript (Timms, R and A.F.Read. 1999. What makes a 
specialist special? Trends in Ecology and Evolution. 14(9): 333-334). 
4. A manuscript worked on in collaboration with Dan Haydon, Nick Colegrave and 
Louise Matthews addressing a relevant question to this thesis of what regulates 
- 
	
	peak parasite density during infection (Regulation of malaria parasitaemia: a 
theoretical approach). 
5. A reprint of the manuscript based on Chapter 2 (Timms, R., N. Colegrave, B. H. 
K. Chan, and A. F. Read. 2001. The effect of parasite dose on disease severity in 
the rodent malaria Plasmodium chabaudi. Parasitology. 123:1-11). 
ONLINE 
Text only 
BBC Nature Online - Animals - News 
	
http://www.bbc.co.uk/nature/animals/newsf46news3  .shtml?survey 
TUESDAY 
23rd October 2001 
. A-Z Index I Search 
f 
 Select an article 	 ii
Nature Programmes 
[-, Main Sites fl  
NEWS 
Find out more about: 
BBC Homepaqe 28 July '00 - 	 BBC Wildlife Maqazine 
Nature 	Fire alarm Nature BBC Shop 
Raging fires in Greece have prompted The World Wildlife _______ 
Fund (WWF) and The International Conservation Union 	
B i rd (IUCN) to call for world leaders to urgently address the 	 Talk 
underlying causes of forest fires, and develop policy to  
prevent similar events causing a future global catastrophe. 	Ytt 
This call to arms coincides with the publishing of "The 
Global Review of Forest Fires", a joint WV'IF/IUCN action 
plan with recommendations for global, national and local 
levels. 
Lives, livelihoods and ecosystems are at risk from the 
devastating effects of forest fires, says the report. The 
appalling images of people choking on smoke in South 
East Asia in 1998 raised the issue onto an international 
platform, but since then it has slipped from the political 
agenda. "Currently there is little or no political will to stem 
the fire-starting going on," said Steve Howard of 
WWF-International. 
At least 70,000 hectares of forest, including two wildlife 
hotspot areas, have burnt to the ground in the last few 
weeks. On the Island of Samos, where fires have been 
burning for almost a week, vast areas of forest are gone. 
Constant heavy rain over the weekend has brought the 
fires under control in the second biological oasis: the 
Pindos mountains in Greece. However, some areas are still 
burning, and many forests that sustain the local economy 
have been destroyed. 
This is not a surprise to Aristotelis Papageorgiou of 
WWF-Greece who said, "[We have] repeatedly warned the 
government over the past two years that there was a 
catastrophe in the making yet the official response 
continues to be characterised by political expediency, 
short-termism and policy failure." 
These fires are often started to clear forests. However, 
when the annual rains fail to arrive, as in El Niño years, 
then the fires rage out of control, destroying all in their 
path. 
"A big El Niño year, combined with the current practice of 
rampant arson -will mean that what we have already seen 
will be the tip of the iceberg," said Howard. 
Rebecca Timms 
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Features The rampant destruction of our world's forests is declining !,'Message Board  
Postcards according to a statement issued by the Food and Bird Talk 
Wildfacts Agriculture Organization (FAQ) yesterday. 
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Webcams  
Preliminary analysis of over 300 satellite images has  
Quiz & Fun revealed that the rate at which tropical forests were being Bee Research Center 
Directory destroyed in the 1990s decreased by at least 10 per cent vvolfspider 
per year. These results form part of FAQ's Global Forest 
Resources Assessment 2000, due to be made public and 
BBC my 
distributed on the internet at the end of this year. The 
report will review the state and change of forests in all Win a book 
Feedback countries at the end of the millennium as part of the FAQ's Win tickets 
ongoing commitment to regularly monitor the world's 
Help forests. 
The reasons for the reduction in the rate of deforestation Get in touch 
Nature Newsletter Like this page? 
Send it to a friend! 
are not yet clear but, say the FAQ, probably include 
increased awareness of the need to manage forest 
resources in a more sustainable manner, as well as 
technological advances that make sustainable 
management more feasible. 
The major causes of deforestation in the tropics include 
"the expansion of subsistence agriculture in Africa and 
Asia, and large economic development programmes 
involving resettlement, agriculture and infrastructure in 
Latin America and Asia," said Lennart Ljungman, Director 
of the Forestry Policy and Planning Division at the FAQ. "In 
addition, overharvesting of industrial wood and fuel wood, 
overgrazing, fire, insect pests and diseases, storms and air 
pollution cause forest degradation." 
Although these results are encouraging, there is still room 
for improvement because, whilst half of the satellite images 
show a decrease in the rate of destruction, :20 per cent of 
them indicate an increase. Still, if the strong efforts being 
mounted on behalf of forest conservation are maintained, 
then the FAQ hope that this trend will continue. However, 
they stress that deforestation continues at an unacceptably 
high rate and forests are not yet out of danger. 
Hosny El-Lakany, Assistant Director-General of the FAQ 
Forestry Department, voiced the following warning against 
complacency: "These preliminary results do not mean that 
the battle against deforestation is over, and a reduction in 
deforestation must not be used as an excuse for 
unsustainable forest practices." 
Rebecca Timms 
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Nature UK says no to illegal logging 
Animals 
Features The UK Government has said it will no longer purchase 
Postcards timber which has been unsustainably harvested following, 
Wildfacts the pledge it made at the G8 summit last month that it 
Webcams would do more to stem the illegal logging trade, particularly 
Pets that which goes on in developing countries. Friends of the 
Quiz & Fun Earth (FoE) forest campaigner Mall Phillips was delighted 
Directory to see the Government developing a strong policy on this 
"This crucial issue. 	is a substantial step forward," he said. 
my BBC 
Environment minister Michael Meacher told parliament 
yesterday (Wednesday), "Illegal logging damages both the 
Feedback environment and society. It reduces government revenues, 
destroys the basis of poor people's livelihoods and in some 
Help cases even fuels armed conflict. The Government is a 
major purchaser of both timber and timber products and 
- has a responsibility to ensure its own house is in order." 
Like this page? 
Send it to a friend! This follows the embarrassing exposé by FoE that the 
Cabinet Office was planning to buy illegally logged 
Brazilian mahogany for Jack Cunningham's desk. 
Green peace has also campaigned hard on illegal logging 
in the past few months, raising greater public awareness 
about the issue. 
The current voluntary guidance on environmental issues in 
timber purchasing will become a binding commitment on all 
central government departments and agencies. Timber and 
timber products will be obtained from sustainable and legal 
sources where possible, such as those identified under 
independent certification schemes, such as the one 
operated by the Forestry Stewardship Council. 
Also, each central government department will report 
annually on its timber purchases and their sources, and the 
process will be monitored by an inter-departmental group 
reporting to a committee of 'green ministers'. 
The new measures will complement the UK's other work 
combating illegal logging, such as encouraging good 
governance and stopping corruption, tackling the debt 
burden, improving awareness of the true value of forests 
and developing alternative incomes for poor rural people. 
"The destruction of the forests continues," Phillips said, 
"but this is certainly a move in the right direction. We want 
to see the UK having less impact on precious biodiversity 
reserves and forest-dependent people around the world." 
Rebecca Timms 
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Nature 	African rhinos march back from brink of extinction 	Nature CE-0 BBC hop 
Animals 
Features Wild African rhinos are on the increase, according to the 
Postcards latest statistics from the World Conservation Union (IUCN) 
Widfacts and the World Wildlife Fund (WWF). 
Webcams 
Pets The latest estimates from the IUCN's African Rhino 
Quiz & Fun Specialist Group encouragingly show a 50 percent 
Directory increase in rhinos since 1992, the highest numbers since 
the early 80s. The bulk of this increase is due to the 
southern white rhino, which is one of the world's greatest 
BBC my 
conservation successes. In 1895, there were as few as 20 
individuals but in the last century it has clawed its way back 
Feedback from extinction, and the population now stands at just over 
10,300. 
Help 
"Even though overall numbers are positive, there is no 
room for complacency," said Martin Brooks, chairman of 
Like this page? lUG N's African Rhino Specialist Group. "Numbers of two of 
Send it to a friend! the six African rhino subspecies remain very low, and 
invasions of private land in Zimbabwe by war veterans and 
squatters currently pose a threat to several significant 
populations." 
Poaching, fuelled by illegal demand for rhino horn, has 
eroded rhino numbers in the wild. Horns are used in 
traditional Chinese medicine, and to make decorative 
dagger handles in the Middle East. Because of this, 
extinction looms over one of the four subspecies of black 
rhino, the western black rhino: only about 10 animals are 
left in northern Cameroon. Similarly, in contrast to its 
successful cousin, the northern white rhino is fighting for 
survival with as few as 30 individuals remaining in the wild. 
However, effective conservation strategies, involving local 
communities and government agencies alike, are 
stemming the slaughter, and rhino populations are 
beginning to recover. This conservation effort des not 
come cheap though - it costs as much as US$1,000 to 
conserve every square kilometre of rhino habitat each 
year. 
The continuing declines in government funding for 
conservation across the African continent and reduced 
staffing are impeding essential work in the field. This, 
together with the illegal demand for horns, poverty, the 
ready availability of arms and the lack of internal stability in 
some African countries continue to pose a threat to rhino 
populations. "One of the greatest challenges facing the 
future of rhinos in both Africa and Asia is maintaining 
sufficient conservation expenditure and field effort," said 
Brooks. 
Rebecca Timms 
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Nature 	Lope Reserve saved from threat of logging 	 Nature c BBC Shop 
A pioneering agreement between conservation 	 ____ 
organisations, logging companies and the Government of 	
B 	1k Gabon has banished logging from the precious Lope ird Ta l 
Reserve in central Gabon.  
Lope Reserve was created in 1946 and covers 5,000 
square kilometres of mixed habitat ranging from savannah 
to tropical rain forest. It harbours many endangered 
flagship species including gorillas, chimps, and forest 
elephants, all of which are under threat from habitat 
destruction caused by commercial logging. It is also of 
anthropological interest, being home to many archaelogical 
remains. 
Logging companies, many of which are European, have 
been able to exploit a legal loophole that has allowed them 
to extract wood from over half of the reserve. The principle 
source of timber is the valuable Okoume tree, which is in 
demand to produce high quality plywood, and has even 
been used as flooring in Eurostar trains. 
On July 11, negotiations were finalised to move the 
boundaries of the reserve. An important species-rich area, 
previously earmarked for logging, has been exchanged for 
less biologically valuable land. This means that, whilst 
logging can continue, the fauna and flora within the reserve 
will finally be safe after years of conflict and campaigning. 
"Today, Lope is once again a key protected area of prime 
national and international importance," said Dr. Lee White, 
an ecologist with the Wildlife Conservation Society, who 
has studied the impacts of logging in the forest. "This 
agreement is a landmark for conservation in Gabon." 
Other protected areas exist in Gabon, and now the 
challenge is to capitalise on this conservation victory and 
try to link them together to form Gabon's first network of 
national parks. The Government of Gabon has already 
verbally expressed its support, but hard cash will be 
needed to transform these bold ambitions into reality. 
Rebecca Timms 
The BBC is not responsible for the content of other sites listed. 
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When parasites become unlikely allies... 
Infectious parasitic disease is something we have all experienced. In Britain 
each year, most people succumb to the common cold, and flu will debilitate many of 
us. Meanwhile, in tryical countries, people are similarly pursued by parasites. 
However, these tend to be of a more deadly nature. For example, malaria rampages 
throughout equatorial regions, slaying two million people each year. This haunting 
figure commands the best efforts from an army of researchers trying to temper it. But 
an inkling of hope can be gleaned from the fact that not everyone who catches 
malaria dies. In fact, less than one percent of infections kill. But why do some kill 
when others spare their hosts? Armed with a passion to understand this, I started my 
PhD working on the evolution of virulence in malaria parasites. 
Virulence is defined as the amount of damage that hosts suffer following 
parasitic infection. Mortality is one extreme of this continuum, but even if people 
manage to escape this grim fate, they will still become sick. 
But first a little more about the beast. Malaria parasites live inside RBCs, 
quietly hiding from the patrolling garrison of immune cells. After a ten-fold increase 
in a day or so, they spectacularly burst out in synchrony and make a mad dash for 
their next refuge, destroying their home in the process. Malaria is a rapacious 
parasite. A few of them mature into special transmission stages, ready to extend their 
journey into an intermediate host: the mosquito. This sucks them up when feasting 
on a blood meal, and they quickly develop, ready to infect their next victim when 
feeding time comes again. As the song goes, "the female of the species is more 
deadly than the male"-since only she drinks blood. 
So what factors underlie the variable outcomes of infection? It is likely that a 
combination of host, parasite and environmental factors play a part, but I am 
focussing on the parasite's role. We know that clones causing more virulence also 
have higher growth rates, and natural selection will favour these. To make it clear, 
take a bucket, 900 blue and 100 red marbles. If you shut your eyes and randomly 
select a marble from the bucket ten times, you will have more blue marbles than red 
in your hand. So when the mosquito feeds, she will imbibe more of the numerically 
dominant clone. This is a sombre fact to realise: parasites causing the most damage 
are winning the game of life. 
After contemplating this, a faint idea struck me: what if avirulent ("nice") 
clones infecting with virulent ("nasty") clones can protect their host? It was a shot in 
the dark, but I had to know the answer. Fortunately there are closely related species 
to human malaria parasites (Plasmodiumfalciparum) that infect mice (P. chabaudi), 
so important experiments like these can avoid putting humans at risk. And so I 
carefully carried out my experiment with appropriate control groups, and infected 
mice with either a virulent clone on its own or a mixture of l virulent: 9avirulent 
clones. When the time came to collect the data my stomach was leaping with 
anticipation. Would hosts infected with the mixture be better off than those with just 
the virulent clone? I took a small blood sample from each host and, one by one, put 
them into a machine that counts the number of RBCs. I could hardly believe what I 
was seeing! Both groups had been infected witkthe same number of virulent 
parasites, but one group had been given 90 percent more avirulent parasites too, yet 
these were less anaemic. They had also lost less weight. 
This is deeply exciting news: avirulent parasites can protect their host from 
virulent parasites. It has important consequences for how selection will act on 
parasites, but it is only a small link in our struggle to tame the human malaria 
parasite. Many other aspects of its biology are being nailed down by dedicated teams 
in centres of excellence throughout the world. The battle is not yet won, but maybe it 
is only a matter of time? 
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What makes a specialist special? 
Two centuries ago, fleas were feasting on the blood of passenger pigeons 
(Ectopistes migratorius), the most abun-
dant birds in North America'. One hun-
dred years on, Martha, the last passenger 
pigeon, took her final breath, and the 
fleas' fate was sealed. This popular, and 
possibly apocryphal, tale has been used 
to illustrate how 'running out of niche' 
leads to unavoidable extinctions 2. How-
ever, this process begs an obvious ques-
tion: why were the fleas stuck with the 
doomed pigeons? 
The factors that constrain niche ex-
pansion lie at the heart of a key problem 
in evolutionary ecology: why are there so 
many different types of species? Why is 
there not an ultimate organism adapted 
to exploit all ecological niches? Host—
parasite systems provide fertile - and 
important - ground for examining these 
questions: habitat specificity can be 
readily defined (i.e. number of host 
species exploited), and host specificity 
varies, even among closely related taxa 
(e.g. Ref. 3). A new study of cave swiftlets 
(Aerodramus and Collocalia genera) and 
their parasitic feather lice (Dennyus) by 
Tompkins and Clayton4 illustrates both the 
potential and the challenges of investigat-
ing the determinants of host specificity. 
Host specificity 
Why are there no parasite species 
exploiting all the members of large taxa 
such as mammals or birds? Evolutionary 
ecology offers two major classes of expla-
nation for habitat restriction: limited dis-
persal and limited adaptation. Some para-
sites might have a limited host range 
simply because they do not come in con-
tact with other host species. Perhaps the 
fleas of passenger pigeons had opportu-
nities to transmit only to other passenger 
pigeons? Alternatively, host specificity 
could arise because of adaptive special-
ization: pigeon fleas might have been 
incapable of successful reproduction on 
other avian species. 
We have remarkably little understand-
ing of the relative importance of these 
alternatives in limiting host range in 
natural parasite populations. However, at 
least in principle, it is easy to determine 
in particular cases. If host specificity arises 
because of limited dispersal, parasites 
should be capable of proliferating once 
experimentalists help them over the dis-
persal barrier. If adaptive constraints are 
responsible, then parasite fitness will be 
severely reduced on novel host species. 
Lousey swifflets 
Tompkins and Clayton4 tested these 
predictions using host-specific species of 
feather lice from four species of cave 
swiftlets in Borneo. Their study is un-
usual in that they exploited natural host—
parasite combinations and conducted the 
experiments in the field. Importantly, 
they used reciprocal transfer experiments; 
such experimental designs eliminate the 
possibility that some host species are 
simply worse habitat for parasites. 
Cave swiftlets, as their name sug-
gests, live in caves. The feather lice they 
harbour are chewing lice, which are 
obligate ectoparasites that spend their 
lives feeding from their hosts. Some 
species are found almost exclusively on 
one swiftlet species; others are found on 
three different host species. Each year, 
during the bird's breeding season, lice 
reproduce and their offspring infect the 
nestlings 5. Horizontal transmission can 
also occur if lice crawl between nests. 
In an elegant experiment, Tompkins 
and Clayton4 transplanted host-specific 
feather lice between nestlings of closely 
related species of cave swiftlets. The sur-
vivorship of lice transferred between 
species was compared with that of lice 
transferred to different individuals in the 
same species. 
Louse survival was severely de-
pressed following transfers to novel 
hosts. Furthermore, surveys of the louse 
fauna of over 1300 swiftlets turned up the 
occasional specialist louse on the 
'wrong' swiftiet species. Although it is 
hard to eliminate experimental contami-
nation completely, such observations 
argue against an absolute lack of dis-
persal to new host species. Given the 
poor survivorship of lice on abnormal 
hosts, limits to adaptation is implicated 
as the major cause of host specificity in 
this system. 
Correlational evidence points to a 
possible proximate mechanism. Lice that 
were transferred to hosts with similar 
feather barb dimensions did less poorly 
than those that were moved to more dis-
similar species. In addition, those lice 
that did survive were found at feather 
positions with the same barb diameter as 
their usual location on their original host. 
Apparently, some of the negative effects 
of host shift can be offset by microhabi-
tat shift. But quite why barb diameter 
should matter is unclear. Bill morphol-
ogy suggests that preening is not likely to 
be a major source of louse mortality. 
However, adult swiftlets feed on the wing 
and feather lice must have a hard time 
clinging on during aerial acrobatics. This 
problem might also occur in nestlings 
because vigorous wing flapping is appar-
ently common before fledging. It would 
be useful to know whether the stresses 
encountered by lice during such activity 
generate an optimal morphology (e.g. leg 
size) for a given barb size. Attachment 
per se need not be involved: microcli-
mate around the lice on the feathers is 
also likely to be affected by barb size, 
and many other host features probably 
covary with barb size, not least body size 
and the morphological and physiological 
variation that goes with that. 
Constraints on adaptation 
Nailing down the relevant proximate 
mechanism might help address the next 
key question: what is constraining adap-
tation in this system? In theory, limits to 
adaptation can arise by several routes 9 . 
The strength of selection might be insuffi-
cient to counter the mutational degra-
dation of alleles conferring benefits in 
rarely encountered environments, or 
there might be tradeoffs - a jack-of-all 
trades might be a master of none. Empiri-
cal evidence for any of these ideas is 
sparse. If legs and barb sizes are 
involved, it might be possible to deter-
mine whether tradeoffs exist in the 
louse—swiftlet case from aerodynamical 
principles alone. 
Alternatively, it might be the low 
rates of dispersal between swiftlet 
species that limit adaptation. If lice were 
more frequently encountering the 
'wrong' host species, they might have 
adapted to more than one host. One of 
the lice species in the Borneo cave is fre-
quently found on three swiftlet species, 
which suggests that the barriers to 
adaptation revealed by the transplant 
experiments are not insurmountable. 
Evolutionary responses to experimental 
manipulations of dispersal rates be-
tween different host species would 
help, but are probably feasible only in 
laboratory models. 
Prospects 
These general issues have impli-
cations far outside the traditional remit 
of evolutionary ecology. By definition, 
zoonotic disease agents have the ability 
to cross species boundaries and, as HIV 
has tragically demonstrated, emergent 
diseases of biomedical significance are 
frequently the result of a host switch. 
How much are we, and the animals we 
depend on, protected by host specificity? 
How much of this specificity is due to 
adaptive specialization? How can we 
create conditions that inhibit parasite 
TREE vol. 14. no. 9 September 1999 	0169-5347/99/$ - see front matter 0 1999 Elsevier Science Ltd. All rights reserved. P11: S0169-5347(99)01697-3 333 
NEWS & COMMENT 
adaptation to hosts we care about? Even 
at a proximate level, major questions 
remain unanswered. For instance, how 
do host responses to infection vary 
between host species? Does adaptation 
to new hosts principally involve evasion 
of protective host responses or other 
host-specific physiological conditions? 
Evolutionary ecologists could be playing 
a major role in addressing these ques-
tions in the biomedical and veterinary 
context. What keeps parasites host-
specific matters at least as much for us 
as it did for passenger pigeon fleas. 
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Toxins, nutrient shortages and droughts: 
the serpentine challenge 
Serpentine is the common (and strictly speaking erroneous) name used by 
biologists for a suite of rock types that 
contain ferromagnesian minerals. Ser-
pentine is in fact just one of those miner-
als and the igneous or metamorphic rocks 
containing them are better designated as 
ultramafic - a more recent geological 
term emphasizing their high magnesium 
(Mg) and iron (Fe) concentrations'. 
These rocks are also often relatively rich 
in chromium (Cr), cobalt (Co) and nickel 
(Ni), and have relatively low concen-
trations of silicon (Si), and usually low 
concentrations of phosphorus (P), potas-
sium (K) and calcium (Ca). The soils 
derived from these rocks can offer an 
edaphic environment with toxic concen-
trations of Mg and Ni, a dearth of mineral 
nutrients (including micronutrients), and 
with a strong tendency to drought and 
the associated proneness of their veg-
etation to burning. The soils are very 
variable but, in their extreme forms, their 
combination of adverse chemical and 
physical conditions presents a major 
challenge to plant growth and hence they 
can bear open, low-stature vegetation that 
is floristically distinct with a high propor-
tion of endemic or disjunctly distributed 
species. They were first recognized as 
bearing unusual plants by Caesalpino in 
1583 (Ref. 2) and a large literature on 
their plants and soils is available for 
many countries in the world34 . 
The biological importance of ultra-
mafics far outweighs the c. 1% of the  
earth's surface they occupy. For exam-
ple, they can be refuges for whole veg-
etation types, as is seen in parts of west-
ern California where the native grasslands 
have succumbed to European introduc-
tions except on ultramafics, where the 
exotics have been unable to produce 
resistant races. 
Until this decade, the separate groups 
of scientists working on the biology of 
ultramafics had done so with little inter-
national contact. This situation was 
changed by the 'First International Con-
ference on Serpentine Ecology', which was 
held at Davis, California in 1991 (Ref. 5). A 
second international conference was 
held in 1995 in New Caledoniat and the 
third, organized by K. and M-J. Balkiwill,in 
March this year in South Africa (University 
of the Witwatersrand, Johannesburg). I 
am reporting on some of the important 
features of the third conference. 
The conservation importance of ultra-
mafic rocks quickly emerged as a major 
theme of the conference and it is clear that 
a high proportion of their endemic plant 
species must be endangered. Ed Witkowski 
(University of the Witwatersrand) showed 
this emphatically using the Swaziland 
endemic red-hot poker, Kniphofia umbrina, 
as an example, and it was implicit in many 
of the other presentations, including the 
elegant work of Roger Reeves (Massey 
University, New Zealand) eta!, on the highly 
fragmented outcrops in western Turkey. 
Several papers dealt with ultramafic 
soil microbes and 1-lamid Amir and Rend 
Pineau (Université Française du Pacifique, 
New Caledonia) demonstrated not only 
adaptations of free-living microorgan-
isms to high soil Mg, Co, manganese 
(Mn) and Ni, but also their role in releas-
ing these elements into a plant-available 
form. Mycorrhizas were briefly dealt 
with, but we await critical experiments 
before an assessment can be made of 
their possible roles in ultramafic resist-
ance. Certainly the Brassicaceae and 
Caryophyllaceae, two predominantly non-
mycorrhizal families, are a conspicuous 
component of many ultramafics at higher 
latitudes in the north temperate zone. 
The evolutionary adaptation of plants 
to ultramafic soils is a crucial aspect 
of their ecology. Mark Macnair (Exeter 
University, UK) et al. reported some 
recent work on inherited and correlated 
traits apparently for drought tolerance and 
also for ultramafic soil tolerance in five 
species of the Mimulus guttatus (monkey-
flower) complex. This is important not 
only because it shows the genetic com-
ponent in tolerance, but also because it 
backs ideas of the role of drought in ultra-
mafic soils. The studies of Anna-Britt 
Nyberg (Mid Sweden University) et al. on 
Cerastium alpinum (Alpine mouse-ear) 
neatly demonstrated the capacity for 
independent evolution of ultramafic resist-
ance in different races of this species, 
which each have a separate genetic back-
ground. The existence and importance of 
soil heterogeneity was highlighted by the 
detailed studies of Nishanta Rajakaruna 
and Bruce A. Bohm (University of British 
Columbia, Canada) on Jasper Ridge, Cali-
fornia, who showed the existence of two 
virtually noncrossing races of Lasthenia 
californica growing on different but juxta-
posed ultramafic soils. 
The consideration of the physiology 
and chemistry of organisms on ultramafic 
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Regulation of malaria parasitaemia: a theoretical 
approach 
Abstract 
We develop a theoretical framework with which to consider the intra-host regulation of malaria 
parasitaemia. We analyse a general model that relates timing and magnitude of peak parasite 
density to initial dose under three different regulatory processes. Dynamics can be regulated by 
either top down processes (up-gradable immune regulation), bottom up processes (fixed immune 
response and RBC limitation) or a mixture of the two. This framework allows us to define and 
estimate the following relevant parameters: the rate of RBC replenishment; the rate of 
destruction of uninfected RBCs, and maximum parasite growth rate. Comparing predictions of 
this model with experimental results allowed us to reject functional forms of immune up-
regulation and/or effects of RBC limitation that were inconsistent with the data. Bottom up 
regulation alone was insufficient to account for observed patterns without invoking either 
localised depletion in RBC density or merozoite interference. In contrast, an immune function 
up-regulated in proportion to either merozoite or infected RBC density was consistent with 
observed dynamics. An immune response directed solely at merozoites required twice the level 
of activation of one directed at infected RBCs. 
Introduction 
The population dynamics of organisms has long been an obsession of ecologists, and the 
potential factors that can regulate population numbers are, in theory at least, well understood. 
Within host dynamics of parasitic infections are increasingly viewed from the same perspective, 
and this approach has provided useful insight into many aspects of parasitic disease (e.g 
Gravenor et al 1995; Haydon and Woolhouse, 1997; Nowak and May, 2001). Knowledge of 
factors that limit parasite numbers offers hope of better designed treatment and intervention 
strategies (Levin, and Antia, 2001; Levin and Bull, 1996; Gravenor et al., 1998; Gravenor and 
Kwiatkowski, 1998), as well as providing information on selective forces that have moulded 
parasite life-history strategies. 
Plasmodium chabaudi is a malaria parasite that can infect laboratory mice. It has a life 
cycle typical of malarial parasites - divided between a mammalian host and mosquito vector. We 
focus on the former. Parasites infect host RBCs and undergo rounds of asexual replication. 
Infected RBCs rupture synchronously every 24 hours, releasing asexual progeny (merozoites) 
which then go on to infect new cells. This continues until the host dies, or infection is cleared. 
In the first 'acute' phase of infection, parasite numbers rise rapidly to a peak before crashing to 
very low levels. Host anaemia and weight loss, and potential mortality (Timms et a! 2001) 
accompany this. Given the importance of the early dynamics of infection for disease severity, it 
is critical to understand what factors limit parasite numbers during this phase. Three possible 
mechanisms could regulate parasite density: a shortage of RBCs to infect (c.f. bottom up 
regulation); an immune response directed at merozoites and/or infected RBCs (c.f. top down 
regulation); or a combination of both. Discriminating between these alternatives requires a 
bringing together of both theory and data, and in this paper we begin this process. 
We start by briefly reviewing results of an experiment that investigated the dynamics of 
infections of P. chabaudi in mice during which parasite and RBC densities were monitored daily 
and examined across a range of inoculation doses (Timms et al 2001). We go on to propose a 
theoretical framework in which these results can be understood, estimate key parameters, and 
examine the empirical results for evidence supporting these alternative hypotheses concerning 
regulation of infection. 
Experimental results 
Groups of mice were infected with doses ranging from 100 to one hundred million parasites. 
Two parasite clones differing in virulence were used. Parasite dynamics and morbidity measures 
(RBC density and weight) were monitored daily. 
The key results are that parasite dose affected both timing and magnitude of peak 
parasite density irrespective of strain. Despite increasing dose by six orders of magnitude, peak 
parasite density was only found to increase by 50% (Figure la); and for every order of 
magnitude that dose was increased, this peak occurred approximately one and a half days earlier 
(Figure lb). Finally, higher parasite dose also affected morbidity - inducing greater anaemia 
(Figure ic). The overall dynamics of parasite and RBC densities for a single dose treatment 
(CW lx 10) are shown in Figure 2a. 
On the day of peak parasite density, RBC densities were reduced to an average of 68% 
(s.e.= ± 3.9%) of pre-infection levels for the avirulent clone (CW), and 62% (± 2.7%) for the 
virulent clone (BC). At this time for CW and BC respectively, an average of 20% (± 1.6%) and 
39% (± 2.1%) of RBC were infected. However, for both clones, maximum anaemia typically 
occurred 3 days after this, and on average RBC densities were depressed to 42% (±2.6%)  of 
maximal levels for CW, and 19% (±1.8%) for BC. 
The model framework 
We consider the following set of equations to describe the dynamics of uninfected RBCs 
(B), infected RBCs (P), and an immune response (I). The dynamics of erythropoiesis, 
infected RBC destruction and immune activation are arguably continuous processes best 
described by differential equations: 
dB 
—=s(K–B)–v(B,P,I) 	 (1) 
dt 
V 	 (2) 
dt 
= pb(j 	 (3) 
dt 
Here K is the 'equilibrium' density of RBCs, s is the rate at which any deficit is made up, the 
function v(BPI) describes the rate at which uninfected RBCs are killed by the immune system, 
$ is a parameter that describes interaction of infected RBCs with the immune system, flu) is 
unspecified function that describes how immune systems activation depends on densities of 
parasites and current immune activation levels, and b a constant determining dependency of 
immune activation on density of infected RBCs. 
Because rupture of RBCs and release of merozoites into the blood stream is a highly 
synchronized event in P. chabaudi infections, this process is best modelled discretely. If rupture 
occurs after fixed intervals of duration z, at times iz (i = 1, 2 .... ), and iz- indicates the time 
immediately prior to rupture, and iz+ a short time after rupture then: 
P(iz+) = Tg (B, I)P(iz—) 	 ITJIII 
T is the maximum number of merozoites that are released into the blood-stream per infected 
RBC and g(B, 1) is a function on [0,1] that describes how this 'fecundity' falls with RBC density. 
We denote maximum growth R(max). 
If regulation is 'bottom-up', i.e. through availability of RBCs for infection, then analysis must 
focus on the parameters and function v(B,P,l) in Eq (1), and on the form of the function g(B,J) in 
Eq (4). In this situation we would assume that the immune response, while perhaps detectable, 
was not regulating. if regulation is 'top-down', i.e. through immune responses, attention must be 
directed at the function JP,1) in Eq (3), parameter 13 in Eq (2) and dependency of g(B, 1) on I in 
Eq (4). We denote values of variables at the time of peak parasitaemia by circumflexes (i.e. 
P, B , I, and 1), and the value of these variables immediately following inoculation to be 
P0 ,B0 and I. 
Parameter estimates 
Erythropoiesis 
By examining the rate at which RBC density increases from its lowest point, and assuming that 
by this time removal of infected RBCs (by rupture) and 'collateral' damage to the uninfected 
RBC population is small, a lower estimate on rate of replenishment can be obtained. 
Assuming v(BPI) to be small, and setting the initial condition to be equal to Birough, Eq 
(1) can be solved directly to give: 
B lrough+t  = K - e 5' (K - B trough) 	 (5) 
The equilibrium pre-infection RBC density (K) estimated independently from pre-inoculation 
data and for all mice averaged 8.98x i0 9 RBC/ml. Estimates of s were separately made for each 
clone using standard non-linear regression, and were found to be consistent across dose 
treatments (F 1 , 37 = 0.09, p = 0.80), but significantly different between clones (F 1 ,38 = 7.68, p = 
0.009): the average value of s for CW was 0.16 (s.e.= ±0.01) and for BC was 0.23 (s.e.= ±0.03). 
Thus, the percentage of RBCs replaced per day depends on the deficit. Net  daily replacement 
rates never exceeded 9% for CW infections and 16% for BC infections. Figure 2b shows an 
example the model fitted to data. 
Immune destruction of uninfected RBCs 
We estimated the ratio of number of uninfected RBCs that are destroyed by the immune system 




f v(B,l,P)dt[B1 —B +1]—F 	 (6) 
 P1 	 P1 
where i refers to sampling day. The integral represents numbers of uninfected RBCs that are 
destroyed by the immune system between day i and i+1, which can be approximated by the 
difference between those known to be lost through the infection process and the overall change 
in RBC density. This difference will be positive if the reduction in RBC density is greater than 
that accounted for by direct destruction of parasitised cells. The expression does not account for 
RBCs that may have been replenished as a result of erythropoiesis, thus this estimator represents 
a lower bound on Q i  • This method of estimating ~ is only applicable during the period of 
falling RBC density, and is unstable in the early stages of infection when counts of infected 
RBCs are low, and when sampling error in B1 indicates occasional small increases in RBC 
density about K. Figure 2c shows estimated values of Q 1 for days 3 —7 post day of first 
detection from different dose experiments. 
R(max) 
Let R, be the number of merozoites that go on to infect RBCs after the ith parasite 'generation' 
(R, :5 T). We estimated the maximum number of merozoites that can go on to infect uninfected 
RBCs, R(max), by using the maximum value of 	observed for each mouse. R(max) did not 
Pi 
differ between dose treatments (F 1 ,63 = 2.71; p = 0. 105), but did differ significantly between 
clones (F 1 , 63 =5.70 p = 0.020). The average value CW was 6.84 (s.e.= ±0.70) and for BC was 
9.03 (s.e.= ±0.64). R(max) generally occurred at the first rupture event, and in the following 
discussion it is assumed that it did. 
Predictions from the model 
Using this theoretical framework with these parameter estimates permits a rigorous examination 
of the relationship between key experimental variables when regulatory processes are dominated 
by either 'top-down' or 'bottom-up' phenomena. Comparing these predictions with experimental 
results is informative about the form of immune activation functions and those governing 
parasite resource limitation. 
Top down regulation 
Immune resources could be directed at infected RBCs, or at merozoites, or both. 
1. Immune resources directed at infected RBCs 
In this case, regulation arises through parasite killing as indicated in Eq (2), and the rate at which 
this occurs will be determined by the nature of the functionftP,l) in Eq (3) which models the rate 
of immune activation. We consider four broad classes of functions describing immune 
activation: 	= a constant, is proportional to I (b = 0), is proportional to P (b > 0), or is 
dt 
proportional to some product of! and P. It can be shown that if immune activation is of the form 
= c or 	= ci, then the timing of peak parasitaemia does not depend on dose at all, and 
dt 	dt 
the peak is directly proportional to initial dose (see appendix 1A). These predictions are 
inconsistent with experimental observations and so we reject these functional forms for immune 
activation. 
However it can be shown that for immune activation functions proportional to pb . h(I) 
(with b >0) the peak parasitaemia is equal to [constant + Po bj 1/b and timing of the peak 
becomes a decreasing function of dose (see appendix 1A). Using non-linear least squares 
regression of log peak parasitaemia on log dose, b can be estimated to be 0.44 for CW and 0.57 
for BC. Thus, we can deduce that the immune activation function must be, at least in the early 
stages of infection, proportional to parasite density. 
Initially, we estimate that R, is 7 and 9 for the CW and BC clones respectively. If each 
infected RBC actually contained T merozoites that were released into the blood stream, and the 
level of immune activation is assumed to be constant between rupture and daily sampling time, 
Eq (2) can be solved to give: P(t +,r) = P(t)e lt where r is the time interval between shortly 
after rupture and daily sampling time. Prior to immune activation (at say the first rupture event) 
P(z+) = TP(z—) and P(z +) = R 1 P(z—), and so R1 = 	and f31 0r = —In [.L]. At 
time of peak parasite density the observed reproductive rate (R,) is less than or equal to 1, and 
therefore 131,z > - In( !). Carter et a! (1975) have suggested that T is on average 10-12, thus 
with average observed R 1 values (in this case assumed to equal R,,,) of 7 and 9, we can estimate 
I 	—ln(1/T) 	 I 
the ratio - from 	 'For the CW - is likely to be somewhere between 4 and 7 
10 	—ln(R 1 IT) 10 
(depending on whether Tis 10 or 12); and for BC -p-- between 9 to 22. 
10 
If there is a threshold parasite density beneath which the immune system is not activated, 
then parasites will be able to replicate subject only to a non-specific immune response until such 
time that this threshold density is surpassed. At this time, the immune system and parasite 
'begin' their interaction at the initial values 10 and Pfhreshold, and the effect of dose variation 
beneath the threshold will be irrelevant. The small but significant rise in peak parasitaemia 
observed argues against existence of such a threshold. If there is a fixed time interval before 
which immune activation can begin (and during which the parasite population increased 
exponentially), differences in dose would be maintained and the immune system and parasite 
would begin their interaction at the initial values Jo  and constant x Po. Such a time lag cannot be 
ruled out on the basis of these data. If infections starting with higher doses were subject to some 
bottom-up control then this would ameliorate the effective differences in initial condition of 
parasite numbers. 
2. Immune resources directed at merozoites 
In this case the growth rate is regulated directly by the immune response, hence f3=0 in Eq (2), 
but g(BI) results in the immune response directly lowering its reproductive ratio. A continuous 
approximation to the dynamics might be 	= P - dP where ln(R) = b - d. As before we can
dP 
consider three basic forms for the immune response: constant, exponential, and forms of parasite 
density dependent rates of increase. We show in appendix lB that this alternative approximation 
to the parasite dynamics does not qualitatively change the behaviour of the peak or its timing 
with respect to dose compared to when immune resources are directed at infected RBCs. 
Merozoites are released synchronously at 24-hour intervals, and are widely believed to 
persist for only a few minutes in the blood stream (e.g. Ramasamy et al., 2001). If merozoite 
density w time units after rupture (w <z), denoted by M(w), is reduced by only two processes - 
immune killing, and RBC invasion - then: 
dM = —aMB -'MI 
dw 
(7) 
where M(0) = TP(iz-), and over this time-scale the immune system is regarded as a constant, I, 
which interacts with merozoites according to a mass action term governed by coefficient y. 
Dynamics of infected RBCs can be represented as: 
(8) 
with P(w = 0) = 0, and uninfected RBC's by: 
 
If immune resources are directed solely at merozoites, and infected RBCs are not removed prior 
to releasing merozoites, then the maximum density of infected RBCs, denoted P(max), will have 
occurred just prior to the ith+1 rupture event and the observed growth rate of infected RBCs as a 










B0 + I 
and thus R(i) can be estimated as: 
TB(iz—) 
R(i) 	 (12) 
B(iz —)+I 
With R(i) varying between < 1 and 7 (CW) and < 1 and 9 (BC), and if RBCs are not limiting, 
this decline must be brought about by increase in I with each sequential rupture (i.e. yl in Eq 8). 
This indicates that 	
= R 1 (T 
—1) and that with R 1 values of 7 and 9, and T of 10 to 12, 
Ic (0) B0(T—RI) 
C  would be in the range of 10 to 15 for the CW, and 20 to 50 for BC. 
1 (0) 
Bottom-up regulation 
In this case immune killing is assumed to be minimal, and infection is governed by g(BI) in Eq 
aB 
(5) which as suggested by Eq. 12, might take the form g(B, I) = 
y10 + aB 
. However, an 
obvious problem immediately becomes apparent. Since 	<0 for all RBC densities, g cannot 
be a concave function of B. Furthermore, this curve must pass through the origin. The 
experimental evidence suggests that a 40-50% decrease in RBC density results in an —80% 
decrease in R, but such a steep decline cannot be brought about by a function of the form 
g(B,I)= aB 
y1 + czB 
What, apart from an increase in immune activity, could account for the insufficiency of 
this function? It is possible that the function is structurally appropriate but that the actual density 
of RBCs available to merozoites differs from our empirical estimates of RBC density. Perhaps as 
a result of sequestration of infected RBCs in smaller blood vessels prior to rupture, and a 
consequent reduction in blood flow ('sludging'), local uninfected RBC availability is less than 
that estimated to be circulating more generally. However to bring the growth rate down to one, 
the local density would have to be at most 1/5 of observed RBC density at time of peak 
parasitaemia. 
Discussion 
We have assembled a theoretical framework with which to examine mechanisms of regulation of 
the acute phase of malaria parasitaernia. This framework is very general and sets out initially 
only to define the 'envelope' within which dynamics of regulation must reside. We use it here 
for three purposes. First, to identify and define key parameters that govern dynamics of 
variables involved in regulation. Second, to suggest ways in which some of these parameters 
might be estimated from data. And third to predict the 'signatures' of parasite dynamics that 
result from different assumptions regarding the functional form of key processes. 
Specifically, we define and quantify dynamics of RBC replacement, immune destruction 
of uninfected RBCs, and maximum growth rates of merozoites. We highlight the potential value 
of determining the number of merozoites that infected RBC release into the bloodstream in 
revealing the extent to which the immune system may be up-regulated. We proceed by 
providing direct experimental evidence that available data strongly support the notion that 
activation of immune responses must be dependent on parasite densities, and that the data is not 
readily explained solely through bottom-up regulation, as a consequence of restricted availability 
of RBCs. 
The experimental data on erythropoiesis suggests that RBCs are resupplied at a rate 
proportional to the RBC deficit. However, the rate constant differs significantly between clones. 
Anaemia was significantly greater for virulent infections (19% of uninfected levels) compared to 
avirulent infections (42% of uninfected levels), consistent with the idea that as anaemia becomes 
more acute qualitatively different means of RBC re-supply are stimulated. 
Estimates of the ratio of immune destruction of uninfected to infected RBCs are 
complicated in the early stages of infection by the slight and fluctuating estimates of anaemia, 
and in the late stages of infection by beginnings of erythropoiesis. Nonetheless, we estimate this 
ratio to be between 2 and 4, irrespective of clone. However, our method of estimation is likely 
to result in these being only lower estimates, and other methods have found higher ratios (Saul 
1998). The marked decline in our estimates of this ratio could arise because erythropoiesis masks 
the real level of destruction of uninfected RB Cs, or because the immune response changes over 
the early stages of infection (for example, the proposed switch from a predominantly type 1 T -
cell dependent response to a type 2 response suggested to occur during an infection, Taylor-
Robinson & Phillips 1994). 
Maximum growth rates are found to differ between clones. This could arise for at least 
3 different reasons. Firstly, the virulent clone may possess some feature that renders merozoites, 
or the cells they infect, less apparent to immune agents. Secondly, merozoites of the virulent 
clone may be more efficient at infecting RBCs, reducing the impact of immune responses 
directed at merozoites, and/or the reduction in RBC density. Finally, RBCs infected with the 
virulent clone may release a larger number of merozoites into the bloodstream. Given that these 
maximum growth rates are observed in the initial stages of infection when anaemia and immune 
regulation are less influential, we consider the third explanation the most likely. If regulation 
was entirely top-down, then our model predicts that the virulent clone should release about 20% 
more merozoites into the bloodstream, relative to the avirulent clone, if differences in peak 
density (Fig. la) are to be explained. This hypothesis is testable by direct observation of 
infected RBCs just prior to rupture. 
Unfortunately this analysis does not permit an inference to be made about which parasite 
life history stage immune resources are directed at. The model predicts that if immune resources 
are directed at infected RBC, the level of immune stimulation over pre-infected levels need be 
only half that compared to if immune resources are directed at merozoites. This is because every 
infected RBC taken out by the immune system is equivalent to the destruction of at least 10-12 
merozoites (and possibly more depending on the value of 7). There is evidence for protective 
immune responses directed against both merozoites (e.g. Conway et al., 2000) and infected 
RBCs (e.g. Bull et al., 1998) in malaria infections. However, as far as we are aware there is no 
current estimate of the relative importance of each in removing parasites. Measuring T is 
important since it will permit a direct estimate of the 'functional extent' of immune up-regulation, 
a quantity that is rarely estimable in terms of the direct effect of the immune system on a 
pathogen. 
Theoretical models of immune dynamics are commonplace in the literature, often resting 
on largely unsubstantiated assumptions regarding the form of immune activation and its 
dependence on pathogen density. We argue that the overall up-regulation of immune resources 
must be dependent on pathogen density. No other simple functional form accounts for the 
experimental results described. Up-regulation appears not be directly proportional to parasite 
density, but to a quantity corresponding to the square-root of parasite density (b 0.5 for both 
clones). We tentatively interpret this as suggestive of some finite immune capacity to process 
antigen, perhaps immune receptor saturation. 
Our analysis indicates that the experimental data is essentially inconsistent with a solely 
bottom-up explanation for regulation of parasitaemia. The difficulty lies in finding plausible 
explanations for the required shape of the function governing the relationship between RBC 
density and parasite growth rates. Parsimonious hypotheses suggest that this function is (at best) 
likely to appear linear, if not convex (sensu Fig. 3a), when the data requires that it be quite 
dramatically concave (Fig. 3b,c). Only with this concavity is it possible to explain an 80% 
decrease in growth rate (7 or 9 down to less than 1) with only a 40% reduction in RBC density. 
However there is some empirical evidence to suggest that bottom-up regulation may play some 
role in regulation. Mice that had had their anaemia alleviated by transfusion maintained higher 
levels of parasites than mice that were given no extra blood (Yap & Stevenson, 1994). Bottom-
up explanations for regulation become more tenable if merozoites interfere with each other's 
access to the RBC population as parasite density increases. A tenable hypothesis for such 
interference is if characteristics of blood-flow change substantially over the course of 
parasitaemia. For example, if infected RBCs sequester in narrow capillaries prior to rupture, this 
would have the effect of restricting flow of uninfected RBC through these capillaries at exactly 
the time that the parasite might most benefit from improved access to the uninfected RBC 
population. This would provide the required non-linearity between overall RBC density and 
growth rate obvious from Fig. 3b and c. However, such an effect would have to effectively 
reduce RBC density to about 20% of its actual value at time of peak parasitaemia. Clones of 
parasites that vary in their ability to sequester do not differ in their growth rate (Gilks, Walliker 
and Newbold 1990) and this suggests that local depletion due to sequestration is unlikely to play 
an important role. We are not arguing for the absence of a bottom-up role, only that regulation 
looks most unlikely to be solely bottom-up. 
Malaria infections are notoriously complicated, resulting from a complex interaction of 
many variables, heterogeneously dispersed in space (throughout the body) and time (throughout 
the course of infection). As with our understanding of many other dynamic biological systems, 
further progress will be greatly facilitated by a more intimate linking of theory and data. Such 
interplay will aid theoretical progress - in terms of shrinking the volume of parameter space 
within which infection dynamics are modelled, thereby rendering models more insightful. But 
also, in turn, such models will indicate areas in which only careful experimentation can tease 
apart competing functional forms governing interaction of relevant variables and which 
parameters are most worthy of experimental evaluation. This paper is intended as an example of 
the value of such a combined approach. 
Appendix 1 
Peak parasitaemia and dose 
Assume that the parasite population grows continuously according to the equation: 
dP =rP—flP1 
dt 
and that the initial value of P is Po, and peaks at density P when I = r / /3. 
Consider that immune resources are activated at a constant rate c, 
Thus dt = c, and starts from a baseline activation level Jo.  So 1(t) = I + Ct, the time of the 
peak is given by: = 	$jO and P=P exP[0 
/3c 	 2f3c 
Consider that immune resources are activated at an exponential rate c, 
W 	 In(r) - In( p)  - dt = ci and 1(t) = 1 exp(ct). The time of the peak is given by: - - 
cln(10
In( and 
p=p0exp( rt+ f3i (1 _ e ct ) 
C 
c) Consider immune activation functions of the form - = Pbf(J) and a parasite growth rate 
dt 
determined by the general form 	= Pg(I). Parasite density peaks at P,,, when '=J which 
dt 
satisfies (Ipak 	0. 
ldU ldP 
Substituting U = pb, gives 
bUdt Pdt 
= -- which enables rewriting the equations in the form 
1 dU 	 dl  
--- =Ug(l) and - Uf(l) Now 	
= 	
which gives 
bdt dt 	 b f(I) 
= 
1 
 UO + h(l) - h(10 ), or equivalently 
!pb ..!pb +h(l)—h(10) 
where Po and 10 are the initial values of P and I and h(l) = j g 
	
dl . Thus, peak parasitaemia 





If the dependence of the immune activation function on I is constant, f(l) = c, and 
g(I)=r—yI we obtain 'pea =- and 
y 	 c 	2 
Hence 
!pb Jpb +L(J0 _!.) 2 
b 	b ° 2c 	y 
If the dependence of the immune activation function on I is proportional to I, f(i) = ci , and 
g(i)=r—yI we obtain h(I)=--(rini—yi) and 'pea T 
C 	 V 
Hence, 
!pb _!pb y ' r In( )+I0 __ 	+—I — 	
- r 
b 	b ° cy yi 	yJ 
Timing of peak with respect to dose 
If -dI  = cPb and -dP  = rP - f3Pi then the coupled set of equations for I and P can be solved 
dt 	dt 
directly to give an expression for the time of peak, 1. Again, making the substitution 
U = Pb we obtain the pair of equations 
and 
b dt 
dl - = CU, 
dt 
which yield 
1 dU = r—fl 
b 	c 
and hence 
= --(rI — 1---)+d 	.Y_(I —2-fli +d') where d,d"are arbirtrary constants. 
b 	c 	2 	2c 	y 
We may rewrite this expression in the form 
- V 	- 	 2r U 	(I a)(I—(--a)) 
2c[ ,. 
where a = - (1 -- /) and  is given by q = 1Jd'. 
Hence, 
- 	2r 
(I a)(I—(--a)) I 
	
bdt 	2[ 
which can be integrated to give 
1 	I 	I—a 	I In 
 __________I 
= bt + k 	where k is an arbirtrary constant. 
(r—ya) I—(2r/y--a) 
At t=o, u = u0 = p0b and I=Io. Thus, 
° yb ° 	
and k= 1  1n_
10—a 
(r—ya) 1 0 —(2r/y—a) 





Peak parasitaemia and dose 
Assume that the parasite population grows continuously according to the equation: 
dt I 
and that the initial value of P is P0, and peaks at density P when I = b / d. 
Consider that immune resources are activated at a constant rate c, 
Thus 
di
- = c, and starts from a baseline activation level jo•  So 1(t) = l + Ct, the time of the 
dt 
peak is given by: 1= b—d10 and P=Poec0?hi 
cd 
If immune resources are activated at an exponential rate c. Thus 	= ci and 
dt 
1(t) = I exp(ct). The time of the peak is I = 1n[_.]c_1 but the peak remains of the 
form P = Poe co'  t. 
Consider immune activation functions of the form 	= 	f(i). Using the result from 
dt 
part c) of Appendix 1A we obtain the expression 
!pb!pb 
b "• 	b 	
+h(ipe)h(io) 
where g(I)=k_d, I eak = and h(I)=f ' di. I f  
Appendix 1  
Assume the dynamics of merozoites M, infected RBCs P and uninfected RBCs B, at time w 
after rupture can be represented by 
dB dM 
= —c/MB - yMI, 	= —ciMB and 	= cxMB 
cit 	 dt 	 cit 
where I is assumed to be a constant immune response. Dividing the equations for M and B gives 
dB 	a  
which on integration yields 
M =B+- In B+MO —B 0 —-1nB 0 
where M0 and B0 are the densities of merozoites and uninfected RBCs at w=O. We wish to 
determine the density of uninfected RBCs, B, when all the merozoites have either occupied 
RBCs or been removed by the imune system. Setting M=O we obtain 
M 0  =B0 _B_&1n-. 
a 	I3 
01. 
Setting B0 - B = AB gives, 
M 0 =AB—-1n(1 
a 	BO 
Thus, for AB much less than B0 , we obtain 
M 0 = LB - (_ AB ) 	
2 
a B0 B0 
IC 
ie M 0 &8(1+--- 
aBO 
Since the maximum number of infected RB Cs, P(max) is equal to the reduction in uninfected 





Figure 1. The effect of dose on (a) maximum parasite density, and (b) the timing of maximum 
parasite density for BC- (circle) and CW-infected (square) mice. Lines are the least squares 
regressions from the minimal models, which contained log dose and clone in (a) and log dose 
only in (b). Data from all mice in the second block are included. The least squares slopes (± s.e.) 
and p values for log dose are: (a) 0.085 ± 0.03, p<0.01 (b) —0.27 ± 0.08, p<0.001; (c) The effect 
of dose on logio minimum red blood cell densities for BC- (circle) and CW-infected (square) 
mice. Lines are the least squares regressions from the minimal model, which contained log dose 
and clone. Data from the surviving mice in the second block are included. The least squares 
slopes (± s.e.) and p values for log dose are: -0.02 ± 0.008, p.<0.05. 
Figure 2. (a) The relationship between the timing of peak parasite density and minimum red 
blood cell density. The data shown are for the avirulent clone (CW) and the lx 102  dose 
treatment in the second block. These data are representative of the general pattern seen across 
other dose treatments with both clones. The lines represent the mean of 5 mice; (b) The 
dynamics of erythropoiesis. Data are shown for a typical mouse infected with the CW clone. 
Points show the actual red blood cell density measured and the line shows the fitted values from 
a model of the form BOU8h+, = K - e_st (K - Birough) (see text for details). For the data shown, 
the estimated values of s and K are 0.13 and 8.91x10 9 respectively. The model fits the data well 
(R2 = 0.92), and this is typical of most mice; (c) The ratio of uninfected : infected RBC 
eliminated by the immune system (Q ) as deduced using Eq 6 for the ith day post date of first 
detection of parasitaemia. 
Figure 3. The dynamics of bottom-up infection, a) The function Tg(B,I) is anticipated to define 
a curve that is either convex (emboldened upper curve) or appear almost linear (emboldened 
straight line). However, neither shape can explain the required change in the growth rate from 
R,,, (of 7 or 9) to < 1, which occurs with only a 40% change in RBC density (down to 5-6 x 109 
cells ml- '). b) A plot showing the corresponding empirical overlay to a) with observed growth 
rates and associated RBC densities of the virulent clone (BC) plotted by dose and joined by a 
line reflecting the temporal order in which they were observed (one measurement per day). c) 
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The effect of parasite dose on disease severity in the 
rodent malaria Plasmodium chabaudi 
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SUMMARY 
Experiments were designed to look at the relationship between infective dose and disease severity using 2 clones of 
Plasmodium chabaudi that differ in virulence. We asked whether there were dose—severity relationships, whether clone 
differences in virulence were maintained over a range of doses, and whether disease severity could be accounted for by 
parasite dynamics. Groups of mice were infected with parasite doses differing by an order of magnitude, ranging from 100 
to 1 x 108 parasites. Infective dose affected the probability of death, but only with the more virulent clone. Dose also 
affected morbidity. For both clones, higher doses induced greater anaemia. Larger doses caused greater weight loss, but 
only for infections with the more virulent clone. Here, for a given dose, mice lost a fixed amount of weight, irrespective 
of their initial weight. Larger doses induced earlier mortality and morbidity than did lower dose treatments. Finally, dose 
affected parasite dynamics, with earlier and higher peak parasite densities in larger dose infections. All these effects were 
small relative to clone differences in disease severity, which were apparent across the range of doses. Dose effects were 
manifested through the timing and/or magnitude of peak parasite densities, broadly supporting the idea that dose affects 
disease severity by altering the time the host has to control parasite densities and ameliorate the effects of parasites. We 
discuss the possible efficacy of intervention strategies aimed at reducing human disease severity by reducing infective 
parasite dose. 
Key words: dose, disease severity, malaria, virulence, Plasmodium chabaudi. 
INTRODUCTION 
The clinical outcome of malaria infection in humans 
is highly variable. Some people harbour malaria 
parasites and show no symptoms, while others die 
rapidly. Many factors may influence this outcome, 
and one candidate is the inoculating dose of parasites 
(Greenwood, Marsh & Snow, 1991; Marsh, 1992). 
Dose might affect disease severity by altering the 
time available for hosts to mount a defensive 
response before parasite loads cause clinical disease 
(Marsh, 1992). Alternatively, lower doses could 
cause less severe disease by giving the host more time 
to ameliorate the effects of parasites, rather than just 
control their densities. For example, the host can, to 
some extent, offset red blood cell (RBC) destruction 
by increasing erythropoiesis. 
The prevailing view that dose and severity are 
positively related has been largely encouraged by 
indirect evidence (e.g. Snow et al. 1988; Alonso et al. 
1991; Greenwood et al. 1991; Bermejo & Veeken, 
1992; Marsh, 1992), which may have other inter-
pretations (Glynn, Lines & Bradley, 1994). Direct 
data on the impact of infecting dose on severity of 
malarial disease in humans are ambiguous. Glynn 
(1994) has systematically reviewed the medical 
Corresponding author. Tel: +44(0)131 650 5506. Fax: 
+44 (0) 131 650 6564. E-mail: a.read@ed.ac.uk  
literature on artificially-induced malaria infections, 
including malaria therapy administered to neuro-
syphilis patients. No strong, consistent relationships 
were found: a few studies suggested a positive 
relationship between dose and severity (variably 
measured as duration of illness, experience of chills, 
type and number of fevers, relapse rates, or whether 
the patient made a spontaneous recovery), but many 
found no effect (see also Glynn & Bradley, 1995 a, b; 
Glynn et al. 1995). There are also problems with 
estimating dose in many of these studies which make 
it difficult to draw unequivocal conclusions (Glynn, 
1994). For instance, in mosquito-induced infections, 
dose is often equated with bite rates, which is true 
only if all mosquitoes are equally infected and 
transmit the same dose of sporozoites. 
Experiments have also been performed in birds, 
monkeys and rodents (see references in Glynn, 
1994), but most concentrate on how dose affects the 
time-course of infection (of pre-patent period or 
death usually). The only studies of which we are 
aware that report relevant data do not explicitly test 
for a dose—severity relationship, or they involve con-
founding factors (Coggeshall, 1937; Hewitt, 1942; 
Hewitt, Richardson & Seager, 1942; Ferraroni 
1983). 
Here, we report the results of a controlled 
experiment designed to look at the relationship 
between dose and disease severity using 2 clones of 
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Plasmodium chabaudi chabaudi known to differ in 
virulence. We ask (i) whether there are dose—severity 
relationships, (ii) whether clone differences in viru-
lence are maintained over a range of doses, and (iii) 
whether the severity of disease can be accounted for 
in terms of the time hosts have to develop responses 
capable of controlling infection. 
MATERIALS AND METHODS 
Parasitology 
Two cloned lines of the rodent malaria parasite, P. c. 
chabaudi, were used to infect 7-week-old female C57 
b16J mice (Harlan, England and B&K Universal, 
England). The 2 clones, CW and BC, were obtained 
from different isolates collected in the Central 
African Republic in 1969 and 1970 from their natural 
hosts ( Thamnomys rutilans) and were stored in liquid 
nitrogen until cloning (Mackinnon & Read, 1999). 
BC infections peak at higher parasite densities and 
induce greater weight loss and anaemia than CW 
infections (Mackinnon & Read, 1999). 
Mice were fed on 41B maintenance diet (Harlan, 
England). Drinking water was supplemented with 
005 % para-amino benzoic acid to enhance parasite 
growth (Jacobs,  1964). Artificial light was provided 
from 0530 h until 1730 h. 
Parasite densities were estimated from the pro-
portion of RBCs infected (calculated from a 
Giemsa's-stained thin blood smear) and the number 
of RBCs per ml of blood (counted using flow 
cytometry: Coulter Electronics"). Blood sampling 
and measurements of body weight (to the nearest 
001 g) were carried out daily between 15.00 h and 
19.00 h. 
Experimental design 
Mice were weighed and allocated at random to 
treatment groups. Within each treatment group, 
groups of 5 mice were infected with I x 102,  1 x 10, 
1 x 10, 1 x 106,  1 x 10, or 1 x 108  parasitized RBCs 
of either clone CW or clone BC. The whole 
experiment was replicated in a second block that also 
contained an additional dose treatment of 1 x 10 
parasitized RBCs for each clone. Thus, with 1 
uninfected control group in each block, there were 
13 groups in the first block (a total of 65 animals) and 
15 groups in the second block (a total of 75 animals). 
In the second block, 1 animal from the CW 1 x 10 6 
treatment unexpectedly died on the day after 
infection, and 2 animals, one from each of the CW 
I x 10 and I x 10 treatments, failed to develop 
patent parasitaemias. Data from these 3 mice were 
excluded from the analyses. 
To administer an exact dose of parasites in a fixed 
volume of liquid, the appropriate volume of infected 
blood from the donor mice was diluted in a solution  
of calf serum-Ringers (50% heat-inactivated calf 
serum; 45% Ringers solution (27 mm KCL, 27 mm 
CaC1 2 , and 0- 15 M NaC1); 5% heparin (20 units/ml 
Ringers)). Each infection was initiated with an 
intraperitoneal injection of Oi ml of this solution. 
Control mice received the same volume of uninfected 
calf serum-Ringers. 
Disease severity was measured in terms of mor-
tality and morbidity. From surviving mice, acute 
and chronic morbidity measures were estimated: 
minimum weight and RBC density, and average 
weight and RBC density (from day —4 to 35 p.i. for 
average weight and RBC in block 1 and, in block 2, 
from day —1 to 35 for average weight, and day 0 to 
40 for average RBC). 
Statistical analyses 
Mortality data were analysed using binary logistic 
regression. Only the data from surviving mice were 
included in the morbidity analyses,.and these were 
analysed using general linear models (Crawley, 
1993). Maximal models were fitted first and, be-
ginning with higher order interactions, non-
significant terms were, sequentially removed in a 
process of backward eliminatin to generate minimal 
models. 
( Fitted terms in the maximal models included dose 
(specified as a covariate), block and clone (factors), 
and all linear interactions between factors and 
covariates. In addition, pre-infection RBC density or 
body weight was fitted as a covariate to control for 
initial differences' between mice. - - 
Minimal models frequently had akly significant, 
biologically uninteresting higher order interactions, 
usually involving block and/or clone. These inter-
actions involved quantitative but not qualitative 
differences between blocks. To simplify the analysis, 
we report the results of separate models for each 
clone. All P-values reported for significant terms are 
from the appropriate minimal models and P-values 
for non-significant terms are from the step at which 
they were removed. Our comparison of clone 
differences in dose—severity relationships is based on 
the approximate 95 % confidence intervals of the 
slopes (taken as twice their standard errors). 
In most cases there were significant differences 
between the 2 experimental blocks because both 
parasite clones were more virulent in the second 
block (possibly because they had been through 2 
additional mice passages). In the current context, 
block main effects are of little interest in their own 
right, and so only significant interactions between 
block and other model terms are reported. 
Infective dose was logarithmically transformed to 
reduce the levering effects of the highest dose 
treatment, and because this transformation 
linearized any relationships with virulence. In no 
cases did log 10 dose fitted as a quadratic or cubic term 
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Fig. 1. The effects of dose on (A) the timing of mortality and (B) the mortality rate for BC-infected mice. In (A) 
points shown are the mean per treatment (±s.n.) and the line is the least-squares regression from the minimal model 
which contains log dose only. Slope±s.a. = — 114±013, n = 37 mice. In (B) points are the proportion of mice from 
the 2 blocks that died in each dose treatment (±s.E.  calculated using the formula /([p(l —p)]/n), where p = 
proportion that died), and the line is from logistic regression (see text for further details). 
significantly improve model fit. Two of the 3 RBC 
densities (minimum RBC density and day-1 p.i. 
RBC density, but not average RBC density) were 
also log transformed to satisfy the assumptions of the 
statistical models. 
For each infection, the growth rate of the parasite 
population on day t was calculated by subtracting the 
log parasite density on day t from the log parasite 
density on day t+1 (McCallum, 1999). Thus, the 
daily growth rate is the number of new, infected 
RBCs produced by a single parasite after 24 h. The 
maximum parasite growth rate for all mice (including 
those that died) was used in the analyses and usually 
occurred on the first or second day that parasites 
were detected (parasite growth rates were not 
different in mice that died or survived). Similarly, 
data from all mice were used for analyses of  
maximum parasite density. Mice that died had 
higher maximum parasite densities (mean parasite 
densityx 109/ml±s.E.: survivors = 15±006, dead 
= 24±009; F1, 121 = 79, P <0001), but excluding 
them from the relevant analyses would only serve to 
strengthen our conclusions. The total number of 
parasites produced in infections, obtained by sum-
ming the daily parasite densities from days 1 to 23 p.i. 
in the first block and days 1 to 16 p.i. in the second, 
was calculated for surviving mice only. 
RESULTS 
Mortality 
About half of the mice infected with parasites of 









R. Tjrnjns and others 



















0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 
E 	2.5 




- 4_10A 6  
(fl O5 
—B-10"7 
. 41- .10A8 
Ix 
!11 . x 0I01  
0. Mr—rod 
day post-infection 
Fig. 2. For legend see facing page. 
1 CW-infected mouse died. Among BC-infected 	Mortality rates also increased with inoculating dose 
mice, death occurred about a day earlier for every (Fig. 1 B, x2 = 455 D.F. = 1, P<005). However, 
10-fold increase in inoculating dose (Fig. 1A). 	dose only explains a small amount of the variation in 
4 
BC 









0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 
D 6 
.$ ---U--.  
4 	 .a 










1 	2 	3 	4 	5 	6 	7 	8 	9 	10 	11 	12 	13 	14 	15 	16 
day post-infection 
Fig. 2. Mean daily RBC densities (A and B), changes in weight (C and D) and parasite densities (E and F) for mice 
infected with parasite clone CW (A, C and E) or BC (B, D and F) for each dose treatment in the second experimental 
block. Each line represents the mean of the mice in the dose treatment. Initially there were 5 mice per group, but 
subsequently numbers were reduced where mice died. For example, in (D) the 10 treatment contains only I mouse 
from day 7 onwards. 
R. Timms and others 	 6 
the probability of death (around 7%), and this result 
is highly sensitive to the 2 extreme dose treatments 
(10 and 100 million parasites). When either of these 
were removed, dose no longer explained a significant 
amount of variation in death rates (P> 02). 
Morbidity 
The infection kinetics, RBC dynamics and patterns 
of weight change in one experimental block are 
illustrated in Fig. 2; the dynamics were qualitatively 
similar in the other block. BC infections grew faster 
(mean number of new infected RBCs produced by a 
single parasite ±S.E.: BC = 736±105; CW = 
507±106, F1121 = 242, P < ftOOl), reached higher 
parasite densities (F,,,,=90-8, P <0-001),  and 
generated more parasites over the whole infection 
(F181 = 264, P < 0001) than did infections with 
clone CW. BC also induced greater maximum weight 
loss and more anaemia (Fig. 2). The same patterns 
were also found for average weights and RBC 
densities p.i. (data not shown). 
Dose had a substantial impact on the time-course 
of infections (Figs 2 and 3). For both clones, 
maximum parasite densities, anaemias and weight 
losses occurred later in infections initiated with 
fewer parasites. Overall, this delay was around 1 day 
for every 10-fold decrease in dose (Fig. 3). 
Dose also had an effect on morbidity (Fig. 4). For 
both clones, mice inoculated with more parasites 
were more anaemic (Figs 2A, B and 4A; Table 1). 
Once initial weight was controlled for, dose affected 
minimum weight, but only for the more virulent 
clone (BC). Here, mice lost about a third of a gram 
more for every 10-fold increase in inoculum size 
(Figs 2D and 4B; Table 1). Within a dose treatment, 
mice lost a fixed amount of weight, irrespective 
of their initial' weight (F 183 = 106, P < 0001, 
slope ±s.E. = 096±009). The administered dose of 
CW had no effect on either the minimum weight or 
the average weight of mice, even allowing for initial 
mouse weight (Figs 2C and 4B; Table 1). 
Dose had an effect on parasite dynamics. The total 
number of parasites produced in infections was 
greater in high dose treatments for clone CW (Table 
1), and bigger inoculating doses led to greater peak 
parasite densities for both clones (Figs 2E, F and 
4C; Table 1). Nevertheless, it is striking that 
variation in dose across 6 orders of magnitude 
generates peak densities that differed by substantially 
less than I order of magnitude. Parasite population 
growth rates early in the infections were unrelated to 
inoculating dose (Table 1). 
In summary, inoculating dose affected morbidity 
as measured by maximum anaemia and weight loss. 
But bigger doses also led to earlier and higher peak 
parasite densities. In order to investigate whether 
dose affected morbidity independently of its effects  
on parasite dynamics, we incorporated peak parasite 
density and the timing of peak parasite density into 
models relating dose with anaemia or weight loss. 
Once peak parasite density, and the timing of it, 
had been controlled for, there was no independent 
effect of dose on morbidity. Similarly, there were no 
independent effects of parasite dynamics on mor-
bidity when dose was controlled for, with one 
exception: peak parasite density independently 
affected minimum RBC density of CW-infected 
mice (F155 = 296, P < 0001). However, peak para-
site density and the timing'of it are highly correlated, 
making it hard to disentangle their, effects. Thus, 
dose affects morbidity only through its effects on the 
timing and/or magnitude of peak parasite density (or 
variables highly correlated to these). 
DISCUSSION 
Fatal infections were common for only 1 of the 2 
clones used in these experiments (BC), but there, 
inoculating dose affected the probability of death 
(Fig. 113). Dose also had an impact on morbidity. 
Anaemia was greater among mice given larger 
infective doses of'either clone (Fig. 4A). Larger 
doses also led to greater weight loss', but only for 
infections with the more virulent clone (Fig. 413). 
Dose also affected the timing of morbidity, with 
maximum anaemia and weight loss occurring earlier 
in infections initiated with larger doses (Figs 3A 
and B). Death, where it occurred, was also earlier in 
the higher dose treatments (Fig. 1A). Finally, 
inoculating dose affected parasite dynamics, with 
earlier and higher peak parasite densities in larger 
dose infections (Figs 3C and 4C). In so far as death, 
anaemia and weight loss are measures of disease 
severity, we have thus demonstrated positive dose—
severity relationships. As far as we are aware, these 
are the first controlled experimental demonstrations 
of these relationships in mammalian Plasmodium. 
The 2 clones used in this study, CW and BC, were 
chosen because they were known to differ in 
virulence (Mackinnon & Read, 1999). This 
difference was also evident in our experiments: BC 
was more often lethal and induced greater anaemia 
and weight loss. The clone difference is, at least in 
part, because BC populations grow more rapidly (see 
Results section), and achieve higher parasite 
densities than do CW (Mackinnon & Read, 1999). 
That earlier work (Mackinnon & Read, 1999) 
involved infections initiated with 10, 10, and 10 6 
parasites in different experiments, with the onset of 
symptoms being earlier in the experiments involving 
larger doses. The experiments we report here 
confirm that the dose effects on the timing of 
symptoms reported there were not due to uncon-
trolled confounding variables across experiments. 
They are also consistent with the widespread finding 
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Fig. 3. The effect of dose on the timing of (A) minimum RBC density, (B) minimum weight and (C) maximum 
parasite density, for BC- (—s--) and CW-infected (--D--)  mice. Lines are the least squares regressions from 
separate minimal models for each clone. Only data from surviving mice are included. In (A) the numbers in 
parentheses represent the number of mice the means represent, and are the same for Figs 313, C and 4A, B. The least 
squares slopes (±s.E.)  and P values for log dose from models controlling for block are: (A) BC: —099±016, 
P<O001; CW: —148±0083, P<0OO1;(B)BC: — O76±Oi 7 , P<0001; CW: —132±016, P<0001; (C)BC: 
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Fig. 4. The effect of dose on (A) minimum RBC density, (B) minimum weight and (C) maximum parasite density, 
for BC- (-s-) and CW-infected (--Li--) mice. Lines are the least squares regressions from separate minimal 
models for each clone, except for (B). Here, to produce the figure, maximum weight and block were included in the 
first model for BC and CW simultaneously (to correct for initial body size and block), and the residuals from this 
model were then run against log dose and clone. Thus, the fitted values come from the same model. Only data from 
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Table 1. The effects of inoculating dose on morbidity and parasite 
densities 
(Tabulated values are least squares slopes (±s.E.) from models controlling for 
block, and incorporating the relevant covariate (initial weight or RBC density) if 
present in the minimal model (shown as 
BC CW 
Minimum RBC density -0-039+0-01*** -0-023 ± 0006*** 
(log (RBC x 10/ml)) 
Average RBC density _0.13±0.04** _0090±0.02*** 
(RBC x 10 9/ml) 
Minimum weight (g) _038±009*** —0084±007 N.S. f 
Average weight (g) —011±006 N.S. 0032±005 N.S. f 
Maximum parasite density 0076±002** 0.14±0.03***t 
(parasites x 10 9 /ml) 
Total number of parasites 0-18+0-1 N.S. 070±009 
(parasites x 10 9 /ml) 
Initial parasite population —0026±003 N.S. f 00026±002 N.S. 
growth rates. 
Significant block x dose interaction, but the relationship between dose and the 
relevant variable is in the same direction in each block. * P < 005, ** P < 001, 
*** P <0001. 
N.S., Not significant. 
from several other studies that larger doses lead to 
earlier symptoms (for example, Hewitt et al. 1942; 
Cox, 1966; Glynn, 1994). 
For most of our measures of morbidity, timing of 
morbidity and parasite dynamics, the form of any 
relationship with dose is quantitatively similar for 
the 2 clones (comparing the slopes of the relation-
ships given in Fig. 3 and Table 1 for the 2 clones). 
The relative virulence of the 2 clones is unaltered by 
dose and the more virulent clone is always more 
virulent. Thus, an avirulent clone cannot be trans-
formed into a virulent clone by simply giving it a 
numerical boost early in the infection. Models of the 
evolution of virulence (for reviews see Ewald, 1983; 
Bull, 1994; Levin & Bull, 1994; Read, 1994; Frank, 
1996) assume that virulence phenotypes are at least 
partly determined by heritable genetic parasite 
variation on which selection can act. Substantially 
more complex models would be required if the 
relative virulence of strains is qualitatively altered at 
different doses, and/or if the severity of disease rose 
with dose and hence the force of infection. The 
broad picture which emerges from our experiments 
is that, at least to a first approximation, the implicit 
assumption that infective dose is irrelevant to 
evolutionary models of virulence is probably justi-
fied. We are currently exploring the effects of dose 
on transmissibility. 
It has been postulated that dose may affect the 
severity of disease by altering the time the host has to  
control parasite density before it reaches a clinical 
disease threshold (Marsh, 1992). In the particular 
scenario sketched out by Marsh (his Fig. 5), he 
envisages a set time-interval before an immune 
response can be activated, and implicitly assumes 
this response will control parasite growth after a 
further fixed delay. This hypothesis generates 2 
testable predictions. First, that peak parasite density 
will increase with increasing dose, and second that 
across dose treatments, all parasite peaks will occur 
on the same day. 
Our results support the first of these, but there is 
no support for the second: the timing of peak 
parasite density was not constant, and instead 
occurred later with decreasing dose. Nevertheless, 
our data do bolster the idea that dose effects are 
dependent on parasite dynamics if the assumption of 
a fixed time-interval from immune activation to 
parasite control is relaxed. 
The timing of peak parasite density across treat-
ments is consistent with the suggestion made by Cox 
& Millott (1984) that, for P. vinckei, parasite-
controlling mechanisms are triggered at a fixed 
threshold level. However, if the speed of this 
response, once activated, was similar across dose 
treatments, then one would expect peak parasite 
densities to be of similar magnitudes. Our data 
suggest that this is not the case, and something more 
complex must be involved. We are currently ex-
ploring theoretical models that can account for the 
surviving mice were included in the analyses for (A) and (B), and each point represents the mean (± s.a.) with sample 
sizes as shown in Fig. 3(A). For (C) data from all mice (including those that died) were used - see Materials and 
Methods section for sample sizes. 
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dual effects of dose on the timing and magnitude of 
peak parasite density. 
The effect of dose appears to be manifested 
through the timing and magnitude of peak parasite 
density: higher dose treatments have earlier and 
higher parasite densities, which cause greater mor-
bidity. This implies that there is a per parasite effect 
of virulence, because more parasites cause greater 
morbidity. It also suggests that the number of 
parasites that mice are initially exposed to are 
secondary to how much time they have to mount a 
defensive immune response which can temper para-
site growth. This might be because having more time 
to mount an immune response allows the host to 
reallocate resources that aid this response, and help 
to minimize the damage that parasites can potentially 
cause. For example, experiencing RBC destruction 
induces erythropoiesis. If this is stimulated before 
too many RBCs are destroyed (i.e. when there are 
few parasites causing it), then the host might be 
better able to withstand the parasitic assault on 
RBCs. However, if hosts experience high parasite 
densities before they can mobilize these processes, 
then the damage they endure could be more 
devastating. 
The different dose treatments in this experiment 
cover 6 orders of magnitude. However, the effects of 
dose on mortality were highly sensitive to the 2 
extreme dose treatments (100 and 1 x 10  parasites), 
and overall, dose accounted for just 7% of the 
probability of death. And while the effects of dose on 
morbidity are statistically highly significant, dose 
explains only 20 % of the between-mouse variation 
in anaemia for both clones, and just '10% of weight 
loss for the most virulent clone. These effects are 
small in comparison to those caused by clone 
differences. 
In the field, it is extremely unlikely that naturally 
infected hosts experience this range of inoculating 
doses. The average number of P. falciparum sporo-
zoites transmitted is typically less than 25 
(Rosenberg et al. 1990; Beier, 1993), and more than 
1000 has never been observed (Beier et al. 1991; 
Lines & Armstrong, 1992). Liver schizonts produce 
up to 30000 merozoites (Garnham, 1966). Thus, a 
biologically realistic dose of merozoites released into 
the blood from a single infective bite is in the region 
of between 1 x 105  and 1 x 10 6 , and exceptionally 
1 x 10. If only these treatments are considered, then 
dose has no effect on the severity of disease (P> 05 
in all cases). 
However, the differences in disease severity for the 
1 x 105 and 1 x 106  treatments predicted from our 
regression lines (fitted across our full range of doses) 
are rather small (for instance, a 10% difference in 
mortality and minimum RBC density). If these 
differences did exist, we would almost certainly not 
detect them, given the within-group variability we 
observed and our sample sizes: standard power  
calculations (Armitage & Berry, 1987) show that we 
had a < 8% probability of detecting such differ-
ences. Indeed, in excess of 100 mice would be 
needed to afford an 80 % chance of detecting such 
differences as significant. Nonetheless, differences of 
these magnitudes, which would also not be statisti-
cally significant in small clinical trials, could be 
biologically significant given the world-wide malarial 
disease burden: interventions capable of achieving a 
10% reduction in mortality are highly desirable. To 
the extent that the results of our experiments across 
a large range of doses extrapolate to mosquito-
induced human infections, our data provide grounds 
for believing that interventions that reduce infective 
dose will have an effect on the subsequent severity of 
disease. 
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